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ABSTRACT 
 
Trisomies 18 and 13 are rare genetic conditions (occurring around 1 in 6,000 and 10,000 
newborns respectively) which are caused by an extra copy of either chromosome 18 or 13, 
similar to trisomy 21 (Down syndrome). The only known risk factor for these syndromes is 
maternal age, however previous cluster analyses have linked trisomy risk to a number of 
alternate factors, including radiation exposure and infection. 
Cases of trisomies 18 and 13 from the National Down Syndrome Cytogenetic Register (NDSCR) 
were scanned for temporal and spatial clusters throughout England and Wales between 2004 
and 2010. No temporal clusters were detected, however there were multiple significant spatial 
clusters detected for both trisomies in London. These clusters were likely caused by advanced 
maternal age in the region, and it is also possible that regional differences in gestational age at 
the time of prenatal screening could have contributed to these clusters. 
In order to account for maternal age and gestational age at diagnosis, a novel method was 
developed in R to directly weight cases based on these factors. Applying weights to cases 
directly allowed both factors to be simultaneously accounted for by multiplying weights 
together. This method was evaluated using synthetic data and compared with an alternate 
method in the widely used program SaTScan. Both programs returned similar results when the 
weighting method was mild, but when extreme weights were applied at random significant 
clusters were observed in SaTScan but not in R. 
The NDSCR data was weighted and then rescanned for spatial clusters in both programs. No 
evidence of clustering was detected using the novel method, while SaTScan returned multiple 
highly significant clusters. These findings, combined with those obtained using the synthetic 
data, indicate that the novel method produces more reliable results than SaTScan when 
extreme adjustment is applied.  
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GLOSSARY OF TERMS 
 
Amniocentesis – Medical procedure used to prenatally diagnose congenital anomalies. 
Chorionic villus sampling (CVS) – Medical procedure used to prenatally diagnose congenital 
anomalies. 
Congenital anomaly – A medical condition that a baby has at birth. 
Government office region (GOR) – Administrative region of government in the United 
Kingdom. 
National Down Syndrome Cytogenetic Register (NDSCR) – Congenital anomaly register 
collecting all cytogenetically diagnosed cases of trisomies 21, 18 and 13 in England and Wales. 
Primary care trust (PCT) – Administrative region of the National Health Service (NHS) in the 
United Kingdom. 
R – Freely available programming language and software environment for statistical computing 
and graphics. 
SaTScan – Freely available software for the analysis of spatial, temporal or spatio-temporal 
data. 
Stata – Statistical software package. 
Trisomy – Chromosomal disorder characterised by the presence of a third copy of a particular 
chromosome. 
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Chapter 1: Introduction 
 
Cluster detection in biosurveillance is a useful tool for discovering new risk factors and 
improving the overall understanding of medical conditions. Previous cluster analyses of 
trisomy 21 cases have suggested the possibility of several environmental factors which may 
increase a woman’s risk of having an affected pregnancy. The only confirmed risk factor for all 
3 trisomy syndromes is maternal age. Since mean maternal age is currently increasing in 
England and Wales and varies geographically, the detection of age-independent clusters of 
trisomies 18 and 13 will require cluster detection methods which adjust for maternal age. The 
presence of clusters after adjusting for maternal age could indicate the involvement of 
alternate risk factors. 
 
In this thesis, trisomy 18 and trisomy 13 data from the National Down Syndrome Cytogenetic 
Register (NDSCR) between 2004 and 2010 were scanned for temporal and spatial clusters 
using commonly used cluster detection methods developed and proposed in the mid 
1990s.The main focus of this thesis is the development of a novel weighting method to 
statistically account for maternal age, the strongest trisomy risk factor. The method is also 
used to account for gestational age at diagnosis, which is not a risk factor but may still 
contribute to the formation of spatial clusters. This novel weighting method is compared with 
a corresponding adjustment technique in SaTScan, a freely available piece of software for the 
detection of temporal and spatial disease clusters. Comparison between the novel method and 
SaTScan is performed in spatial cluster analyses using both synthetic data and observed data 
from the NDSCR.  
In the remainder of chapter 1, a general introduction to Edwards and Patau syndromes is 
presented, along with a review of previously reported trisomy clusters. Finally, an overview of 
cluster detection methods is presented. 
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Section 1.1: Epidemiology and Aetiology of Edwards and Patau Syndromes 
 
Edwards Syndrome (trisomy 18) and Patau Syndrome (trisomy 13) are, along with Down 
Syndrome (trisomy 21), the only viable autosomal trisomies in humans (Edwards et al1960, 
Patau et al 1960, Lejeune et al 1959). The word “trisomy” is given to a genetic condition which 
is caused by the presence of either a whole or part of a third copy of a chromosome (in 
humans), while “autosomal” means that the affected chromosome is one of the numbered 
autosomes (1-22), not one of the sex chromosomes X and Y.  
While it is estimated that 1-2% of human conceptions are affected with triploidy, most are 
aborted at the very early stages of pregnancy resulting in all triploid conditions being rare in 
live borns. The severity of a trisomy increases as the amount of genetic material on the 
affected chromosome increases, as a result of which only 3 autosomal trisomies are capable of 
surviving to term. These are, in order of least to most severe, trisomies 21, 18 and 13.  
Recently reported fetal loss rates in England and Wales between the time of amniocentesis (18 
weeks) and birth are 65% for trisomy 18 and 42% for trisomy 13 (Morris & Savva 2008). These 
figures compare with 25% for trisomy 21 (Savva et al2010), and around 2% in the general 
population between 14 weeks and term (Rodeck & Whittle 2008).  
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Section 1.1.1: Trisomy 21 (Down Syndrome) 
 
 
Figure 1.1.1.Common visible symptoms of trisomy 21. 
 
Trisomy 21 occurs about 1 in every 800 live births and is the most common trisomy in humans. 
Individuals with trisomy 21 can often be identified by their facial features, while other 
common symptoms include intellectual disability, poor muscle tone, short neck and reduced 
growth. Cardiac defects are present in around 40% of trisomy 21 cases (Freeman et al, 1998). 
Some common visible symptoms of trisomy 21 are shown in figure 1.1.1. 
Data from the NDSCR Annual Report in England and Wales in 2009 reported that 62% of 
trisomy 21 cases were prenatally diagnosed, consisting of 76% terminations, 5% births, 3% 
stillbirths and 16% are awaiting outcome. 6% of cases with unknown outcome are expected to 
result in a live birth. The remaining 38% of cases were diagnosed post natally, consisting of 
96% live births and 4% were stillbirths. 
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Section 1.1.2: Trisomy 18 (Edwards Syndrome) 
 
 
Figure 1.1.2.Common visible symptoms of trisomy 18. 
 
Trisomy 18 occurs about 1 in every 3,000 live births and is the 2nd most common trisomy in 
humans. There are a wide range of symptoms, including heart defects, kidney problems, 
digestive tract defects, small jaw, small head, excess amniotic fluid, severe developmental 
delays and delayed growth. There is strong evidence that trisomy 18 is more lethal in males, 
with female live born survival rates up to double those of males (Niedrist et al, 2006). Some 
common visible symptoms of trisomy 18 are shown in figure 1.1.1. 
Data from the NDSCR Annual Report in 2009 reported that 91% of trisomy 18 cases were 
prenatally diagnosed, of which 74% were terminations, 2% live births, 7% were stillbirths and 
17% are awaiting outcome. 3% of cases with unknown outcome are expected to result in a live 
birth. The remaining 9% of cases were diagnosed post natally, consisting of 65% live births and 
35% stillbirths.  
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Section 1.1.3: Trisomy 13 (Patau Syndrome) 
 
 
Figure 1.1.3.Common visible symptoms of trisomy 13. 
 
Trisomy 13 occurs about 1 in every 16,000 live births and is the 3rd most common trisomy in 
humans. Common symptoms include heart defects, brain or spinal cord abnormalities, very 
small or poorly developed eyes (microphthalmia), extra fingers and/or toes, an opening in the 
lip (a cleft lip) with or without an opening in the roof of the mouth (a cleft palate), and weak 
muscle tone (hypotonia). Some common visible symptoms of trisomy 13 are shown in figure 
1.1.1. 
The NDSCR Annual Report in 2009 showed that there were too few trisomy 13 cases to present 
outcomes according to time of diagnosis, but that 66% were terminated, 12% were live born, 
7% stillborn and 15% are awaiting outcome, of which 4% are expected to result in a live birth.  
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Section 1.1.4. Survival After Birth 
 
Many studies examining survival of trisomies 18 and 13 have focused on survival after birth, 
where both trisomies also exhibit very low survival rates. Tables 1 and 2 show reported 
survival percentages for trisomy 18 (table 1.1.1) and trisomy 13 (table 1.1.2) from numerous 
studies carried out around the world. In each table the top row shows the primary author on 
the report, while the second row shows the year of publication.  
Survival of trisomy 18 live borns was reported between 60 and 98% after a day according to 
the studies in table 1, with this figure falling to around 30-55% according to most studies after 
a week. All studies reported less than 10% survival at 1 year of age. Survival for trisomy 13 was 
comparable, with studies reporting between 69 and 92% survival after a day and 38 – 72% 
after a week. All studies reported less than 10% survival after a year with the exception of 
Magenis et al in 1967, who found that 12% of trisomy 13 live borns were still alive after a year. 
For trisomy 18 live borns, the reported median survival was most commonly between 3 and 6 
days with 3 studies (Irving et al 2011, Vendola et al 2010, and Nembhard et al 2001) not 
providing a median survival time and 2 studies (Weber, 19j67 and Rasmussen et al, 2003) 
reporting greater than 10 days life expectancy. The Weber paper in 1967 noted that females 
with trisomy 18 were more likely to survive for longer than affected males, and presented 
survival estimates for each gender individually. Probability of survival for male trisomy 18 
cases was reported to be 0.638 at 2 months, while the study estimated that the likelihood of 
affected females to survive to 2 months was 0.769, to 6 months was 0.311 and to 3 years was 
0.175. These survival estimates are much greater than those in more recent studies. One 
possible explanation for this is that some of these cases were incorrectly diagnosed and were 
actually cases of trisomy 21, which has a much longer life expectancy. Cases in this study were 
obtained from 9 previously published studies of trisomy 18 mortality and survival, and 
personal communication to the author. It is possible that some of these cases were incorrectly 
diagnosed, or that the studies used to ascertain cases were biased in favour of longer surviving 
cases. 
The Rasmussen study in 2003 also reported a longer life expectancy (14.5 days) than any of the 
other recent estimates. This study collected liveborn cytogenetically confirmed cases from the 
Metropolitan Atlanta Congenital Defects Program (MACDP) between 1968 and 1999. Again, it 
is possible that either cases were incorrectly diagnosed or that there was a form of bias 
present in favour of longer surviving cases, as the median survival time in this study was more 
than double the next highest estimate (excluding the Weber study in 1967). 
Recent median survival estimates for trisomy 13 live borns were more varied; falling within 2-
10 days according to those studies which provided median survival estimates. This is likely due 
21 
 
to scarcity of data making it difficult to accurately estimate survival. The study by Magenis et al 
in 1968 estimated a much longer median survival of between 30 and 60 days. This study used 
data from the laboratory at the University of Oregon medical school, cases from previously 
published literature, and through direct communication with cytogenetic laboratories around 
the world. Similarly to the 1967 Weber study into trisomy 18 survival, it is possible that either 
some of the cases were misdiagnosed or that some of the studies used to ascertain cases were 
biased in favour of longer surviving cases. 
In congenital anomaly studies, prevalence (the total number of cases in the population at a 
given time point) is studied rather than incidence (the total number of ‘new’ cases in the 
population at any given time point). This is because is it not possible to ascertain all ‘new’ 
cases as a proportion of affected pregnancies will miscarry before diagnosis is possible. There 
is also no population estimate of the total number of pregnancies at risk due to miscarriages 
and terminations. Therefore, prevalence estimates are provided for congenital anomalies per 
1,000 or 10,000 total births (live births and stillbirths).  
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Table 1.1.1. % Survival of trisomy 18 live borns. 
 
  Weber Carter Goldstein Root Embleton Nembhard Brewer Rasmussen Lin Niedrist Vendola Irving 
Year 1967 1985 1988 1994 1996 2001 2002 2003 2006 2006 2010 2011 
Cases 192 43 76 64 34 68 84 114 39 161 140 67 
1 day 98 60 60 86 70 84 88 86 95 68 - - 
1 week 89 35 44 45 - 56 43 63 46 40 52 36 
1 month 72 11 21 34 15 40 25 39 16 22 30 27 
6 months 13 5 3 9 - - - 11 3 9 - - 
1 year 8 4 - 5 0 - 2 8 3 6 3 6 
Median 
(days) 70 5 6 4 3 - 6 14.5 6 4 - - 
 
 
Table 1.1.2. % Survival of trisomy 13 live borns. 
 
  Magenis Goldstein Wyllie Nembhard Brewer Rasmussen Lin Vendola Irving 
Year 1968 1988 1994 2001 2002 2003 2007 2010 2011 
Cases 172 76 16 27 84 114 28 200 30 
1 day 92 77 69 85 75 86 89 - - 
1 week 72 40 38 59 50 56 61 42 43 
1 month 56 23 13 44 28 30 29 20 30 
6 months 20 10 0 - - 11 7 - - 
1 year 12 - 0 - 3 9 4 3 3 
Median 
(days) 30-60 2.5 4 - 8.5 7 9 - - 
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Section 1.1.5: Trisomy Screening Procedures 
 
Screening is defined by the National Down’s Syndrome Screening Programme for England as “a 
public health service in which members of a defined population, who do not necessarily 
perceive they are at risk of, or are already affected by a disease or its complications, are asked 
a question or offered a test to identify those individuals who are more likely to be helped than 
harmed by further tests or treatments to reduce the risk of disease or its complications” 
(National Down’s Syndrome Screening Programme for England Handbook for Staff, 2004). 
Prenatal diagnosis of a trisomy requires a sample of foetal DNA, taken via invasive methods 
which present a small risk of miscarriage to the developing foetus. In order to minimise the 
number of such procedures performed, mothers are screened using a variety of non-invasive 
measures which assess the risk of the foetus being affected with a trisomy. Only those 
pregnancies at high risk (e.g. a risk of ≥ 1 in 250, Wald et al 1999) are then diagnosed using an 
invasive method. Although these tests are primarily designed for use in prenatally screening 
for trisomy 21, they are also effective in detecting trisomies 18 and 13. The UK National 
Screening Committee recommends that all pregnant women are offered trisomy 21 screening 
(UK National Screening Committee Annual Report 2010-11), and as such, all 3 trisomies are 
routinely screened for in England and Wales. 
Screening can be performed in the first and second trimesters. One commonly used screening 
method is to measure the concentrations of maternal blood markers which are present in 
different quantities in affected compared to unaffected pregnancies. In the first trimester, 
levels of free (beta) human chorionic gonadotrophin (hCG) and pregnancy-associated plasma 
protein A (PAPP-A) can be measured, and combined with the ultrasonic measurement of 
nuchal translucency to give the trisomy combined test (Nicolaides et al 1992). Fluid at the nape 
of the neck of the fetus is measured (in mm) in the nuchal translucency scan, which can be 
performed between 11 and 14 weeks. In trisomic foetuses, the nuchal translucency is expected 
to be greater than in unaffected foetuses. However, the reliability of the nuchal translucency 
measurement has led to questions about whether first or second trimester screening is 
preferable (Wald et al 1999).  
Second trimester blood markers used in screening are maternal serum alpha-seroprotein 
(MSAFP, Dimaio et al), unconjugated estriol (uE3), human chorionic gonadotrophin (hCG) and 
inhibin-A (INH-A). Measurements of MSAFP, uE3 and hCG can be combined with maternal age 
to make the triple test, which becomes a quadruple test when INH-A is added (Benn 2002). It is 
possible to combine blood marker results from the first and second trimesters to make up the 
trisomy integrated test (Wald et al 1999). 
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During the study period, the quality of screening in England and Wales improved. In 2004, the 
National Down’s Syndrome Screening Programme for England Handbook for Staff 
recommended that by 2004/05, screening programmes should be able to detect at least 60% 
of cases with a false positive rate of 5% or less. Programmes which met these requirements 
were the quadruple test which measures the level of 4 different hormones in maternal blood, 
and the serum integrated test which measures the level of 5 different hormones in maternal 
blood across the first and second trimesters of pregnancy. 
They also recommended that by 2007 screening programmes should offer a detection rate of 
greater than 75% with a false positive rate of less than 3%. Programmes meeting these 
requirements were the combined test (detailed above), and the integrated test which 
combines the NT measurement with the age of the mother, gestational age of the foetus, and 
level of 5 pregnancy hormones in both the first and second trimester. The integrated test 
performs better than the combined test, however the integrated test takes longer to perform 
due to measuring second trimester blood markers (the integrated test is ideally carried out at 
15-16 weeks of pregnancy rather than 11-13 weeks for the combined test). The big jump in 
performance between 2004 and 2007 was made possible by the more widespread uptake of 
the nuchal translucency scan. The National Screening Committee 2010-11 Annual Report 
recommended that the preferred test from 2007-2010 where available was the combined test.  
 
After screening, high risk pregnancies can be diagnosed using either amniocentesis or CVS. In 
an amniocentesis, a small amount of fluid is taken from the amniotic sac surrounding the fetus, 
while in a CVS a sample of cells is taken from chorionic villi on the placenta. Amniocenteces are 
generally performed between 15 and 20 weeks, compared to 10-12 weeks for CVS. However, 
early amniocenteses may be performed between 11 and 13 weeks at higher risk to the fetus. 
Performing invasive diagnostic tests carries a small risk of miscarriage, so it is important to only 
test those pregnancies which are at high risk (Wilson et al 1998, Rhoads et al 1989). A recent 
11 year national registry study in Denmark (Tabor et al 2009)  estimated that after performing 
an amniocentesis or CVS, 1.4% and 1.9% of unaffected foetuses respectively were lost. 
However, in future it may be that diagnosis can also be performed using noninvasive methods. 
In 2012 Zimmermann et al reported the development of a noninvasive diagnostic test to 
detect aneuploidy of chromosomes 21, 18, 13, X and Y. Cell-free fetal DNA was analysed using 
11,000 genetic markers on the 5 previously mentioned chromosomes, and the result was that 
145 out of 166 individuals in the study were correctly diagnosed (the remaining 21 were 
excluded after failing a DNA quality test). Successful adoption of this technique would allow 
foetuses to be safely diagnosed without any additional risk of miscarriage as a result of the 
test. 
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Section 1.1.6: Genetic Mechanisms 
 
Human trisomies are caused by errors in cell division which result in there being a whole or 
part of an extra chromosome in the cells of an affected individual. There are two types of cell 
division in humans; mitosis which is the production of two identical daughter cells from a 
single parent cell, and meiosis which is the production of four unique daughter cells from a 
single parent cell. Errors in either mitosis or meiosis can result in a trisomy. Mitosis is used by 
somatic cells (all cells in the body other than those producing sex cells) for growth and repair, 
while meiosis is used only by reproductive cells to produce gametes (sex cells). The human 
chromosome number is two, meaning that somatic cells in the human body are diploid 
(contain two copies of each chromosome). During the fertilisation process of sexual 
reproduction two gametes fuse and combine their DNA, so gametes contain half of the 
number of each chromosome in somatic cells and are referred to as haploid cells. 
 
Figure 1.1.4.The key difference between mitosis and meiosis. 
 
Figure 1.1.4 shows that meiosis initially follows the same steps as mitosis, but then has an 
additional cell division to halve the chromosome number. Both processes begin with a cycle of 
DNA replication to give each daughter cell the same number of chromosomes as the parent. 
The production of four daughter cells in meiosis allows for a greater degree of genetic 
variation in future generations, enabling adaptation and eventually evolution. 
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Figure 1.1.5.The 4 key stages of mitosis. 
http://www.accessexcellence.org/RC/VL/GG/mitosis.php 
 
Figure 1.1.5 shows two chromosomes going through mitosis. Suppose the larger chromosome 
is chromosome 1 and the smaller is chromosome 2. Similarly, let the red chromosomes be 
those inherited from the mother and the blue chromosomes be those inherited from the 
father. When DNA replicates before cell division it does so by creating sister chromatids, which 
are identical copies of every chromosome. Therefore at the start of mitosis there are actually 4 
copies of each chromosome in the cell; 2 from the mother and 2 from the father. The sister 
chromatids are pulled to opposite ends of the cell, so that at the end of the cycle the daughter 
cells each have 1 maternal and 1 paternal copy of each chromosome, identical to the parent 
cell. 
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Figure 1.1.6.The key stages of meiosis. 
http://www.accessexcellence.org/RC/VL/GG/meiosis.php 
 
Figure 1.1.6 shows two chromosomes going through meiosis using the same stages as seen in 
mitosis. Again, suppose the larger chromosome is chromosome 1, the smaller is chromosome 
2, red is maternally inherited and blue is paternally inherited. In meiosis, homologous 
chromosomes are separated in the first stage of cell division. This means that rather than 1 
copy each of the maternal and paternal chromosomes, the daughter cells inherit both copies 
of either the maternal or paternal chromosome. This helps to ensure that the 4 daughter cells 
are all genetically unique. 
 28 
 
 
The reason that the majority of trisomy cases arise due to errors in meiosis is that an error 
during gamete production will be present in all offspring cells if that gamete is involved in 
fertilisation. Errors later in development will result in only a fraction of the cells being affected. 
 
 
Figure 1.1.7.Two types of nondisjunction in meiosis. 
 
The most common mechanism which can lead to a trisomy is nondisjunction, which literally 
means “not coming apart” and refers to pairs of chromosomes not separating properly during 
cell division. This problem largely occurs during meiosis and results in gametes having either 1 
copy too many or 1 copy too few of one or more chromosomes. In meiosis there are two 
possible stages of nondisjunction, both of which are shown in figure 1.1.7. A nondisjunction in 
the first stage of meiosis will result in two gametes with one too many chromosomes and two 
gametes with one too few, while a nondisjunction in the second stage of meiosis will result in 
two normal gametes and one each with one extra and one missing chromosome. 
Nondisjunction during meiosis 1 accounts for around 96% of trisomy 21 cases, with 88% due to 
maternal (from the mother) nondisjunction and 8% due to paternal (from the father) 
nondisjunction (Nicolaidis& Petersen 1998), and it is reasonable to assume similar figures for 
trisomies 18 and 13. Mitotic nondisjuncture events during early embryonic development will 
result in some of the foetus’ cells being affected with a trisomy and some being unaffected. 
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Individuals carrying a mixture of affected and unaffected cells are called genetic mosaics. How 
early this process occurs determines the proportion of affected cells (Fishler& Koch, 1991). 
The next most common mechanism is translocation, in which a partial trisomy can occur due 
to a chromosomal translocation where the long arm (q) of chromosome 18 (for example) is 
attached to another chromosome (often 14) and vice versa. An individual carrying this will 
appear normal as there are still only two copies of chromosomes 18 and 14, but any offspring 
who inherit this translocation will be affected by the trisomy. One variation of this process is a 
Robertson translocation, in which the two long arms of chromosomes fuse, losing the two 
short arms. Common Robertsonian translocations are limited to chromosomes 13, 14, 15, 21 
and 22, as the short arms (p) of these chromosomes do not contain necessary genetic material 
(chromosomes with very small p arms are referred to as acrocentric). Around 1/3 of all 
Robertsonian translocations are between chromosomes 13 and 14.  
Finally, in very rare events part of the chromosome can be duplicated, resulting in a partial 
trisomy. The severity and effects of the condition depend on how large the duplicated section 
was and which genes it contained.  
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Section 1.2: Risk Factors 
 
Section 1.2.1: Maternal Age 
 
Trisomies 21, 18 and 13 have one consistent risk factor, which is increasing maternal age (Hook 
1981, Hassold& Jacobs 1984). This association is so strong that it was noticed in 1933 
(Penrose), 25 years before it was discovered that Down Syndrome was caused by trisomy 21 
(Hassold& Hunt 2001).  
In 2010, Savvaet al reported the age specific risks of having a pregnancy affected with trisomy 
18 or 13 (age specific trisomy 21 risk was reported by Savvaet al, 2006). The observed 
prevalence figures they obtained are shown in figures 1.2.1, 1.2.2 and 1.2.3 for trisomy 21, 18 
and 13 respectively. 
 
 
Figure 1.2.1.The age specific risk of having a pregnancy affected with trisomy 21. 
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Figure 1.2.2.The age specific risk of having a pregnancy affected with trisomy 18. 
 
 
Figure 1.2.3.The age specific risk of having a pregnancy affected with trisomy 13. 
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Figures 1.2.1, 1.2.2 and 1.2.3 all show that the age specific risk of a trisomy stays low until 
about the age of 30, when it begins to increase. At the age of 35 the graphs become steeper, 
with the risk increasing rapidly until the age of around 45, when the graphs start to flatten out 
and the risk increases more slowly. All three graphs look similar, showing the scale of the 
maternal age effect. A woman aged 45 is around 40 times more likely to have a pregnancy 
affected with either trisomy 18 or trisomy 21 and around 20 times more likely to have a 
pregnancy affected with trisomy 13 than a woman aged 25.  
 
There have been a variety of mechanisms proposed to explain how maternal age increases a 
woman’s risk of having a pregnancy affected by a trisomy (Hassold& Jacobs 1984). The 
simplest mechanism is that, as a woman ages, cellular components which control DNA 
segregation weaken, increasing the likelihood of a nondisjunction event (Jones 2008). The two 
most likely components which degrade over time are: 
• The protein complex controlling cohesion between homologous chromosomes in cell 
division, which is formed during initial egg production and must remain functional 
decades later. An error with this complex could result either in chromosomes not 
lining up properly in the centre of the cell or chromosomes not segregating when 
being pulled to opposite ends of the cell. The latter will result in a nondisjunction 
event like that seen in figure 1.1.7. In 2004 Revenkovaet al demonstrated that 
mutation of the meiosis-specific cohesion complex component SMC1β in mice made 
both sexes sterile. However, in 2005 Hodges et al reported that the genetic material 
present in the eggs of the mutant female mice changed over time. As DNA takes the 
form of pairs of homologous chromosomes when meiosis is arrested, examining the 
proportion of DNA in this form in eggs of different ages reflects the effect of maternal 
age in humans. At 1 month old, 98.8% of chromosomes in eggs of the mutant mice 
were present as pairs of homologous chromosomes, while at 2 months old this 
number had dropped to just 35% (in healthy control mice 100% of chromosomes were 
present as pairs of homologous chromosomes at 6 months old, decreasing to 98.8% at 
9 months old). This decease suggests that proteins involved in cohesion deteriorate 
over time and need to be replaced, a function which the mutant mice were unable to 
perform. Similar deterioration in humans could result in pairs of homologous 
chromosomes failing to properly segregate and the incorrect production of gametes. 
• The spindle assembly checkpoint (SAC) which alerts the cell to any problems when 
chromosomes line up along the centre of the cell. When this system functions 
properly, any improper alignment of chromosomes is detected and cell division halted 
until the chromosomes align properly. In 2001, Steuerwaldet al used quantitative 
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analysis to show that the concentration of two genes believed to be involved in this 
checkpoint (MAD2 and BUB1) was reduced in older women, which could lead to a 
failure in the meiotic checkpoint system and cells carrying the incorrect number of 
chromosomes being allowed to continue through meiosis.  
 
In 1996, Lamb et al proposed a “Two hit” model for trisomy 21, theorising that two separate 
events are required to result in an age-dependant trisomy. The first was the age-independant 
establishment of a poorly recombined pair of homologous chromosomes during meiosis 1, and 
the second was the inability of the cell to detect this failure, allowing chromosomes to 
segregate incorrectly when dividing. As decades elapse between the two stages, the second 
stage is highly age dependant, and allows for the reduction in concentration of cell cycle 
components or the failure of cohesive units as previously described. 
In 2010, Hultenet al proposed the Oocyte Mosaicism Selection Model (OMS). Rather than the 
risk of nondisjunction increasing over time, this model suggests that a proportion of oocytes 
(immature egg cells in women) carry a trisomy when they are first produced. The affected 
oocytes develop more slowly than unaffected oocytes, so that over time the proportion of 
affected oocytes increases as more unaffected oocytes are lost. As this proportion increases so 
does the probability of one of the affected oocytes being released and subsequently fertilised, 
leading to a trisomic pregnancy. Figure 1.2.4 shows the theorised proportions of both types of 
oocyte over time. This model is particularly interesting because it accounts for the trisomy risk 
levelling out at the age of about 45, which other models do not explain. 
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Figure 1.2.4. The Oocyte Mosaicism Selection Model (Hultenet al, 2010). The red line marked 
T21 oocytes represents the number of oocytes carrying trisomy 21, while the line marked DS 
shows Down Syndrome prevalence. 
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Section 1.2.2: Ionising Radiation 
 
Besides maternal age, the most commonly linked risk factor to the human trisomies is ionising 
radiation. The opportunity to first study the relationship between radiation and DNA damage 
arose in 1945 during the second world war when the United States of America conducted 
atomic bombings of the cities of Hiroshima and Nagasaki in Japan. In Hiroshima, approximately 
70,000 people in were killed directly as a result of the bombing, but a further 20,000 – 96,000 
died by the end of 1945, and some estimates state that as many as 200,000 had died as a 
result of the immediate and long-term effects of the blast by 1950. Those who died in the 
aftermath of the bombings died from a variety of conditions, including burns, cancer and 
radiation poisoning. Those who survived exhibited similar symptoms, and it was believed that 
the radiation they had been exposed to had affected their DNA structure in some way. In the 
early 1960s there were reports linking DNA mutations to ionising radiation from X-Rays and 
nuclear reactors, and a few years later the same results were found amongst survivors of the 
atomic bombings. 
In 1966 Bloom et al reported that among 94 exposed survivors of the bombings (51 from 
Hiroshima and 43 from Nagasaki) and 94 matched controls who were all under 30 years old at 
the time of the atomic bombings, complex chromosomal abnormalities (either breaks in 
chromosomes or large scale chromosomal rearrangements) were found in 0.6% of cells of the 
exposed and 0.01% cells of the controls. A year later Bloom et al presented similar findings 
among those over 30 years old at the time on the bombings, using 77 heavily exposed 
survivors of the atomic bombings and 80 controls. The second report showed complex 
chromosome aberrations in 61% of the exposed cases and 16% of the controls. Among these 
individuals, the abnormalities were found in 1.5% of cells in the cases and 0.3% of cells in the 
controls. In 1971 Awa et al demonstrated that the frequency of cells with radiation-induced 
chromosome damage was proportional to radiation dose. These findings were important in 
establishing a link between ionising radiation and chromosomal damage, and in the future this 
would lead to investigations into how radiation exposure affected a woman’s chance of having 
a pregnancy affected by a trisomy. However, due to the high mortality rates in the aftermath 
of the bombings there were not enough babies born in affected areas of Japan in the following 
years to investigate radiation as a risk factor for the trisomy syndromes.  
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Chernobyl 
 
On April 26th 1986, the disaster at the Chernobyl nuclear power plant sent a plume of 
radioactive fallout into the air. This plume drifted over large parts of Eastern Europe, 
contaminating most of Europe. Most severely affected were Belarus, Ukraine and parts of 
Russia, as shown in figure 1.2.5. As ionising radiation was a known mutagen by this time, this 
disaster gave investigators a chance to examine the proposed link between ionising radiation 
and Down syndrome. Any increase in the prevalence of Down syndrome could occur in the 
short term when radiation levels were highest or in the long term after prolonged radiation 
exposure. 
The map below shows the distribution of radiation around Europe from Caesium-137 in the 
aftermath of the Chernobyl disaster. Particularly high levels of radioactive fallout can be seen 
in the countries neighbouring the Ukraine, as well as parts of the Scandinavian countries, 
South Germany and Austria. Caesium-137 was first created during atomic weapons testing and 
does not occur naturally (Okumura2003), and has been found to be lethal when injected into 
Beagles (Redman et al 1972). 
 
 
Figure 1.2.5. Map of fallout levels from Chernobyl.  
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Reports were published from different areas of Europe throughout the 1990s indicating 
clusters of Down Syndrome in early 1987, although the authors of these all noted that the 
increase could not be definitely linked to Chernobyl. In 1994 Ericson and Kallen reported that 
more exposed areas of Sweden (those with at least 5 kBq/m2) showed a Down syndrome risk 
ratio of 1.47 (95% CI 1.01 – 2.14) in 1987, falling to 1.08 in 1988 and 1.00 in 1989. Analysing 
only the most severely affected areas (those with at least 30 kBq/m2 of radiation), the relative 
risk rose to 1.61 (95% CI 0.80 – 3.24), but the reduced number of cases led to wider confidence 
intervals and the result was not statistically significant.  
A similar finding was reported by Ramsay et al in 1991, showing that there were more Down 
Syndrome cases in the Lothian region of Scotland in 1987 than any other year between 1978 
and 1989 (26 cases in 1987 compared to the next highest annual total of 15 in 1986 and 1988). 
This increase was significant when compared to the mean from the whole time period (p < 
0.001). It was interesting to note that in Scotland, the most severe increase in Down syndrome 
risk was observed in mothers aged 35 or older, suggesting that cells in older women are the 
most susceptible to radiation damage. However, the authors of this study believe that the 
levels of ionising radiation in Scotland from Chernobyl were too low to cause any extra cases of 
trisomy 21, stating that a greater understanding is needed of the effects of low level radiation 
exposures. 
There were also two important studies carried out in Germany. The first was in Berlin 
(Sperlinget al, 1994) and showed that in January 1987 there was a Down Syndrome prevalence 
of 6.8 per 1,000 live births, a large increase from the usual prevalence of 1.56 per 1,000 births. 
The second was in Bavaria (Burkart et al, 1997), and showed that the Down Syndrome 
prevalence peaked in December 1986 at 2.45 per 1,000 births compared to the usual rate of 
0.94 per 1,000 births. The Berlin cluster could be due to Chernobyl radiation as it took place 
exactly 9 months after the disaster. The same cannot be said of the Bavaria cluster because it 
occurred a month too early, and the monthly Down Syndrome prevalence figures for the 
region show similarly sized peaks earlier in 1986 and in 1985. The Burkart paper also reported 
that the Chernobyl radiation in Germany was at a low level and would be expected to affect 
fewer than 0.5% of foetal cells. This would suggest that radiation is not the cause of the 
observed cluster in Bavaria, and instead this could merely be the result of random variation in 
the monthly Down syndrome prevalence. 
In 2007, Zatsepin et al published an article showing Down Syndrome time-clustering in Belarus 
in January 1987. The close proximity of Belarus to Chernobyl meant that large parts of the 
country were exposed to high levels of ionising radiation in the short term and low levels in the 
long term, so it is an ideal place to see if there is a link between radiation and Down Syndrome. 
They reported that in January 1987 there was a statistically significant cluster of 26 cases 
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observed compared to 9.84 expected (observed: expected ratio of 2.64; 95% CI 1.72-3.76), 
however there were no apparent long term effects and in February 1987 the prevalence had 
returned to usual levels. The Down syndrome prevalence during January 1987 was 
substantially larger than during any other month between 1981 and 1992, and the highest 
prevalence was observed in the most contaminated areas.  
Table 1.2.1 shows the time and place of all 5 of these significant trisomy 21 clusters, with 
observed and expected numbers of Down syndrome births. Expected Down syndrome figures 
were reported in each article, and were calculated based on the previously observed Down 
syndrome prevalence and the number of births in the specified time period. The locations of 
each cluster are then shown in figure 1.2.6. These results stand to date as the strongest 
evidence of a trisomy risk factor besides maternal age. 
 
Table 1.2.1. Comparison of studies of Down Syndrome clusters due to Chernobyl radiation. 
 
    DS Infants  
Reference Year Cluster Time Location Observed Expected O/E 
Ericsen 1994 1987 Sweden 30 15.87 1.89 
Ramsay 1991 1987 Scotland 26 11.22 2.32 
Sperling 1994 Jan-87 Berlin 12 2.75 4.36 
Burkart 1997 Dec-86 Bavaria 10 4.4 2.27 
Zatsepin 2007 Jan-87 Belarus 26 9.84 2.64 
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Figure 1.2.6. Map of Europe showing potential trisomy 21 clusters arising due to Chernobyl 
radiation. The red outlined areas denote clusters observed in January 1987, the blue shaded 
area denotes a cluster observed in December 1986 and the solid red circle is the location of 
Chernobyl. 
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Semipalatinsk 
 
Between 1949 and 1989, the Soviet Union performed 456 nuclear tests at the Semipalatinsk 
test site in North East Kazakhstan. The location of this site is shown in figure 1.2.7. These tests 
were comprised of atmospheric and surface explosions from 1949-1963, and underground 
tests from 1963-1989. Since the testing was ceased in 1989, the population of the irradiated 
zone has been a unique resource in terms of examining the effects of radiation on the body. 
 
 
Figure 1.2.7. Map of Kazakhstan showing the Semipalatinsk nuclear test site. The test site is the 
red shaded area, and is of a similar size to Wales. Map taken from 
http://www.spiegel.de/international/world/0,1518,741679,00.html 
 
In 2003, Abil’dinova et al studied 149 individuals who were born and had permanently lived in 
the irradiated zone, and reported that the frequency of mutated cells in this group was 1.7-3.0 
times higher than that in an unexposed control group. The authors also noted that the highest 
mutation rates were observed in cases born in the irradiated zone before 1960, as this was 
when air and surface nuclear tests were still being performed. A similar study was carried out 
in 2002 by Svyatova et al, which demonstrated that populations exposed to higher levels of 
radiation displayed higher mutation rates. There was a statistically significant increase in the 
mutation rate from a population at low radiation exposure to a population at very high 
exposure. 
These findings were followed by an article in 2002 by Dubrova et al, who compared 40 three-
generation families inhabiting rural areas around the nuclear test site with 28 three-generation 
families from a geographically similar (but non-irradiated) region of Kazakhstan. It was 
reported that 85% of the effective radiation dose for the case families was attributable to four 
surface explosions in 1949, 1951, 1953 and 1956. These shall henceforth be referred to as 
major events. Amongst parents in the first generation, who were living in the irradiated zones 
for all four of the major events, there was a statistically significant 1.8-fold rise in the cell 
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mutation rate. Among the second generation, some of whom were born after the four major 
events had occurred, the rise in mutation rate had decreased to 1.5-fold (but remained 
statistically significant). Among those born after 1960, when the major events had already 
occurred (air and surface testing stopped altogether in 1963), there was no significant rise 
above the mutation rate among the control group. These findings suggest that long term, low 
level radiation exposure does not cause significant DNA damage, which in turn could mean 
that the Down Syndrome prevalence would be expected to be no higher than unexposed areas 
of Kazakhstan. 
These findings suggest that if there was ever an increase in Down Syndrome prevalence in the 
irradiated region, it would have occurred in the most heavily exposed zones between 1949 and 
1960. However, it was only discovered in 1958 that Down Syndrome was caused by trisomy 21, 
and without cytogenetic technology it could have been very difficult for doctors in the region 
to accurately diagnose Down Syndrome among the other congenital anomalies and 
malformations that affected newborns. Information regarding Down Syndrome prevalence is 
therefore very scarce, but a technical report for the United States Defence Threat Reduction 
Agency (Balmukhanov et al, 2006) was published that referenced an article from 1993 
(Kuderinov et al) which studied 490 children born to permanent residents of a highly 
contaminated area around the test site and estimated a Down Syndrome prevalence of 12%. 
There is no more information available as the original article cannot be located. The same 
technical report also reported Down Syndrome prevalence in two other highly contaminated 
areas in 1995 as 1 case in 408 births and 1 case in 653 births. This prevalence is roughly double 
that in England and Wales in 2010 (Morris, NDSCR Annual Report 2010), but such small 
numbers cannot be relied upon as accurate evidence. In 2006, Chebotarev et al reported that 
the Down Syndrome prevalence in Semipalatinsk between 1979 and 1996 was 0.11%, only 
slightly higher than that in England and Wales in 2010. There may have been an increased 
Down Syndrome rate in Semipalatinsk due to the nuclear tests, but information is both scarce 
and unreliable.  
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Other Radiation Studies 
 
Chernobyl fallout is not the only proposed link between ionising radiation and Down 
syndrome. In 1995, Bound et al examined data from Lancashire in the North West of England 
between 1957 and 1991 for trisomy 21 clusters, and discovered a strong peak among cases 
conceived between October 1962 and November 1964. During this time period, the Down 
syndrome prevalence rose from 0.0012 to 0.0031 (p = 0.01). A secondary peak in late 1958 was 
found to be non-significant (p = 0.1). Neither of these peaks was due to a change in maternal 
age. These clusters are interesting because they coincide with high levels of atmospheric 
radiation in the sample area due to the testing of atomic weapons, the maximum level of 
which occurred between 1963 and 1964, with the next highest level in 1958. Graphs showing 
the coinciding peaks of Down syndrome prevalence and radiation levels are shown in figures 
1.2.8 and 1.2.9. 
 
 
Figure 1.2.8. Prevalence of Down Syndrome cases by year. LMP stands for last menstrual 
period. 
 43 
 
 
 
Figure 1.2.9.Estimated dose equivalents of radiation from weapons fallout. 
 
A study carried out by Verger in 1997 examined the link between ionising radiation and Down 
syndrome prevalence in two zones of Southern India, one with high levels of naturally 
occurring radiation (14 to 28 mSv per yr) and a control area with much lower levels of radiation 
(0.9 mSv per yr). There was no significant difference between the two areas in terms of age 
and sex distribution, mean maternal age, mean family size and abortion rate. The high 
radiation zone had a trisomy 21 prevalence of 0.9% among 12,918 persons compared to the 
control zone which reported no trisomy 21 cases among 5,938 persons. For comparison, the 
region of Madras in Southern India has a Down syndrome prevalence of 0.26%. Verger also 
compared the rate of chromosomal aberrations (anomaly type and cell not specified) between 
46 exposed subjects and 39 controls, and found that the mean frequency of aberrations was 
significantly higher in exposed individuals (1.9 ± 3.1 vs. 0.2 ± 0.6, p < 0.01).  
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These results, along with those from the Chernobyl based research, provide strong evidence 
that trisomy 21 (and by association, trisomies 18 and 13) is associated with high levels of 
atmospheric radiation. Exposure to ionising radiation from accidents, such as Chernobyl, are 
believed to pose only a very small additional risk for many potential mothers, but for those 
living in areas with high levels of natural or artificial radiation this may be sufficient to greatly 
increase their risk of having a pregnancy affected by a trisomy.  
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Section 1.2.3: Other Explanations 
 
Ionising radiation has been investigated extensively with regard to Down syndrome, but there 
have been very few other risk factors proposed. In 2008, McNally et al examined data taken 
from the Northern Region of England between 1985 and 2003 for space-time clustering in 
trisomies 13, 18 and 21, finding statistically significant evidence of trisomy 21 clustering only. 
This study used both a fixed boundary approach (cluster scans take place using a set of pre-
selected critical distances) and a nearest neighbour approach (uses distance between pre-
selected numbers of individuals rather than fixed distances, and included 1084 cases of 
trisomy 21, 240 cases of trisomy 18 and 116 cases of trisomy 13. Cases of trisomy 21 were 
found to cluster in more densely populated areas (p = 0.01 by geographical distance and p = 
0.02 by nearest neighbour), whereas there was insufficient evidence of clustering in either 
trisomy 18(p = 0.37 and p = 0.06, respectively) or trisomy 13(p = 0.57 and p = 0.19, 
respectively). Investigators hypothesised that transient environmental factors, such as an 
infectious agent, might explain these study findings. The theory of an infectious agent, which 
can be spread more easily in areas of high population density, is consistent with the finding 
that clustering of trisomy 21 was associated with cases from more densely populated areas 
and is a plausible (and potentially replicable) explanation of this result. 
 
There have also been several trisomy clusters recorded with no hypothesised risk factor. These 
were observed clusters which did not use any specialised statistical methodology to identify 
them. In 2000, Dean et al reported a trisomy 21 cluster in offspring of former pupils of a girls’ 
school in Ireland in 1956-57. There were 387 live births to such women, amongst which were 6 
cases of trisomy 21 compared to 0.69 expected (p < 10-4). 5 of these births were to women 
under the age of 30, compared with 0.15 expected (p < 10-6). The cluster was confined to that 
particular year group at that school only, with no increase seen either in the surrounding area 
of Ireland or in other schools. It was suggested that an influenza epidemic or contamination 
from a nearby nuclear reactor fire could be responsible (both of which occurred in October 
1957), but 3 of the women had left the school and moved away by the time the accident 
occured (while another of the cases arose due to an error after fertilisation). Despite the 
apparently high level of statistical significance, the characteristics of the cases led the 
investigators to believe that this cluster arose purely due to chance. 
In the late 1970s there were observed clusters of trisomy 13 and trisomy 18 in hospitals in the 
USA. Warburton et al (1977) found a trisomy cluster in New York in the winter of 1976, Paiet 
al(1978) found a trisomy 13 cluster in Maryland between August 20 and October 31 1977 and 
Barsel-Bowers et al(1980) found a trisomy 18 cluster in Rhode Island and Massachusetts 
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between November 8 1977 and May 12 1978. They suggested no biological explanation reason 
for these clusters. 
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Section 1.2.4:  Strength of Evidence for Risk Factors 
While there appears to be strong evidence to link high levels of atmospheric radiation to 
trisomy risk, the lack of biological explanation has led investigators to advise caution regarding 
this link. Levels of radiation were believed to be insufficient to cause several of the trisomy 21 
clusters reported in the aftermath of the Chernobyl meltdown, with even the investigators of 
the cluster in nearby Belarus stating that the involvement of radiation was far from certain. 
The study by Bound et al (1995) reported a Down Syndrome cluster in Lancashire, England 
between 1962 and 1964 which coincided with high levels of atmospheric radiation in the area 
due to the testing of atomic weapons. All of this evidence shows time-specific increase in 
trisomy 21 prevalence which coincided with high levels of atmospheric radiation, and as such it 
is possible that the findings are merely coincidental. 
The discovery of clusters by Verger et al (1997) in India provides evidence of a different nature. 
This study compared 2 similar populations, one of which was situated in an area of high 
natural radiation and the other in an area of low radiation. Results showed that the rate of 
chromosomal aberrations was significantly higher in the population which was exposed to 
more radiation. Besides radiation, no biological link has been proposed to explain this 
difference. Overall, there is evidence that exposure to radiation can increase trisomy risk both 
in the short term and the long term. However, it appears that the level of radiation present in 
order to cause clusters must be very high. The Chernobyl meltdown sent a strong burst of 
concentrated radiation around Europe, while the difference in atmospheric radiation between 
the two regions of India in the Verger study was somewhere between 15:1 and 30:1. Data 
analysed in this thesis was taken from England and Wales between 2004 and 2010, during 
which time there has been no large scale catastrophic nuclear event such as Chernobyl. There 
is also no previous evidence to suggest that trisomy clusters in England and Wales have been 
caused by high levels of natural radiation. Therefore, while the evidence linking radiation and 
trisomy risk is strong, it may be difficult to repeat that observation in this thesis. 
The McNally et al (2008) study in the North of England found space-time clustering in trisomy 
21 and suggested an infectious agent as the cause, but no clusters were detected for trisomies 
18 or 13. Given that all 3 syndromes are caused in a similar way, it is unlikely that clusters 
would exist for one but not the others. It is more likely that the data used in this investigation 
was too sparse to have sufficient power to detect clustering of trisomies 18 and 13 (especially 
if the clustering is weak), a possibility which is briefly discussed by the authors. Their 19 years 
of data (1985 – 2003) included 240 cases of trisomy 18 and 116 cases of trisomy 13, which 
both fall far short of the 1,084 cases of trisomy 21 in the same study. The greater number of 
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cases available in the NDSCR should make it possible to detect weaker clusters in the study 
presented in this thesis, although it is still possible that even the NDSCR data has insufficient 
numbers to detect very weak clusters caused by risk factors with a small effect size. The size of 
effects which may be detected using different sample sizes is evaluated further in chapters 3 
and 4.  
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Section 1.3: Introduction to Cluster Detection Techniques 
 
Section 1.3.1: Why Look For Clusters? 
 
In disease surveillance, the presence of clusters can indicate the presence of a localised excess 
risk which leads to the presence of more affected individuals. This excess risk can be localised 
either in time, in which case temporal clusters would be observed, or in space, in which case 
spatial clusters would be observed. For example, a factor which only affected risk in winter 
would be expected to produce seasonal, temporal clusters while a risk factor resulting from a 
rare environmental exposure (such as a hazardous landfill site) would be expected to produce 
spatial clusters. Some risk factors would be expected to produce clusters in space and time, 
such as the trisomy 21 clusters resulting from the Chernobyl disaster. In that instance, all 
clusters were observed in the same time period (January 1987), but the strongest clusters 
were observed closest to the meltdown site. 
 
Aside from the trisomy 21 clusters arising from Chernobyl, evidence was presented in section 
1.2.3 (McNally et al, 2008) suggesting that trisomy 21 clustering in the North of England may 
be caused by an infectious agent. The same study did not find any evidence of clustering in 
trisomies 18 and 13, however this may be attributable to low sample sizes for both syndromes. 
The NDSCR is a national, high quality data source which collects information on all 
cytogenetically confirmed cases of trisomies 21, 18 and 13 in England and Wales, and has 
higher sample sizes available than those used in the McNally etal study. Scanning the NDSCR 
data would therefore have greater power to detect clusters, potentially arising due to 
exposure to infection or some other environmental hazard.  
 
For clusters of some diseases, it is necessary to adjust for previously known risks, the effects of 
which could mask the effect of alternate risk factors. In the case of trisomy clusters, 
adjustment for maternal age is required before searching for clusters, as the strong effect of 
maternal age would be expected to produce age dependant clusters. While maternal age is the 
strongest risk factor for the trisomy syndromes, other risk factors have been linked with the 
conditions, most notably radiation arising from the Chernobyl disaster (detailed in section 
1.2.2). Other highly radiated areas also appeared to show increased trisomy prevalence. Since 
radiation related clusters have only been reported in extreme circumstances (either through a 
catastrophic event or an abnormally high level of naturally occurring radiation), it is not 
necessary to adjust for radiation levels. It would also be difficult to obtain accurate data 
regarding radiation levels in England and Wales. However, any regional differences in prenatal 
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screening procedures (such as some areas screening earlier than others) could produce 
clusters and need to be accounted for. 
 
Using cluster analysis, the aetiology of multiple diseases has been improved. In 1997, Kulldorff 
et al used the spatial scan statistic (Kulldorff & Nagarwalla 1995, further explanation in 
chapter 1.3.3.1) to perform scans of breast cancer cases from 1988-1992 in the Northeast USA, 
discovering several significant clusters in multiple cities and providing further evidence of the 
involvement of several previously hypothesised risk factors for which the investigators could 
not account in the analysis. In 2013, Massenet et al performed spatial and temporal cluster 
analysis of tuberculosis cases in the city of Saint-Louis in Senegal, identifying a densely 
populated fishing area as a highly likely cluster for further study. 
Cluster analyses have also been used in biosurveillance to predict disease outbreaks. 
Mostashari et al (2003) proposed an early warning system for the emerging threat of West Nile 
virus (WNV) in the Eastern USA, which used spatial cluster analyses of dead bird numbers to 
identify areas of increased human risk. WNV is most commonly spread by mosquitos and birds, 
so an elevated number of dead birds in an area could indicate the increased presence of WNV. 
This method was implemented prospectively in 2001, enabling pre-emptive reduction of 
mosquito breeding 4 weeks before WNV activity was confirmed by laboratory analysis. 
In 1999 English et al used a distance based clustering test (Cuzick & Edwards 1990, more 
details in chapter 1.3.3.3) to test for association between childhood asthma and traffic flow in 
a low-income population in San Diego county, California in 1993. Cases residing near high 
traffic flows were found to be more likely than those residing in low traffic areas to have 2 or 
more hospital visits for asthma during the year. Although there was no evidence of association 
between asthma risk and traffic counts, the study provided strong evidence that repeated 
exposure to air pollutants from traffic exhaust exacerbates symptoms in individuals already 
diagnosed with asthma. The same method was used in 2011 by Schmeidel et al to test for 
clustering of leukaemia and type 1 diabetes (T1D) in children aged 0-14 years Denmark. Their 
discovery of clusters of both leukaemia and TID within both the defined subsets and whole age 
range led the investigators to propose that the diseases shared etiological factors which varied 
by geographical location, including exposure to infections and agents which may compromise 
the immune system.  
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Section 1.3.2: Temporal Cluster Detection 
In 1965, the first temporal scan statistic was proposed by Joseph Naus. This method scanned 
through one dimensional temporal data using a scanning window of fixed size to identify the 
maximum number of events occurring within the window. 
In 1995, Nagarwalla proposed a method entitled the “Scan Statistic with a Variable Window”. 
This technique differed from those previously available because it used a scanning window of 
variable size and position, meaning that any investigators would not have to judge the size of 
potential clusters before performing the analysis. The mechanics of the temporal scanning 
window are illustrated in figure 1.3.1. 
 
 
Figure 1.3.1.The Nagarwalla scanning window method of temporal cluster analysis. 
 
The method scans through every combination of cases and finds the minimum amount of time 
for every possible cluster size to occur, starting at two cases and continuing until a 
predetermined limit is reached. This limit can be imposed by the investigator. It then generates 
scan statistics for those clusters using the formula below.  
The statistical formula is a generalized likelihood ratio test for a null hypothesis of uniform 
distribution against an alternative hypothesis of non-random clustering, and is shown below.  
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Where n = the number of cases in the cluster, N = the total number of cases, dmin = the 
minimum number of days for n cases to occur and ][nλ  = the scan statistic for that value of n. 
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Section 1.3.3: Spatial Cluster Detection 
The detection of spatial clusters is a much-studied subject area, and there have been many 
different methods developed to enable such analysis. The most useful of these methods can 
be divided into two classes: quadrat-based and distance-based (Ripley, 1977). Quadrat-based 
methods take measurements of a population using overlapping spatial windows, where the 
most likely cluster location will be that which has the highest number of cases for the number 
of non-cases contained within the window. Distance-based methods (also referred to as a 
nearest-neighbour approach) examine the distance between each case and its nearest 
neighbour, takes the average of all of these nearest neighbour distances and compares this 
with the expected figure of a hypothetical random spatial distribution.  
 
Quadrat-Based Methods 
The quadrat-based methods are well suited to searching for disease clusters in an unevenly 
distributed population as the method accounts for the population distribution. The data must 
include cases and a background population at risk, and is usually divided into small 
administrative zones for ease of analysis. All cases and non-cases within each zone are 
assigned to a specified point within the zone (usually the administrative centre). A standard 
quadrat method would then involve placing a grid over a map of the study region and counting 
the number of cases and non-cases within each square, where the null hypothesis states that 
cases are evenly distributed throughout the study region and the alternative hypothesis states 
that the cases cluster in one or more squares. However, greater power can be achieved by 
generating a series of overlapping quadrats instead as this improves the coverage of the study 
region and makes it less likely that a cluster will be missed due to the positioning of the grid. 
The first attempt to use this type of method to discover clusters of a rare disease was detailed 
in 1987 by Openshaw et al, who examined 853 cases of acute lymphoblastic leukaemia (ALL) in 
the North of England diagnosed before their 15th birthday between 1968 and 1985, using a 
background population of 1,544,963 children registered within the study area in the 1981 UK 
census. They proposed the Geographical Analysis Machine (GAM), which laid a closely spaced 
grid over the study region and generated circles with radii from 1km to 25km at each grid point 
(figure 1.3.2). This method was particularly useful because it avoided a pre-selection bias by 
scanning the entire study area equally. The number of leukaemia cases within each circle was 
recorded and statistical significance was judged using Monte Carlo testing, which involved 
generating 499 sets of data in which 853 individuals in the population were randomly selected 
to have leukaemia. Any circle containing two or more cases which was more extremely ranked 
(i.e. contained more leukaemia cases) than the 499 equivalent simulated circles was judged to 
be statistically significant at the 0.002 level. In total there were 812,993 circles generated, 
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1,792 of which were significant, most of which were clustered around five distinct areas. Only 
one of these areas had previously been identified as a leukaemia hotspot.  
 
 
Figure 1.3.2. Graph illustrating the Openshaw et al method of spatial cluster detection. 
 
While this method was a new way to search for disease clusters, it received criticism for having 
no control for multiple testing beyond accounting for the number of circle radii tested (Besag 
and Newell, 1991). Carrying out sufficient numbers of tests over a large region will result in a 
high likelihood of finding some clusters in the data purely by chance, but accounting for this in 
the analysis could then result in the method failing to detect genuine clusters. On a smaller 
scale, large numbers of circle radii are tested on a high resolution grid in order to determine 
the most likely position of any detected clusters, leading to each scan being comprised of 
many thousands of individual tests. However, this is also not accounted for in the calculation 
of significance levels. 
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In 1989, Turnbull et al proposed a method similar to the GAM by generating a circle of 
preselected radius at each administrative centre instead, while also considering techniques 
used in the distance-based methods (detailed later in this chapter). This method, described as 
the Cluster Evaluation Permutation Procedure (CEPP), was less computer intensive than the 
grid-based GAM, but still gave good coverage of the region as areas with more dense 
population tend to have more administrative zones, and therefore were covered by multiple 
circles. This method differed from the GAM as it required all circles to contain a fixed 
population R (say, for example, 5,000 individuals), which was chosen to be larger than the 
population of any individual administrative zone. The population of each zone (referred to as 
zone i) was added to a fraction of that of its nearest neighbour (referred to as zone j) in order 
to reach the fixed population. So if the population of cells i + j was equal to the fixed 
population then the entire population of j was included, but if the combined population was 
above the fixed population then only the necessary fraction of zone j was considered. In the 
event that the population of zones i + j did not contain the required population, the next 
nearest neighbour was considered and so on. Besag and Newell detailed a similar method in 
1991 which used nearest neighbour areas to look for clusters of a fixed number of cases; this 
method will be detailed in the distance-based methods section. Similar to the Openshaw 
method, the CEPP used a Monte Carlo simulation to determine whether results were 
statistically significant by performing repeated analysis on sets of data in which the cases had 
been randomly allocated from the background population. However, the CEPP only uses the 
circle which contains the maximum number of cases. This eliminates the problem of multiple 
testing as only one significance test is being performed, and as a result the method needs no 
further multiple testing corrections (however, if multiple values of R are used adjustment for 
multiple testing is required). Therefore, if the observed number of cases in a test exceeds that 
of 99 replicates in a Monte Carlo simulation, the result has an estimated p value of 0.01 and is 
significant at the 1% level.  
In 1995, Kulldorff and Nagarwalla proposed a circular scan statistic which was capable of 
detecting clusters of variable size and location on a map without making any prior assumptions 
regarding either of these variables. This method used a combination of techniques seen in the 
GAM and CEPP procedures, but with a maximum likelihood ratio test rather than simply the 
number of cases in each quadrat. Similarly to the GAM and CEPP, a number of circular zones 
are generated which act as quadrats. These can either be generated on a fixed grid as in the 
GAM, or at the centroids of census districts (or some other measure of population 
aggregation) as demonstrated by the CEPP. However, the circular scan statistic differs by 
generating circles of continuously increasing radius size at each position. This allows the 
method to simultaneously search for clusters of varying size and position without having to 
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account for multiple testing, as only the largest result is stored. This is an extension of the 
method seen in the CEPP.  
The model being used takes one circular zone at a time, referred to as z, within which there is 
a probability p of being a case. Individuals outside the circle have a probability q of being a 
case. The statistical method is derived from the likelihood function under a binomial model 
where cases are labelled as ones and non-cases are labelled as zeros, which is: 
𝐿(𝑧,𝑝, 𝑞) = 𝑝𝑐𝑧(1 − 𝑝)𝑛𝑧−𝑐𝑧𝑞𝐶−𝑐𝑧(1 − 𝑞)(𝑁−𝑛𝑧)−(𝐶−𝑐𝑧) 
Where N is the total number of individuals in the data, nz is the number of individuals inside 
the circle, C is the total number of cases in the data and cz is the number of cases in zone z.  
Therefore, for a fixed zone z in which the ratio of cases to non-cases is greater than that 
outside the zone, the likelihood ratio can be expressed: 
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The most likely cluster is that for which the outcome of the above equation is maximised. 
 
In the same article, the authors used this method to scan for leukaemia clusters in New York, 
and the results were compared with the GAM and CEPP methods. The GAM failed to detect 
any evidence of clustering using circle radii of 1, 2 and 4km, while the CEPP detected a 
statistically significant cluster with the population size fixed at 20,000. With fixed population 
sizes of 2,500, 5,000 and 10,000 the CEPP failed to detect any clusters. The circular scan 
statistic, using the likelihood ratio test, detected two statistically significant clusters. 
Subsequent power evaluations also revealed the circular scan statistic to be equally or more 
powerful than the CEPP under a range of simulated conditions (the GAM was not included in 
the comparison). The circular scan statistic has since become a widely used spatial cluster 
scanning technique due to the method being adaptable, powerful and relatively easy to apply. 
Professor Kulldorff has since published this method as part of the freely available software 
package SaTScan, which also includes scan statistics for temporal and space-time data analysis. 
All methods detailed in this thesis focus on the detection of clusters where observed > 
expected, i.e. where the risk is abnormally high. As a result, one-sided p values are sought 
exclusively. 
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Detecting Irregularly Shaped Clusters 
 
The main problem with many cluster detection techniques is that they have substantially less 
power for searching for irregularly shaped clusters. Consider the circular scanning method that 
generates circles at designated points on a map with a defined population (shown in figure 
1.3.2), and assume that there is a cholera outbreak along a river floodplain. The resulting 
cluster would appear on a map to be long and thin, and therefore could be difficult to detect 
using circles. The three most likely results in this instance are that the method does not 
identify the cluster at all, the method identifies the entire cluster in a large circle which also 
incorporates areas of low risk, or the method identifies the cluster as a series of adjacent small 
circles. As such, there have been several methods developed recently which are capable of 
detecting clusters of irregular shape.  
 
Figure 1.3.3. Cluster scanning using a new graph-based strategy.  
 
Figure 1.3.3 is taken from a report by Duczmal and Assuncao in 2004, in which a method for 
detecting irregularly shaped clusters is detailed. The diagrams show how a map can be broken 
down into different areas, which are then connected using a central point (the administrative 
centre of a borough, or capital of a state for example). Any combination of connected zones 
can then form a cluster of arbitrary shape. The technique used to determine which connected 
subset of zones is the most likely cluster is referred to as a simulated annealing method. The 
name is derived from the annealing process in metallurgy, which is the heating and cooling of a 
piece of metal in order for the atoms to arrange themselves into their least energetic (and 
therefore ideal) state. In this context, the technique scans through every combination of 
regions using the Kulldorff and Nagarwalla likelihood function to generate a scan statistic. Only 
the largest scan statistic is tested; so when a new combination of areas is scanned, the scan 
statistic is recorded if it exceeds the previously stored result. 
This method was compared with the circular scanning method using homicide data from Belo 
Horizonte, a city in Southeast Brazil with over 2 million inhabitants. Both methods located 
areas of high excess risk, with the simulated annealing method detecting a cluster with a 
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mortality rate of 490% higher than the remaining areas of the city, compared to the circular 
scanning method which only detected a cluster with 228% excess mortality rate.  
 
 
Figure 1.3.4. Differences in homicide clusters using the Kulldorff and Nagarwalla method (left) 
and the simulated annealing method (right). 
 
The different clusters are illustrated in figure 1.3.4. In both maps, the cluster location is shown 
by the shaded regions. Yellow regions indicate those which were included in the cluster 
despite no homicides occurring there during the study period. Three regions included in the 
circular cluster (labelled A, B and C) had below-average homicide rates. This evidence appears 
to suggest that the simulated annealing method performs better when searching for clusters 
of irregular shape, although the validity of the cluster they detected has been questioned given 
that it included a region in which there were no homicides during the study period. The 
authors note that the algorithm included this region because it linked two smaller homicide 
clusters, but the homicide rate in other included regions was at least 10 per 100,000 citizens. 
The raw homicide figures in each region were not included in the report. 
 
In 2005, Tango and Takahashi proposed a flexibly shaped spatial scan statistic for detecting 
small clusters of irregular shapes. This method uses a map split into small regions and 
generates circles at designated points, similarly to the circular scanning method. Every 
combination of connected regions within each circle is then scanned, allowing the maximum 
cluster size to be more easily controlled. This gives the advantage of being more flexible than 
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the circular scanning method, but restricting the size of the cluster gives more believable 
results than some of those produced by the simulated annealing method. For example, the 
cluster detected by the simulated annealing method in figure 2 is of a very unusual shape and 
contains a region with no homicides, and could therefore be overestimating the true size of 
the cluster. P-values were obtained using Monte Carlo simulation at 999 repeats, and the 
statistical formula (shown below) was derived from the likelihood ratio test. 
 
𝑠𝑢𝑝
𝒁 ∈ 𝑍 �
𝑛(𝒁)
λ(𝐙)�𝑛(𝒁) �𝑛(𝒁𝑐)λ(𝒁𝑐)�𝑛(𝒁𝑐) 𝐼(𝑛(𝒁)λ(𝐙) > 𝑛(𝒁𝑐)λ(𝒁𝑐)) 
Where window Z is an element of region Z, Zc represents the area of region Z outside window 
Z, n() denotes the observed number of cases within the specified area, λ() denotes the 
expected number of cases in the specified area under the null hypothesis and I() is the 
indicator function. 
 
The same article also included a comparison between the flexibly shaped scan statistic, circular 
scanning method and simulated annealing method when scanning for disease clusters in and 
around Tokyo, Japan. 
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Figure 1.3.5. Comparison of clusters detected using the circular scanning method (a) and 
flexibly shaped scan statistic (b) with a maximum cluster size of 15 regions. The same results 
were obtained with a maximum cluster size of 20 regions. 
 
Figure 1.3.5 shows that the flexibly shaped spatial scan statistic identified the combination of 
regions 14, 15, 26, 27 and 33 as the most likely cluster location, while the circular scanning 
method identified regions 14 and 15 as the strongest cluster.  
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Figure 1.3.6. Comparison of clusters detected using the simulated annealing method with a 
maximum cluster size of (a) 15 regions and (b) 20 regions. 
 
Figure 1.3.6 shows that the simulated annealing method has identified very large, irregularly 
shaped clusters when using maximum cluster sizes of 15 or 20.  
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Table 1.3.1. Most likely cluster locations using the three scanning methods with a maximum 
cluster size of 15 regions. “Circular” refers to the Nagarwalla and Kulldorff scan statistic, 
“Flexible” to the Tango and Takahashi flexible scan statistic and “Duczmal et al” to the 
simulated annealing method. 
 
 
 
Table 1.3.1 shows that the cluster identified using the circular scanning method had the lowest 
log likelihood ratio LLR but highest relative risk of the three, due to the inclusion of only two 
regions each with very high relative risks. The flexible scanning method identified a larger 
cluster with a very small drop in relative risk but a large increase in LLR. The cluster identified 
using the simulated annealing method had the highest LLR of the three but the lowest relative 
risk, due to the inclusion of more regions with lower relative risks. Nevertheless, the authors 
suggested that future methods could impose a penalty based on the complexity of cluster 
shaped, as clusters such as either of those in figure 1.3.5 are likely to be overestimates of the 
true cluster size. In 2008, Takahashi et al proposed an extension to this method which could be 
used to scan for space-time clusters. 
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A method was detailed in 2004 by Patil and Taillie which used an upper level set scan statistic 
to detect irregularly shaped spatial clusters. The upper level set method considers only the 
regions with above average prevalence, ensuring that low risk areas are not incorporated in 
the potential cluster region. Imagine an overall region Ω, divided into many cells (denoted by 
a). Taking Ya as the case count for each cell and Aa as the population size of each cell, candidate 
cells for possible clusters are those with the largest values for the rate: 
a
a
a A
YG =  
Using these cell rates, region Ω can be reduced to ΩULS, including only those regions with large 
values of Ga. This is referred to as taking an upper level set of Ω, and different upper level sets 
can be taken based on different threshold values for Ga. The zones in ΩULS can be considered 
plausible hotspots as they include only those cells with the highest prevalence.  
 
Figure 1.3.7 shows how the upper level set results can change based on the threshold value of 
Ga. At the threshold value of g, there are three components highlighted; Z1, Z2 and Z3. When 
the threshold is reduced to g`, zones Z4, Z5 and Z6 emerge. The graph shows how zones Z1 and 
Z2 join to become zone Z4, zone Z3 grows and becomes zone Z5 and zone Z6 emerges at the 
lower threshold point. Figure 1.3.8 then shows how this method can be applied to a region 
which has been aggregated into population groups. 
 
 
Figure 1.3.7. Graph demonstrating the upper level set method theory. 
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Figure 1.3.7. Graph demonstrating how the upper level set method could be used to search for 
clusters. Each node on the graph represents a region in space, and any combination of 
connected regions which exceeds the upper level can be considered a cluster. 
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Distance Based Methods 
 
Rather than measuring the case :noncase ratio using overlapping quadrats, distance based 
methods examine the distribution of cases in the study area. This can involve comparing the 
position of cases either with other cases or with controls selected from the population at risk. 
The following two examples illustrate these two different approaches. 
In 1987, Whittemore et al proposed a distance based method which examined the mean 
distance between all pairs of cases in the study region. The formula for this method is shown 
below, where )
2
(
n
 is the total number of pairs of cases and ),( 21 ii∆ denotes the distance 
between the i1th and i2th case. 
∑
<
− ∆=
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2
( 21
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δ  
This statistic is then compared with the expected value and variance of δ  under the null 
hypothesis that all cases are independent Poisson variables and that there are no clusters in 
the data. The authors also proposed that, in the event of a disease having varying prevalence 
in different subgroups of the population, the population could be stratified and the disease be 
treated as an independent Poisson process in each stratum. In the case of trisomies 13 and 18, 
cases could be partitioned into subgroups based on maternal age. 
In 1990, Cuzick and Edwards detailed a method which can detect clusters in non-uniformly 
distributed populations without prior knowledge of population density in terms of age and 
gender. Cases are compared with a group of controls selected from the risk population, and 
the statistics are based on whether the nearest neighbour to each case is a case or control. 
Information regarding the population at risk can be obtained from a variety of sources, but 
must be representative of the case population in terms of both age and sex. For example, if 
examining a condition which affects children, the population at risk could be obtained from 
local school records. 
This method is a non-homogenous Poisson process where the expected disease density is a 
function of the age and sex-adjusted population density. Assume that n0 cases are observed in 
some predefined region Ω, and that their positions are denoted (x1,…,xn0). From all individuals 
at risk in region Ω, a set of n1 controls are selected whose positions are denoted (y1,…,yn1). This 
information is then combined such that the cases and controls are denoted (z1,…,zn, n=n0+n1), 
where zi contains no information regarding whether the individual is a case or control. For 
i=1,…,n, δi is defined as 1 if zi is a case and 0 if zi is a control. For each i, di is defined as 1 if 1 if 
the nearest neighbour is a case and 0 if the nearest neighbour is a control.  
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The nearest neighbour test is defined as: 
ii
n
i
dT δ
1=
Σ=  
This test can be extended to count the number of cases among a preset number of nearest 
neighbours for each case, giving additional power when there are a few large clusters rather 
than many smaller ones.  
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Section 1.3.4: Aim Of This Thesis 
 
Using the methods detailed in section 1.3.3.1, it is unlikely that clusters arising due to any risk 
factors besides maternal age could be detected due to the strength of the maternal age effect. 
It is possible to statistically adjust for maternal age which would enable the discovery of 
alternate clusters, this is further explored in chapter 5 of this thesis. Methods detailed in 
section 1.3.3.2 demonstrate progress which has been made in the detection of irregularly 
shaped (i.e. non circular) clusters, however these methods are also likely to require some form 
of adjustment to be made before non-age related clusters can be detected. During the study 
period, the standardised mean maternal age after accounting for changes in population 
structure increased from 29.0 in 2004 to 29.5 in 2010 (Office for National Statistics 
Characteristics of Mother 1, England and Wales, 2011).  
 
There are two distinct objectives which will be addressed in this thesis. The primary 
methodological aim of this work is to develop a method which is capable of accounting for pre-
existing risk factors (in this case, maternal age and gestational age at diagnosis) when 
searching for clusters. Such a method would be able to take advantage of the detailed 
information available on each case from the NDSCR, in order to accurately adjust for both risk 
factors for each case individually. The second objective is to apply this method to NDSCR data 
in order to attempt to discover any clusters which may arise due to alternate risk factors. 
 
Specific aims of this thesis are: 
1. To scan trisomy data in England and Wales from the NDSCR for temporal and spatial 
clusters. 
2. To develop a statistical method capable of accounting for two risk factors 
simultaneously, and to demonstrate the effectiveness of this method using simulated 
data. 
3. To scan the same data for clusters after adjusting for maternal age and gestational age 
at diagnosis using the novel method. 
4. To assess the impact of the findings in the context of both previously undertaken and 
future congenital anomaly research, and NHS policy. 
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Chapter 2: Data Cleaning 
 
Data cleaning is the process of improving the quality of a dataset by detecting and correcting 
or removing errors. Such errors may include inconsistancies within the data, typing errors 
during data entry, duplicate entries and incomplete records. When examining a dataset for 
clusters, especially when analysing conditions as rare as trisomies 18 and 13, a single case can 
be the difference between a cluster being classed as significant or not, so it is essential that 
data is thoroughly cleaned before it is scanned. All NDSCR data is routinely checked and 
cleaned to ensure that it is the highest possible quality and that all available information is 
recorded, however there are still cases in the dataset which are missing vital information for 
one or more of the cluster scanning techniques. For some cases vital missing information can 
be estimated from other information provided in order to include these cases in the relevant 
scan(s). 
 
Data was scanned for temporal and spatial clusters. Temporal scans were performed within 
Government Office Region using sample date and then using estimated conception date. 
Spatial scans were initially performed using the mother’s Primary Care Trust (PCT) at diagnosis 
and then subsequently adjusting for the mother’s age and for the gestational age at diagnosis . 
For each of these procedures, the required information and number of cases lost due to 
missing data is provided as an overview in table 2.1, and then explained in more detail in the 
rest of the chapter. Temporal and spatial data cleaning processes are detailed separately as 
each requires different case information. 
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Table 2.1. Overview of Data Cleaning Processes. 
 
  
Trisomy 18 Trisomy 13 
Scan 
 
Number % Number % 
Temporal by Sample 
Date Total Cases 3507 100 1473 100 
 
Excluded - No GOR 6 0.2 5 0.3 
 
Excluded - No Sample Date 70 2.0 36 2.4 
 
Total Cases Excluded 76 2.2 41 2.8 
 
Total Cases Remaining 3431 97.8 1432 97.2 
Temporal by 
Conception Date Total Cases 3507 100 1473 100 
 
Excluded - No GOR 6 0.2 5 0.3 
 
Excluded - No Conception 
Date 175 5 103 7 
 
Excluded - Out of Timeframe1 107 3.1 46 3.1 
 
Total Cases Excluded 288 8.2 154 10.5 
 
Total Cases Remaining 3219 91.8 1319 89.5 
Spatial without 
Adjustment Total Cases 3507 100 1473 100 
 
Excluded - No PCT 186 5.3 91 6.2 
 
Total Cases Excluded 186 5.3 91 6.2 
 
Total Cases Remaining 3321 94.7 1382 93.8 
Spatial with 
Adjustment Total Cases 3507 100 1473 100 
 
Excluded - No PCT 186 5.3 91 6.2 
 
Excluded - No Maternal Age 91 2.6 61 4.1 
 
Excluded - No Gestational 
Age 105 3 67 4.5 
 
Excluded - Fetal Loss Under 
20 Wks 488 13.9 213 14.5 
 
Total Cases Excluded 870 24.8 432 29.3 
 
Total Cases Remaining 2637 75.2 1041 70.7 
 
1Out of timeframe refers to periods of time at the start and end of the timeframe during which 
the NDSCR would not have complete data. There is a full explanation later in the chapter on 
page 73. 
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Section 2.1.Preparation of Data Before Applying the Temporal Cluster Detection Method 
 
 
Government Office Region 
 
The first essential piece of information for the temporal cluster scanning method is 
government office region, as each region is analysed individually. Government Office Region is 
determined from the mother’s postcode at diagnosis or the mother’s home town (free text). In 
total, 14 cases of trisomy 18 (0.4%) and 11 cases of trisomy 13 (0.4%) were missing both fields 
of information and so could not be assigned a government office region.  
 
Each case is diagnosed and subsequently reported to the NDSCR by one of 21 cytogenetic 
laboratories. All cases therefore have an assigned cytogenetic lab, which can be used to 
impute government office region if the laboratory has a sufficiently large proportion of cases 
originating in the same region. The threshold for this proportion was set at 90%, so if a lab 
takes over 90% of its cases from a one region, it would be reasonable to assume that any case 
from that lab with missing GOR comes from the same region. There is a small chance of error 
in doing this (up to 10% depending on the lab), but it is preferred to losing the case altogether. 
This threshold may appear overly conservative, but as the scans are performed separately by 
GOR and a single case can make the difference between a cluster being significant or not, high 
accuracy is essential when imputing GOR. Using this information 7 / 14 trisomy 18 cases and 5 
/ 11 trisomy 13 cases could be assigned to a government office region (specific case details are 
shown in the appendix), leaving 7 and 6 cases respectively still unassigned. The number and 
proportion of diagnoses from each government office region by cytogenetic lab are shown in 
the appendix tables 2.9 and 2.10 respectively. Tables 2.11 and 2.12, also in the appendix, list 
all cases which were assigned to a government office region on the basis of cytogenetic lab 
information. 
 
Of the remaining cases, one trisomy 18 case was diagnosed at lab 30, but had the referring 
hospital on the form. Since 31 of the 35 cases in the database from this same hospital were 
from government office region H, this case was assignedto region H. The 6 remaining trisomy 
18 cases (0.2% of the total) and 6 trisomy 13 cases (0.3% of the total) could not be assigned a 
government office region, and were excluded.  
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Date of Sample 
 
Initially, temporal scans are performed using the date of sample as the time point for each 
case. Date of sample refers to the date when the tissue sample was taken for cytogenetic 
testing and diagnosis. The samples ranged in age from a gestation of 10 weeks to 40 weeks. 70 
cases of trisomy 18 and 36 cases of trisomy 13 did not have complete sample date information 
recorded and had to be excluded from this analysis, which was a loss of 2.0% of trisomy 18 
cases and 2.4% of trisomy 13 cases. All of these cases were missing both month and day of 
sample except for 2 cases of trisomy 18 and 1 cases of trisomy 13, which were only missing day 
of sample. There was no way to accurately infer this information from other variables in the 
data. 
 
Date of Conception 
 
After these scans had been performed, a further series of scans were run using the date of 
conception as the time point for each case. Conception date is not reported to the NDSCR, but 
can be estimated by subtracting either gestational age at sample from date of sample or 
gestational age at outcome from outcome date. Both methods are equally accurate as 
outcome and sample dates are recorded accurately by day. Sample information was used 
initially as this was more likely to be complete. If the sample information was incomplete the 
outcome information was used. Gestational age at sample and outcome is reported to the 
NDSCR either in complete weeks only or in weeks and days, however weeks and days are only 
available for only a small proportion of cases. For this reason, whenever gestational age 
information is used throughout this thesis only complete weeks are used. The percentage of 
cases included in each scan by date of conception is shown in table 2.5. 
 
Table 2.2. Initial estimates of conception dates using either complete sample or outcome 
information. 
 
  Trisomy 18 Trisomy 13 
Calculated Using Number % Number % 
Sample Date – Gestational age at Sample 3124 89.1 1258 85.4 
Outcome Date – Gestational age at Outcome 193 5.5 104 7.1 
Total Calculated 3317 94.6 1362 92.5 
Could not Calculate Conception Date 184 5.2 106 7.2 
Previously Excluded (Missing GOR) 6 0.2 5 0.3 
Total Missing 190 5.4 111 7.5 
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Table 2.2 shows that 3,124 cases of trisomy 18 (89.1%) and 1,258 cases of trisomy 13 (85.4%) 
had complete sample date and gestational age at sample information, and therefore their 
conception date could be estimated using these variables. Around half of the remaining cases 
had complete information regarding outcome date and gestational age, and so could have 
their conception date estimated from gestation at outcome and outcome date. Date of 
conception could not be estimated for 184 cases of trisomy 18 (5.3% of total) and 106 cases of 
trisomy 13 (7.2% of total). These are detailed in table 2.3. 
 
Table 2.3.Breakdown of missing information showing proportions of complete data. 
 
  Trisomy 18 Trisomy 13 
Information Present Number % Number % 
Sample date, no gestational age at sample 146 4.2 84 5.7 
Gestational age at sample, no sample date 18 0.5 11 0.7 
Neither sample date nor gestational age 20 0.6 11 0.7 
Total 184 5.2 106 7.2 
Outcome date, no gestational age at outcome 85 2.4 44 3 
Gestational age at outcome, no outcome date 15 0.4 12 0.8 
Neither outcome date nor gestational age 84 2.4 50 3.4 
Total 184 5.2 106 7.2 
 
 
The largest proportion of cases in table 2.l3 are those with a recorded sample date but no 
gestational age at sample, and it was thought that the type of cytogenetic sample used could 
provide an estimate of gestation at sample as different tests are performed depending on the 
gestational age of the pregnancy; CVS, generally performed early during the pregnancy, and 
amniocentesis, usually performed later in the pregnancy. Table 2.4 shows the number and 
proportion of cases which were confirmed using either CVS or amniocentesis. 
 
Table 2.4. Number and proportion of total cases missing conception date which were 
diagnosed using a CVS or amniocentesis sample. 
 
  Trisomy 18 Trisomy 13 
Tissue Sample Number % Number % 
CVS 37 1.1 19 1.3 
Amniocentesis 27 0.8 10 0.7 
 
 
Table 2.4 shows that around 1.9% of total cases for trisomy 18 and 2.0% for trisomy 13 could 
be included in the analysis if their gestation at sample could be accurately estimated by tissue 
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sample type. All NDSCR cases between 2004 and 2010 (including trisomy 21) which were 
diagnosed after either a CVS or amniocentesis were analysed for gestational age at sample. 
The same analysis was also performed using each trisomy individually to ensure that the 
distributions did not significantly differ, which they did not. However, after examining the 
distribution of gestational ages in all CVS and amniocentesis diagnoses, there was insufficient 
evidence to be able to accurately impute gestation at sample using tissue type. The 
distributions of gestational ages for cases diagnosed using either CVS or amniocentesis are 
included in the appendix in tables 2.13 and 2.14.  
 
For cases with gestation at sample but no sample date, it could be possible to obtain the 
sample date using the unique identifier assigned to the sample by the cytogenetic laboratory. 
In most labs, cases from each calendar year are divided by tissue type and assigned a reference 
number in the order in which they are processed. For example, the first CVS sample to arrive in 
2006 would be given the laboratory ID C060001, the second would be C060002 etc. 
Amniocentesis samples would be similarly labelled, with the first sample of 2006 labelled 
A060001. For each case missing date of sample, the dates of the previous and following cases 
can be used to estimate sample date. 
 
 
 
 
Figure 2.1. Imputing sample dates based on the case sample dates immediately before and 
after the case being examined. 
 
For example, figure 1 shows a hypothetical trio of cases at the start of a calendar year. 
Assuming that case 1 occurs on January the 1st and case 3 occurs on January the 11th, case 2 
can be estimated to have occurred in the middle of this time period on January the 6th. In 
order to maintain uniformity across all sample dates estimated in this way, the assigned 
sample date was always the middle of the timeframe. Where the timeframe spanned an even 
number of days and the exact middle fell across 2 days, the sample date was assigned to the 
first of these days. For example, if case 1 occurred on January the 1st and case 3 occurred on 
January the 10th, case 2 would be assigned the sample date January the 5th rather than the 6th. 
As sample date accuracy is so important to this analysis, it was decided that the sample date 
estimate could be no less precise than the process of estimating conception dates. As 
gestational ages are processed in whole weeks only, there is a maximum potential error of 6 
days when subtracting the gestational age at sample from the sample date. Therefore, the 
Case 1 - January 1st Case 2 Case 3 - January 11th 
 73 
 
maximum error in estimating sample dates using adjacent cases is 6 days. This means that the 
difference between the previous and following case sample dates should be no more than 12 
days. Using this cutoff, 3 cases of trisomy 13 and 9 cases of trisomy 18 were assigned sample 
dates and could be included in the analysis. Full details regarding all cases which had sample 
date estimated using this method are included in the appendix in tables 2.15 and 2.16. 
 
Timeframe 
It must also be considered that using estimated date of conception changes the temporal 
study period from 2004 – 2010 to 2003 – 2010. 126 cases of trisomy 18 and 47 cases of trisomy 
13 were conceived in 2003, as were other cases which were diagnosed in 2003 and therefore 
not included in this study. This means that the data we have on cases conceived in 2003 is 
incomplete. It would be possible to exclude all cases which were conceived in 2003 from the 
analysis, but this would incur a further loss of 3.8% of trisomy 18 cases and 3.5% of trisomy 13 
cases. Instead, we can use a cutoff time in late 2003 for which we are confident that the 
majority of cases would not be detected prenatally until 2004. Prenatal screening starts at 
around 10 weeks gestation, and it is unlikely that any trisomy 18 or trisomy 13 case would be 
diagnosed before 10 weeks. Cases diagnosed in the final 10 weeks of 2003 can therefore be 
included. This allowed 71 cases of trisomy 18 and 25 cases of trisomy 13 to be included despite 
being conceived in 2003. Overall, 55 trisomy 18 cases (1.6% of total) and 22 trisomy 13 cases 
(1.4% of total) were conceived before the final 10 weeks of 2003 and were excluded from the 
study. 
Similarly, there were cases conceived in the latter part of 2010 which would not be expected 
to be detected until 2011. While this could potentially occur any time in the last 9 months of 
2010, excluding all cases from such a large timeframe could have a significantly detrimental 
effect on the power of the analysis. Therefore, the data was analysed by gestation at sample 
for each trisomy, and it was found that around 85% of cases for both trisomies had been 
diagnosed by the gestational age of 21 weeks. Excluding only the last 21 weeks of 2010 
includes as many cases as possible without compromising the overall quality of the dataset. A 
further 52 trisomy 18 cases and 24 trisomy 13 cases were conceived in the final 21 weeks of 
2010 and subsequently excluded. In total, 8.2% of trisomy 18 cases and 10.5% of trisomy 13 
cases were excluded from the temporal scans by date of conception. 
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Sensitivity Analysis 
For the temporal scans by conception date, a large proportion of cases were excluded due to 
the larger amount of information required for the scans, and the desire to only include cases 
for which those variables were either known or could be imputed with very high accuracy. 
Cases whose conception date fell outside the temporal window for which the NDSCR had 
complete data available were also excluded.  
In order to assess the effect of these exclusions, a second analysis was undertaken which 
relaxed the imputation accuracy requirements. In these scans, date of conception was imputed 
for cases which had no gestational age at sample recorded by assigning the mean gestational 
age of the tissue sample used in their diagnosis. For example, a case diagnosed by CVS would 
be assigned the gestational age at sample of 12 weeks, whereas a case diagnosed by 
amniocentesis would be assigned a gestational age of 19 weeks. This was undertaken for 9 
different tissue types (CVS, amniotic fluid, fetal blood, fetal skin, placenta, product of 
conception, villi, umbilical cord and postnatal), and the resulting gestational ages at sample 
were subtracted from the date of sample (where available) to provide an estimate of the 
conception date. There were also no timeframe restrictions applied, so all cases reported to 
the NDSCR between 2004 and 2010 were included in the scans even if they were diagnosed 
early in 2003 or late in 2010.  
Using this approach, the proportion of cases excluded from the scans by date of conception 
could be significantly reduced in every government office region (table 2.5). For trisomy 18, 
the percentage of cases included increased from 91.8% to 98.4%, while the trisomy 13 the 
percentage rose from 89.5% to 98.0%. For trisomy 18 all regions had less than 3% of cases 
excluded, while for trisomy 13 all had less than 3% excluded except the East of England where 
3.1% were removed. The percentage of cases excluded was consistently low across all regions 
in the sensitivity analysis. The results from this analysis are shown and discussed in chapter 3.  
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Table 2.5. Percentage of cases excluded in scans by conception date. 
  Conception Date Scans Sensitivity Analysis 
Government Office Region T18 T13 T18 T13 
North East 4.3 7.5 1.2 0 
North West 12.5 15 2 2.3 
Yorkshire and the Humber 12.1 10.3 2.2 2.6 
East Midlands 8.9 10.6 1.4 0 
West Midlands 8 11.6 2.9 2.5 
East of England 5.7 8.1 0.5 3.1 
London 9.9 11.7 1.3 2.1 
South East 5.2 7.7 0.6 0.4 
South West 4.2 8.8 0 2 
Wales 9.2 9.4 1.8 0 
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Section 2.2.Preparation of Data Before Applying the Spatial Cluster Detection Methods 
 
Sample Year 
 
Cases are divided by year of sample so as to avoid excess data loss at the start and end of the 
study period which would be incurred if date of conception was being used (as demonstrated 
in the temporal scanning method). Years can be analysed individually or all together to give a 
single scan for the entire dataset. All cases in the NDSCR database have a recorded sample 
year, so no data is excluded on this basis. 
 
PCT 
 
Part of the NDSCR data checking and cleaning procedure is to assign PCTs to cases based on 
either postcode or maternal home town. After this process had been performed, 301 trisomy 
18 cases (8.6% of the total) and 134 trisomy 13 cases (9.1% of the total) were missing PCT 
information. Table 2.6 shows what location information was present for cases which were 
missing pct. 
 
Table 2.6. Information present regarding the location of cases with missing PCT. 
 
  Trisomy 18 Trisomy 13 
Information Present Number % Number % 
Maternal Postcode Only 6 0.2 3 0.2 
Maternal Home Town Only 83 2.4 37 2.5 
Postcode and Home Town 121 3.5 48 3.3 
Neither Postcode Nor Home Town 91 2.6 46 3.1 
Total 301 8.6 134 9.1 
 
As the NDSCR procedure assigns PCTs using an automated process, it may be that any 
incorrectly entered or incomplete PCTs could be assigned with manual checks. An online PCT 
finder widget was used to attempt to assign cases to PCTs. The URL for this widget is provided 
here and in the references.  
 
https://www.ndtms.org.uk/emids/cgi-bin/ons_locale.cgi 
 
This method was implemented in three stages. Firstly, the full postcode was entered into the 
widget. For postcodes which were incorrect, the area code (first part of postcode plus the first 
character of the second part) was entered. For area codes which were incorrect, the postal 
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district (first part of postcode) was entered. Postal districts and area codes can span multiple 
PCTs (postcodes cannot), and it is important to ensure that cases are not incorrectly assigned 
to PCTs as a single case can make a big difference in the spatial scans. In the event of an area 
code spanning multiple PCTs, the widget returns the percentage probability of the address 
being located in each PCT. PCTs were only assigned when the probability of the PCT being 
incorrect was less than 10%, as this ensured a low risk of including incorrect data while 
including as many cases as possible. Using this approach, a further 90 trisomy 18 cases and 39 
trisomy 13 cases were assigned PCTs. Maternal home towns could also be checked in the same 
way, as some towns fall entirely within a single PCT and can therefore be used to accurately 
obtain PCT information. For each maternal home town, all potential postal districts were run 
through the same PCT finder tool using the same maximum 10% error rate. A further 25 
trisomy 18 cases and 4 trisomy 13 cases were assigned to PCTs using maternal home town 
information. Full tables showing which cases were processed using these methods are 
included in the appendix. 
Table 2.7 shows the number and proportion of total cases which were assigned to PCTs based 
on either their postcode or maternal home town. A total of 5.3% of trisomy 18 cases and 6.2% 
of trisomy 13 cases could not be assigned to PCTs and were excluded from all spatial analyses. 
 
Table 2.7. Number and percentage of total cases for whom PCT was imputed using either 
postcode or maternal home town information. 
 
  Trisomy 18 Trisomy 13 
Information Used Number % Number % 
Postcode 22 0.6 7 0.5 
Area Code 32 0.9 14 1 
Postal District 36 1 18 1.2 
Maternal Home Town 25 0.7 4 0.3 
Total  115 3.3 43 2.9 
Total Still Missing After Cleaning 186 5.3 91 6.2 
 
 
Two cases in the NDSCR database were from the PCT “5QV” (Hertfordshire), which was formed 
in 2008 by merging two existing PCTs (East and North Hertfordshire, and West Hertfordshire). 
The birth figures from the ONS were obtained before this merge happened, so these cases 
were manually reassigned to the correct PCT. 
 
 
 
 78 
 
Maternal Age at Sample 
 
Spatial scans were run adjusting for maternal age at diagnosis and therefore for some analyses 
91 trisomy 18 cases and 61 trisomy 13 cases with missing maternal age at sample were 
excluded from the adjusted analysis. There was no way to impute this information from other 
information on the form. Figures 2.2 and 2.3 shows the distribution of maternal age for both 
trisomies during the study period. 
 
 
Figure 2.2. Graph of maternal age for trisomy 18 cases reported to the NDSCR during the study 
period. 
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Figure 2.3. Graph of maternal age for trisomy 13 cases reported to the NDSCR during the study 
period. 
 
Gestational Age at Sample 
 
Spatial scans were run adjusting for gestational age at diagnosis in cases that were 
subsequently terminated (see chapter 5 for full explanation of weighting methods). Fetal loss 
rates are very high in trisomy 18 and trisomy 13 pregnancies. Areas in which routine prenatal 
screening occurs from 10 weeks gestation will diagnose more cases than those which screen 
later. It is assumed that all pregnancies surviving to 20 weeks are diagnosed. Therefore 
gestational age weights are only applied to terminated cases under 20 weeks of gestation at 
sample. All cases with a gestational age greater than 20 weeks at diagnosis are given a weight 
of 1. All fetal losses under 20 weeks were excluded from the analysis, resulting in a loss of 488 
cases of trisomy 18 and 213 cases of trisomy 13. This means that all cases diagnosed at or after 
20 weeks will receive a default weighting of 1. The weighting method applies variable weights 
to cases diagnosed between 14 and 20 weeks, with all cases diagnosed before 14 weeks of age 
being assigned the same weight. Therefore if the majority of cases (a minimum of 80%) 
diagnosed by a certain tissue type are diagnosed either after 20 or before 14 weeks of age, the 
equivalent weight can be assigned to cases which have known tissue type but are missing 
gestational age at sample. The 80% limit was chosen as it is important to minimise the amount 
of cases which are excluded from the scans while still maintaining a high level of accuracy in 
 80 
 
the imputed data. The distribution of gestational age at diagnosis among cases of trisomies 18 
and 13 during the study period is showed in figures 2.4 and 2.5. 
 
 
Figure 2.4. Graph of gestational age at diagnosis for trisomy 18 cases reported to the NDSCR 
during the study period. 
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Figure 2.5. Graph of gestational age at diagnosis for trisomy 13 cases reported to the NDSCR 
during the study period. 
 
There are 9 named types of tissue in NDSCR data which were sampled for cytogenetic 
diagnosis. The timing of five tissue types (amniotic fluid, fetal skin, placenta, villi and umbilical 
cord) was distributed between 14 and 20 weeks and could not be used to reliably estimate 
gestational age at diagnosis, however four tissue types (CVS, product of conception, fetal 
blood and postnatal) could be accurately used to estimate gestational age with a minimum of 
80% accuracy.. Table 2.8 shows the timing and accuracy of each of these four tissue types.  
 
Table 2.8. Tissue sample types which can be used to estimate gestational age at diagnosis. 
 
Tissue Timing of Test Proportion of Cases 
CVS Before 14 weeks 90% 
Product of Conception Before 14 weeks 85% 
Fetal Blood After 19 weeks 80% 
Postnatal After 19 weeks 80% 
 
 
Table 2.89 shows that a total of 136 cases of trisomy 18 and 61 cases of trisomy 13 were 
assigned gestational age at diagnosis based on their tissue sample type. 105 cases of trisomy 
18 and 67 cases of trisomy 13 could not have gestational age estimated using their tissue type 
and were excluded from all adjusted spatial scans. 
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Table 2.9. Number of cases for which gestational age at diagnosis was estimated using tissue 
sample type. 
 
  Trisomy 18 Trisomy 13 
  Number % Number % 
Missing Gestational Age 241 6.9 128 8.7 
CVS 34 1 15 1 
Product of Conception 2 0.1 0 0 
Blood 33 0.9 14 1 
Postnatal 67 1.9 32 2.2 
Total Estimated 136 3.9 61 4.2 
Total Still Missing 105 3 67 4.5 
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Chapter 3: Temporal Cluster Detection 
 
Section 3.1. Introduction 
 
Temporal disease clusters occur when increased disease prevalence is reported over a period 
of time before returning to the previously observed prevalence. Such clusters arise due to the 
presence of risk factors which are localised in time, such as the radiation related trisomy 21 
clusters in Europe in January 1987. The discovery of temporal clusters can be useful in 
identifying novel risk factors and improving the general understanding of medical conditions. 
In the case of the trisomy syndromes, temporal clusters which could be linked to alternate risk 
factors could be used to provide prospective mothers with more accurate information relating 
to their risk of having an affected pregnancy. 
Recent evidence suggests that the prevalence of trisomies 18 and 13 has been consistent in 
England and Wales in recent years (NDSCR Annual Reports 2004 – 2010). However, there is 
some evidence to suggest that increased trisomy 21 risk can be caused by radiation and 
infection (see literature review chapter 1.4). It is expected that the same factors which caused 
trisomy 21 clusters could also cause clusters of trisomies 18 and 13, however both syndromes 
are so rare that it is often difficult to obtain sufficient data to perform cluster analyses. The 
NDSCR is a large, complete register of all cytogenetically confirmed trisomy 21, 18 and 13 
cases in England and Wales and therefore has the power to detect clustering effects which 
smaller databases may have been unable to discover. However, the only risk factor which been 
identified in England and Wales which influence the observed prevalence of trisomies 18 and 
13 is maternal age at conception, which would be more likely to lead to a long term change in 
trisomy prevalence rather than the presence of distinct temporal clusters.   
 84 
 
Section 3.2. Methods 
 
Temporal cluster analyses used NDSCR data from the 1st of January 2004 to the 31st of 
December 2010, which consisted of 1,218 cases of trisomy 13 and 2,941 cases of trisomy 18. 
All data was analysed within government office region, which have been the primary 
classification for regional statistics since 1996. This allows the location of any clusters to be 
more accurately determined, and allows regional comparison of results. For example, clusters 
found at the same time in adjacent regions could indicate a risk factor affecting both regions 
simultaneously. It is possible that clusters occurring on the border of 2 or more regions could 
be missed using this type of analysis, however it is likely that such clusters would be detected 
in all contributing regions, albeit not as strongly.  The 10 different regions are described in 
table3.1.1 and shown in figure 3.1.1. 
 
Table 3.1.1. Characteristics of government office regions in England and Wales. Population 
estimates in millions and annual births shown are from 2007 (middle of study period). 
 
Code Region Name Population (m) Annual Births 
1 North East 2.6 29,582 
2 North West 6.9 85,947 
3 Yorkshire and the Humber 5.2 64,191 
4 East Midlands 4.4 52,482 
5 West Midlands 5.4 70,098 
6 East of England 5.7 69,311 
7 London 7.6 125,505 
8 South East 8.3 101,238 
9 South West 5.2 57,003 
10 Wales 3.0 34,414 
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Figure 3.1.1. Map of government office regions in England and Wales. This map was generated 
in STATA using the spmap function. 
 
Analysis was performed using the method detailed by Nagarwalla in 1996 (full details in 
chapter 1), which is a generalised likelihood ratio test for the null hypothesis that events 
happening within a set time period are uniformly distributed against the alternative hypothesis 
that the events are not evenly distributed.  
This method finds the shortest time for a set number of cases to occur and uses Monte Carlo 
simulation to determine whether this time is significantly less than would be expected by 
chance. This technique differs from those previously available because it uses a scanning 
window of variable size and position. Using a fixed window means that the investigator must 
judge the size of potential clusters in advance without examining the data, so the variable 
window avoids any potential bias. 
 
1 
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Figure 3.1.2.The scanning window method of temporal cluster analysis. 
 
The scanning window searches through every combination of consecutive cases and finds the 
minimum time for every possible cluster size to occur, ranging from 2 to 2 less than the total 
number of cases in the data. For example, if there are 20 cases in the data the method will 
search for clusters of size 2-18 in sequence and for each cluster size store the most likely 
cluster; i.e. that which occurs over the least number of days. Clusters must have a minimum of 
2 cases and occur over a minimum of 2 days. A scan statistic is then calculated for each of 
these potential clusters using the formula below.  
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Where n = the number of cases in the cluster, N = the total number of cases, dmin = the 
minimum number of days for n cases to occur as a proportion of the total number of days and 
][nλ  = the scan statistic for that value of n. 
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Section 3.3. Programming and Implementation 
 
The temporal scanning method was programmed using R, which is a freely available language 
and environment for statistical computing and graphics.  
The computer program first reads in a file containing every case and the relevant date (either 
date of conception or diagnosis), and then ranks cases by date. It then uses the previously 
detailed variable scanning window to search through the data and find the cluster with the 
largest scan statistic for every possible cluster size and returns the 10 largest scan statistics. 
When data is analysed by individual region, the top 10 results per region are returned. Some 
regions have small numbers of cases and less than 10 results in total; in these instances all 
results are returned regardless of size. The idea of returning the top 10 results per region is to 
have the ability to potentially detect multiple non-overlapping clusters, in such an event p-
values would be calculated for all non-overlapping clusters. However, in this thesis this 
scenario was not encountered as the top 10 results were either overlapping or obviously not 
significant. 
The original publication which detailed this method included test data of 35 cases of the 
congenital anomalies oesophageal atresia and tracheo-oesophageal fistula from Birmingham, 
U.K. between 1950 and 1955. After writing the program in R, I tested it on the test data to 
ensure that the published results matched the results that my program returned. Both results 
were identical and demonstrate that the method is running correctly in the R program. 
 
The probability of obtaining a result at least as extreme as that observed, under the null 
hypothesis, (p value) is calculated using Monte Carlo simulation, which uses repeated random 
sampling to calculate a p-value.  
To perform the Monte Carlo simulation, cases were reallocated in time by generating random 
numbers based on the number of days included in the scan. For example, there are 2,557 days 
from 01/01/2004 to 31/12/2010 so each case would be assigned a random value from 1 to 
2,557. The data was then rescanned and the largest scan statistic was stored. This process was 
repeated a total of 999 times. The position of the observed scan statistic amongst the list of 
simulated scan statistics then gives an estimate of the p-value, for example is the observed 
scan statistic is greater than all the simulated scan statistics p < 1/999, i.e. p = 0.001. 
As both the cluster scans and Monte Carlo simulations return their strongest clusters, there is 
no need to account for multiple testing within a single region. However, it is necessary to 
account for each of the 10 regions being individually scanned. A Bonferroni correction was 
applied to all observed results, which divides the p-value used to determine significance by the 
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number of tests being performed, so for each trisomy the significance threshold was 0.05 / 10 
= 0.005.   
Four sets of temporal scans were run for each trisomy. Separate scans were performed using 
cases arranged by date of sample and by estimated date of conception. Cluster scanning using 
sample dates is a useful tool for quickly analysing data for clusters as soon as case data 
becomes available and when there may be minimal information for each case. However, 
trisomies 18 and 13 are genetic conditions where the initial error must occur at the time of 
conception for an individual to carry a full trisomy, so more informative results can be 
obtained using estimated date of conception.  
Both of these tests were performed with and without a limit imposed on maximum cluster 
size. It is possible that the program could detect very large clusters spanning several years, but 
these would be more likely to be the result of a long term change in maternal age leading to 
higher trisomy rates over time than a distinct temporal cluster of cases. Imposing a limit 
removes the possibility of detecting such clusters. When applied, the size limit was chosen to 
be 20% of the total number of cases in the scan. This limit was chosen as a suitable limit to 
enable the detection of reasonably sized clusters spanning up to around 18 months in length 
without also picking up excessively large clusters. Scans were performed using a range of size 
limits and 20% was consistently found to be a suitable threshold. To avoid excessive repetition 
in this thesis, only the results obtained with a 20% limit are shown. 
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Section 3.4. Results 
a. Characteristics of Sample 
 
All cases of trisomies 18 and 13 which were reported to the NDSCR between January 1st 2004 
and December 31st 2010 and did not have any other trisomy (i.e. were reported as having 
both trisomies 21 and 18) were eligible for inclusion in the analyses undertaken in this thesis. 
In total, there were 4 pairs of twins with trisomy 18 and 1 pair of trisomy 13 in the data. Each 
twin pair was taken to be 1 trisomy event, resulting in the exclusion of 1 case from each pair 
prior to finalising the dataset. Cases which had either an unaffected twin or one affected by a 
trisomy 21 were included in the analyses. There were no twin pairs reported to the NDSCR 
between 2004 and 2010 in which one twin had trisomy 18 and the other had trisomy 13. 
In total, 3,507 cases of trisomy 18 and 1,473 cases of trisomy 13 were included in the dataset 
analysed in this thesis. An overview of the characteristics of these cases is shown in tables 
3.4.1 to 3.4.4.  
 
Table 3.4.1 shows that during the study period, the prevalence of trisomies 18 and 13 
increased by around 25% for trisomy 18 and 29% for trisomy 13. This is likely due to a 
combination of increasing maternal age in England and Wales during this time period and 
advances in prenatal screening techniques resulting in more cases being detected prior to fetal 
loss and reported to the NDSCR. 
 
Table 3.4.1. Birth totals and prevalence per 10,000 births in England and Wales of trisomies 
18 and 13 by year. 
 
  England and Wales Trisomy 18 Trisomy 13 
  Births Births Prevalence Births Prevalence 
2004 639,721 393 6.14 171 2.67 
2005 645,835 466 7.22 186 2.88 
2006 669,601 503 7.51 229 3.42 
2007 690,013 518 7.51 224 3.25 
2008 708,711 531 7.49 217 3.06 
2009 706,248 541 7.66 199 2.82 
2010 723,165 555 7.67 247 3.42 
Total 4,783,294 3,507 7.33 1,473 3.08 
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Table 3.4.2. Sex distribution of cases of trisomies 18 and 13 during the study period. 
 
  Trisomy 18 (%) Trisomy 13 (%) 
Male 1487 (42.4) 737 (50.0) 
Female 1836 (52.4) 646 (43.9) 
Unknown 184 (5.2) 90 (6.1) 
 
Table 3.4.3. Maternal age mean and range for trisomies 18 and 13 during the study period. 
 
Age (years)  Trisomy 18 Trisomy 13 
Mean  36 34 
Minimum 15.4 15.1 
Maximum 51.8 50.8 
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b. Date of Sample with No Cluster Size Restrictions 
 
Table 3.4.4 shows no evidence of clustering for trisomy 18 when cases were arranged by 
sample date. 
 
Table 3.4.4. Date of Sample with No Cluster Size Restrictions – Trisomy 18 Results 
Government Office Region Total Cases Start Date End Date 
Cases in 
Cluster P Value 
North East 161 08-May-04 09-May-04 3 0.409 
North West 284 19-Dec-06 20-Dec-06 3 0.865 
Yorkshire and the Humber 229 10-May-09 20-May-09 6 0.852 
East Midlands 210 19-Oct-10 30-Dec-10 15 0.078 
West Midlands 305 03-Dec-06 05-Dec-06 4 0.650 
East of England 378 31-Oct-06 10-Jun-10 240 0.068 
London 847 13-Oct-10 15-Oct-10 7 0.250 
South East 529 11-Apr-10 28-Apr-10 14 0.341 
South West 333 06-Aug-08 07-Aug-08 4 0.325 
Wales 163 17-Oct-06 19-Oct-06 3 0.834 
 
Table 3.4.5 shows no evidence of clustering for trisomy 13 when cases were arranged by 
sample date. 
 
Table 3.4.5. Date of Sample with No Cluster Size Restrictions – Trisomy 13 Results 
Government Office Region Total Cases Start Date End Date 
Cases in 
Cluster P Value 
North East 93 11-Dec-08 12-Dec-08 3 0.075 
North West 129 14-Nov-07 18-Nov-07 4 0.384 
Yorkshire and the Humber 116 02-Jun-08 03-Jun-08 3 0.131 
East Midlands 84 17-Oct-10 20-Oct-10 3 0.465 
West Midlands 117 30-May-07 01-Jun-07 4 0.031 
East of England 153 13-Jun-08 16-Jun-08 3 0.939 
London 319 09-Jan-06 10-Jan-06 5 0.012 
South East 229 24-Jul-08 25-Jul-08 3 0.561 
South West 145 06-Apr-09 08-Apr-09 3 0.744 
Wales 52 13-Jul-05 24-Jul-05 3 0.895 
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c. Date of Sample with 20% Upper Limit 
 
Table 3.4.6 shows that after the cluster size limit was imposed, there was no evidence of 
clustering for trisomy 18. There was 1 change in the results due to the size limit, which was in 
the East of England. The most likely cluster contained 240 out of 378 cases without the size 
limit and 35 cases with the limit.  
 
Table 3.4.6. Date of Sample with 20% Upper Limit – Trisomy 18 Results 
Government Office Region Total Cases Start Date End Date 
Cases in 
Cluster P Value 
North East 161 08-May-04 09-May-04 3 0.402 
North West 284 19-Dec-06 20-Dec-06 3 0.860 
Yorkshire and the Humber 229 10-May-09 20-May-09 6 0.851 
East Midlands 210 19-Oct-10 30-Dec-10 15 0.073 
West Midlands 305 03-Dec-06 05-Dec-06 4 0.644 
East of England 378 31-Oct-06 14-Feb-07 35 0.156 
London 847 13-Oct-10 15-Oct-10 7 0.250 
South East 529 11-Apr-10 28-Apr-10 14 0.330 
South West 333 06-Aug-08 07-Aug-08 4 0.321 
Wales 163 17-Oct-06 19-Oct-06 3 0.829 
 
Table 3.4.7 shows that after the cluster size limit was imposed, there was no evidence of 
clustering for trisomy 13. No cluster sizes or locations changed in any region as a result of the 
upper limit.  
 
Table 3.4.7. Date of Sample with 20% Upper Limit – Trisomy 13 Results 
Government Office Region Total Cases Start Date End Date 
Cases in 
Cluster P Value 
North East 93 11-Dec-08 12-Dec-08 3 0.075 
North West 129 14-Nov-07 18-Nov-07 4 0.373 
Yorkshire and the Humber 116 02-Jun-08 03-Jun-08 3 0.129 
East Midlands 84 17-Oct-10 20-Oct-10 3 0.455 
West Midlands 117 30-May-07 01-Jun-07 4 0.031 
East of England 153 13-Jun-08 16-Jun-08 3 0.937 
London 319 09-Jan-06 10-Jan-06 5 0.012 
South East 229 24-Jul-08 25-Jul-08 3 0.552 
South West 145 06-Apr-09 08-Apr-09 3 0.738 
Wales 52 13-Jul-05 24-Jul-05 3 0.886 
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d. Date of Conception with No Cluster Size Restrictions 
 
Table 3.4.8shows no evidence of clustering for trisomy 18 when cases were arranged by date 
of conception. 
 
Table 3.4.8. Date of Conception with No Cluster Size Restrictions – Trisomy 18 Results 
Government Office Region Total Cases Start Date End Date 
Cases in 
Cluster P Value 
North East 156 03-Feb-09 05-Feb-09 3 0.701 
North West 259 23-Feb-10 24-Feb-10 3 0.851 
Yorkshire and the Humber 203 25-Sep-07 26-Sep-07 3 0.567 
East Midlands 195 14-Jun-10 16-Jun-10 4 0.244 
West Midlands 288 13-May-07 16-May-07 6 0.043 
East of England 361 30-Jan-06 27-Sep-09 238 0.061 
London 775 03-Jul-08 04-Jul-08 5 0.683 
South East 513 02-Mar-09 03-Mar-09 5 0.095 
South West 321 23-Dec-04 31-Dec-04 7 0.556 
Wales 148 05-Nov-06 06-Nov-06 3 0.272 
 
Table 3.4.9 shows no evidence of clustering for trisomy 13 when cases were arranged by date 
of conception. 
 
Table 3.4.9. Date of Conception with No Cluster Size Restrictions – Trisomy 13 Results 
Government Office Region Total Cases Start Date End Date 
Cases in 
Cluster P Value 
North East 86 16-May-10 18-May-10 3 0.298 
North West 113 04-Jan-10 06-Jan-10 3 0.563 
Yorkshire and the Humber 104 20-Jul-04 28-Jul-04 4 0.734 
East Midlands 76 14-Sep-05 21-Sep-05 3 0.993 
West Midlands 107 09-Feb-09 11-Feb-09 3 0.491 
East of England 147 27-May-06 29-May-06 3 0.729 
London 288 24-Apr-07 25-Apr-07 4 0.215 
South East 215 15-Jun-09 16-Jun-09 3 0.598 
South West 135 10-Nov-05 05-Apr-10 105 0.941 
Wales 48 19-Aug-08 03-Sep-08 4 0.618 
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e. Date of Conception with 20% Upper Limit 
 
Table 3.4.10. Date of Conception with 20% Upper Limit – Trisomy 18 Results 
Government Office Region Total Cases Start Date End Date 
Cases in 
Cluster P Value 
North East 156 03-Feb-09 05-Feb-09 3 0.691 
North West 259 23-Feb-10 24-Feb-10 3 0.849 
Yorkshire and the Humber 203 25-Sep-07 26-Sep-07 3 0.557 
East Midlands 195 14-Jun-10 16-Jun-10 4 0.240 
West Midlands 288 13-May-07 16-May-07 6 0.042 
East of England 361 31-Aug-06 07-Sep-06 8 0.130 
London 775 03-Jul-08 04-Jul-08 5 0.682 
South East 513 02-Mar-09 03-Mar-09 5 0.093 
South West 321 23-Dec-04 31-Dec-04 7 0.438 
Wales 148 05-Nov-06 06-Nov-06 3 0.267 
 
Table 3.4.10 shows that after the cluster size limit was imposed, there is no evidence of 
clustering for trisomy 18. The only change in results due to the size limit was a much smaller 
cluster identified in the East of England. 
 
Table 3.4.11. Date of Conception with 20% Upper Limit – Trisomy 13 Results 
Government Office Region Total Cases Start Date End Date 
Cases in 
Cluster P Value 
North East 86 16-May-10 18-May-10 3 0.294 
North West 113 04-Jan-10 06-Jan-10 3 0.552 
Yorkshire and the Humber 104 20-Jul-04 28-Jul-04 4 0.726 
East Midlands 76 14-Sep-05 21-Sep-05 3 0.881 
West Midlands 107 09-Feb-09 11-Feb-09 3 0.484 
East of England 147 27-May-06 29-May-06 3 0.724 
London 288 24-Apr-07 25-Apr-07 4 0.212 
South East 215 15-Jun-09 16-Jun-09 3 0.594 
South West 135 14-Nov-07 18-Nov-07 3 0.971 
Wales 48 19-Aug-08 03-Sep-08 4 0.603 
 
Table 3.4.11 shows that after the cluster size limit was imposed, there is no evidence of 
clustering for trisomy 13. The only change in results due to the size limit was a much smaller 
cluster identified in the South West. 
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f. Date of Conception: Sensitivity Analysis 
 
In order to assess the effect of excluding around 10% of cases for both trisomies for the 
temporal scans by date of conception, further analyses were performed after imputing date of 
conception for more individuals and removing the timeframe restriction (more details in 
chapter 2).  
As the temporal scans are based on the distribution of cases across the entire timeframe being 
studies, incomplete data at the beginning and end of the temporal period could cause the 
method to detect very large clusters including the majority of cases in the scan. For this 
reason, the previously used maximum cluster size limit of 20% of cases in the scan was applied.  
 
Table 3.4.12. Date of Conception with 20% Upper Limit – Trisomy 18 Results 
Government Office Region Total Cases Start Date End Date Cases in Cluster P Value 
North East 161 03-Feb-09 05-Feb-09 3 0.665 
North West 290 03-May-06 24-Mar-07 57 0.550 
Yorkshire and the Humber 226 23-Jul-04 30-Jul-04 6 0.300 
East Midlands 211 07-Apr-10 09-Apr-10 4 0.220 
West Midlands 304 13-May-07 16-May-07 6 0.027 
East of England 381 31-Aug-06 07-Sep-06 8 0.108 
London 849 28-Jan-09 31-Jan-09 7 0.313 
South East 538 02-Mar-09 03-Mar-09 5 0.046 
South West 335 23-Dec-04 31-Dec-04 7 0.431 
Wales 160 05-Nov-06 06-Nov-06 3 0.175 
 
Table 3.4.13. Date of Conception with 20% Upper Limit – Trisomy 13 Results 
Government Office Region Total Cases Start Date End Date Cases in Cluster P Value 
North East 93 16-May-10 18-May-10 3 0.278 
North West 130 04-Jan-10 06-Jan-10 3 0.463 
Yorkshire and the Humber 113 28-Oct-09 10-Nov-09 5 0.569 
East Midlands 85 11-Dec-04 17-Dec-04 3 0.859 
West Midlands 118 07-Aug-03 16-Aug-03 5 0.268 
East of England 155 27-May-06 29-May-06 3 0.644 
London 319 10-Jul-08 11-Jul-08 4 0.216 
South East 232 08-Apr-09 09-Apr-09 4 0.073 
South West 145 07-Sep-07 11-Sep-07 3 0.971 
Wales 53 19-Aug-08 03-Sep-08 4 0.615 
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The results in tables 3.4.12 and 3.4.13 show that imputing additional information and 
increasing the proportion of cases which can be included in the analyses has changed the size 
and time of clusters in some regions, however there are still no statistically significant results. 
The inclusion of the additional cases has therefore not made much difference to the results 
overall. 
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Section 3.5. Interpretation 
 
The results presented in this chapter show no evidence of temporal clustering of trisomies 18 
and 13 in England and Wales between 2004 and 2010 by estimated date of conception.  
Trisomies 18 and 13 are rare conditions with only a few hundred cases with each trisomy 
reported to the NDSCR every year. When this data is analysed by individual Government Office 
Region there are some regions which have very few cases, even when analysing 7 years of 
data. The fewest cases in one scan was for trisomy 13 in Wales when analysing by date of 
conception, in which there were 48 cases. The most cases in one scan was for trisomy 18 in 
London when analysing by date of sample, in which there were 847 cases. In section 2.3 
(Programming and Implementation), it was stated that an example was provided in the initial 
publication of the temporal scanning method. This example included test data of 35 cases of 
the congenital anomalies oesophageal atresia and tracheo-oesophageal fistula from 
Birmingham, U.K. between 1950 and 1955. It therefore appears unlikely either that the 
sparseness of the NDSCR data was problematic or that the method cannot adequately identify 
clusters in sparse data, as the method had previously been tested in a scenario with fewer 
cases than any of the individual scans performed in this chapter.  
Scanning each Government Office Region individually allows the location of any identified 
clusters to be more accurately determined and can be more informative, however there is also 
the possibility that clusters spanning 2 or more regions could go undetected using such an 
approach. The majority of the clusters identified were very small; including fewer than 10 
cases and taking place over less than a week, even without applying the cluster size limit. 
These clusters also occurred at different points in the timeframe, with no temporal correlation. 
It therefore seems unlikely that significant clusters would be revealed by analysing regions 
together. 
The cluster detection method used in this chapter is primarily intended to search for clusters 
rather than long term increases in prevalence which never return (or at least, not within the 
timeframe of the study) to the original level, and may not be able to detect increases of this 
nature. While long term increase in prevalence is a big concern, it is already known that the 
prevalence of both trisomies 18 and 13 increased during the study period (shown in table 
3.4.1), mainly as a result of increasing maternal age in England and Wales (as shown in figure 
1.3.8). The purpose of this thesis is to search for clusters which appear independently of this 
increase, which is why methods designed to detect long term changes in prevalence were not 
applied.  
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The most likely explanation for the lack of clusters present is that there was no temporal 
clustering in England and Wales between 2004 and 2010.  
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Chapter 4: Spatial Cluster Detection 
 
Section 4.1. Introduction 
Spatial cluster detection is the search for regions of space in which the occurrence of cases of 
interest are higher or lower than the surrounding areas. Spatial disease clusters occur 
wherever the prevalence of disease cases is significantly higher than expected. The discovery 
of spatial clusters can lead to the discovery of new risk factors and improvement in the overall 
understanding of the condition, which can be used to provide more accurate medical advice. 
One recent example of reported spatial disease clustering is the trisomy 21 clustering in the 
North of England reported by Mcnally et al in 2008. 
It would be expected that trisomies 18 and 13 cluster in the area of England and Wales with 
the highest maternal age as this is such a strong risk factor for both conditions. Trisomy risk 
starts to rapidly increase from the age of 35 (Savva et al 2010), so an increase in the number of 
mothers aged 35 and above would be expected to lead to an increased prevalence of trisomies 
18 and 13. 
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Section 4.2.Methods 
Scanning Window 
The spatial method uses a variable circular window to scan through the data and identify the 
most likely clusters. This window moves in two dimensional space (latitude and longitude 
coordinates are commonly used to identify spatial data points) to analyse the entire study 
region. Circles of increasing size are generated at specified points in the study region, and the 
total number of cases and controls within the circle is compared with those outside the circle 
(but within the study region). Different circle sizes are used to search for clusters of varying 
size.  
 
Grid Method 
There are two ways to determine the positions at which the circles are to be generated. The 
first is to lay a grid over a map of the study region and generate a circle at each grid 
intersection. This approach  examines the entire study region, and can therefore be very 
informative when data fills the study region. However, when data is unevenly distributed 
throughout the study region or when the study region is a non-uniform shape there will be grid 
intersections which are not situated close to any data points and are therefore non-
informative.  
 
Aggregated Method 
Alternately, when data has been aggregated into population groups it is possible to centre the 
circles at each aggregation point. Aggregating data is useful when cases / controls do not have 
sufficient information to be individually located, and instead groups individuals into population 
blocks. Aggregation can be by any population subgroup; commonly used groups include health 
regions and census districts. The main advantage of generating circles around aggregation 
points is that all information is included, but the program does not waste time scanning areas 
where there are no cases. 
 
Formula 
The spatial cluster scanning method uses a formula derived from the likelihood function under 
a binomial model, and is shown below. The formula is applied for each circle (z), where cz and 
nz are the number of cases and controls inside circle z, and C and N are the total number of 
cases and controls in the study region.  
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𝐿(𝑧) = (𝑐𝑧
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𝑁 − 𝑛𝑧
)(𝑁−𝑛𝑧)−(𝐶−𝑐𝑧) 
 
Monte Carlo 
Once the test statistic has been calculated, statistical significance is determined using Monte 
Carlo simulation (see Chapter 3), where each case is redistributed at random in the study 
region, the region is rescanned and the maximum test statistic is stored. This is repeated 999 
times to give a p value between 1 and 0.001.  
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Section 4.3.Implementation 
Case and population birth data between 2004 and 2010 were obtained from the NDSCR and 
Office for National Statistics respectively. Case data was available for most cases by maternal 
postcode, while the smallest population unit for which birth data was available was maternal 
primary care trust (PCT). There were 174 PCTs in England (152) and Wales (22) during the 
study period, with an average population of around 330,000 in 2006 and a mean of around 
3,847 births per PCT in the same year. Figure 4.1 shows the coordinates for the administrative 
centre of each PCT, which was taken to be the PCT centroid location. The postcode for each 
PCT administrative centre was obtained from the NHS Organisation Codes Service Access 
Database and converted to latitude and longitude coordinates. The NDSCR Annual Report 
stated that in 2006, 461 cases of trisomy 18 and 204 cases of trisomy 13 were reported to the 
register. This equals an expected prevalence of between 1 and 3 cases per PCT. The use of 
PCTs is an effective compromise between scan resolution and ensuring that cases are present 
at as many aggregation sites as possible. Use of aggregated districts smaller than PCTs would 
result in many districts having no cases present when running scans by individual year.  
 
Figure 4.1. Map of PCT administrative centres in England and Wales. Map generated in STATA 
using the spmap function. 
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PCT administrative centres are clustered around centres of population. This is illustrated in 
figure 4.1, where clusters of PCTs can be observed in England around major cities including 
London, Birmingham and Manchester. In a single year, the total number of births per PCT can 
vary between less than 1,000 to over 10,000 births. Table 4.1 shows the number of births per 
PCT in 2008 arranged into 8 groups on the basis of total births.  
 
Table 4.1.Number of births per PCT in 2008. 
 
Total Births in 2008 Number of PCTs 
Less than 1000 5 
Between 1000 and 2000 28 
Between 2000 and 3000 31 
Between 3000 and 4000 39 
Between 4000 and 5000 18 
Between 5000 and 6000 22 
Between 6000 and 10000 29 
Greater than 10000 2 
 
 
PCT locations and boundaries underwent major restructuring in 2006, when the total number 
of PCTs in England was reduced from 303 to 152. Case location data was converted to PCTs 
according to the 2006 boundaries. Population data was provided using the same boundaries 
for 2006, 2007 and 2008 but was unavailable for 2009 and 2010. Case data from 2004 and 
2005 was compared to birth data from 2006, while cases in 2009 and 2010 were compared to 
birth data from 2008. Over time, the number of births in England and Wales is increasing. 
669,376 births were reported in 2006 compared with 689,771 in 2007 and 708,549 in 2008, 
which is a 3.05% increase in the number of births from 2006 to 2007 and a 2.71% increase 
from 2007 to 2008. It therefore seems likely that of the available data, 2006 most closely 
resembles the expected birth figures from 2004 and 2005 while 2008 most closely resembles 
2009 and 2010. 
 For scans using all 7 years data combined, population birth data was generated by combining 
3 sets of 2006 and 2008 births with one set of 2007 births. Scans were performed using all data 
combined and also individually by calendar year.  A Bonferroni correction for multiple testing 
was applied for scans using all 7 years data individually. This reduced the significance threshold 
to 0.05 / 7 = 0.007.  
When using aggregated data, it is appropriate to generate circles at each aggregation point 
rather than using intersection points on a grid. Using this method does not adversely affect 
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power as areas with high concentrations of cases are still scanned, however the program runs 
more efficiently as no circles are generated in parts of the region where there are no cases.   
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Section 4.4.Programs 
The Kulldorff and Nagarwalla spatial cluster detection method was programmed into 2 
programs using the R statistical package. This method is henceforth referred to as the R 
Program. The first program read in a data file containing PCT location and the total number of 
cases and noncases within each PCT. The scan statistics of the 10 strongest clusters were then 
returned. P-values were then calculated using Monte Carlo simulation in the second program. 
A copy of both programs is included in the appendix. 
Results generated in the R Program were compared with a second set of scans using Kulldorff’s 
widely used SaTScan program. Results were expected to be comparable but not identical due 
to differences between the way in which the programs generate circles. Circles in R were 
generated using latitude and longitude values as radii, while SaTScan generates circles using 
kilometres as the radius size variable. This is significant as latitude and longitude values are not 
always equivalent, for example in England and Wales a latitude difference of 1 is equivalent to 
around 111km compared to a longitude difference of 1 which is around 70km. Consequently, 
circles generated in R were elliptical in shape while those in SaTScan were circular. Neither 
approach is superior or inferior to the other, however the difference would be expected to 
lead to a slight variation in cluster locations and p values. As another result of this difference, 
the methods generate circles of different sizes. Again this is only expected to lead to small 
changes in results.  
In order to prevent both methods from returning excessively large clusters, the maximum 
circle radius was restricted to 90km in SaTScan and 1 unit of latitude and longitude in R. A 
90km limit was chosen for SaTScan as the resulting circle would be of a similar area to the 
largest circle generated by the R Program (25,444km2 in SaTScan vs 24,408km2 in R). A 
comparison of results is provided between R, SaTScan with a 90km radius limit and SaTScan 
with no radius limit.  
In addition to differences in circle size and shape, there are 2 other main differences between 
R and SaTScan which would not be expected to lead to any difference in the results.  
 
Gumbel Approximation in SaTScan 
SaTScan uses a Gumbel Approximation method which allows the program to calculate p-values 
lower than 0.001 even when using 999 sets of simulated results. The maximum likelihood ratio 
from each iteration of the Monte Carlo simulation is used to fit a Gumbel distribution to the 
data, and the resulting estimate of the p-value is the probability that this distribution 
generates a value greater than the observed maximum likelihood ratio for the real dataset. 
This method has been demonstrated to fit the data very well using the SaTScan spatial scan. 
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Sequential Monte Carlo Simulation in SaTScan 
SaTScan uses a sequential Monte Carlo simulation method (Besag& Clifford, 1991) which 
allows the program to terminate the scan when the p-value is insignificant. Scans terminate 
when a fixed number of replicates (the default value is 50 for a 999 replicate Monte Carlo 
scan) have a test statistic greater than that of the observed data. This method does not 
negatively affect power at the 0.05 level, and allows the program to run more quickly when 
there is no evidence of clustering. 
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Section 4.5.Synthetic Data Testing 
Section 4.5.1.Method 
Detection performance for both methods was evaluated using synthetic data. The aim of this 
testing was to evaluate the power of the novel method in R and SaTScan and ensure that both 
programs returned expected results. A data set was created with a fixed number of cases (x) 
and controls (y) in each PCT, with 1 distinct region selected as a simple model cluster. Within 
the cluster, the initial number of cases in each PCT was set at x + 1 and increased by 1 until a 
highly significant p value had been obtained in both programs.  
The test cluster was located in 12 PCTs in the North East of England. This region was chosen 
because it could be identified using both R and SaTScan without including any other PCTs. As 
the programs use different circle sizes and shapes, the test cluster had to be an isolated group 
of PCTs. 
 
Figure 4.2.Location of the synthetic test cluster. 
 
The test data was chosen to approximate the real data as closely as possible by assigning each 
test PCT the mean number of births per PCT in 2008. In 2008, there were a total of 708,459 
births in 174 PCTs, equal to a mean of 4071 births per PCT. For convenience when calculating 
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case: control ratios, this figure was rounded down to 4,000 births per PCT, which was a total of 
696,000 births in the test data. 
The programs were compared using a range of disease prevalence values. In PCTs outside the 
cluster, values of x were evaluated from 1 to 6. This range represents all prevalence figures 
which will be observed in the NDSCR case data (observed prevalence ranges from under 1 case 
per PCT for trisomy 13 to over 3 cases per PCT for trisomy 18) while also testing higher 
prevalence scenarios. 
 
Section 4.5.2.Results 
Results in tables 4.5.1 – 4.5.6 demonstrate that under simple simulated conditions, the p 
values returned by both programs are similar. The test cluster is always identified as the 
strongest cluster by both programs unless the total number of cases per PCT is the same inside 
and outside the test cluster region. The R program returns lower p values than SaTScan does, 
but these differences are small and can be accounted for by slight differences between the 
programs such as using different circle shapes and sizes.  
 
Table 4.5.1. 1 case per PCT outside cluster 
Cases per PCT   P Value 
Inside Cluster Outside Cluster Relative Risk SaTScan R 
1 1 1.00 1 1 
2 1 2.00 0.52 0.5 
3 1 3.00 < 0.001 0.001 
 
Table 4.5.2. 2 cases per PCT outside cluster 
Cases per PCT   P Value 
Inside Cluster Outside Cluster Relative Risk SaTScan R 
2 2 1.00 1 1 
3 2 1.50 1 0.99 
4 2 2.00 0.016 0.006 
5 2 2.50 < 0.001 0.001 
 
Table 4.5.3. 3 cases per PCT outside cluster 
Cases per PCT   P Value 
Inside Cluster Outside Cluster Relative Risk SaTScan R 
3 3 1.00 1 1 
4 3 1.33 1 1 
5 3 1.67 0.14 0.096 
6 3 2.00 < 0.001 0.001 
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Table 4.5.4. 4 cases per PCT outside cluster 
Cases per PCT   P Value 
Inside Cluster Outside Cluster Relative Risk SaTScan R 
4 4 1.00 1 1 
5 4 1.25 1 1 
6 4 1.50 0.59 0.21 
7 4 1.75 0.005 0.001 
8 4 2.00 < 0.001 0.001 
 
Table 4.5.5. 5 cases per PCT outside cluster 
Cases per PCT   P Value 
Inside Cluster Outside Cluster Relative Risk SaTScan R 
5 5 1.00 1 1 
6 5 1.20 1 1 
7 5 1.40 0.77 0.654 
8 5 1.60 0.016 0.011 
9 5 1.80 < 0.001 0.001 
 
Table 4.5.6. 6 cases per PCT outside cluster 
Cases per PCT   P Value 
Inside Cluster Outside Cluster Relative Risk SaTScan R 
6 6 1.00 1 1 
7 6 1.17 1 1 
8 6 1.33 0.89 0.726 
9 6 1.50 0.064 0.03 
10 6 1.67 < 0.001 0.001 
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Section 4.6.Analysis 
Section 4.6.1.Distribution of Cases 
Prevalence of trisomies 18 and 13 between 2004 and 2010 in each PCT were calculated and 
presented in figures 4.3 and 4.4. Groups of high prevalence PCTs may indicate the location of 
possible clusters.  
Figure 4.3 shows one strong cluster location with several high prevalence PCTs in central and 
west London. This location is the only grouping of PCTs with prevalence of greater than 10 in 
10,000 births, and would be expected to be detected as an extremely strong cluster by both R 
and SaTScan.  
 
Figure 4.3.Prevalence of trisomy 18 according to PCT in England and Wales from 2004 to 2010. 
< 2 in 10,000 Births
> 2 in 10,000 Births
> 4 in 10,000 Births
> 6 in 10,000 Births
> 8 in 10,000 Births
> 10 in 10,000 Births
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Figure 4.4 appears to show two potential cluster locations for trisomy 13; one in central and 
west London and another in the North East. The London cluster is larger and contains more 
PCTs, however the north east cluster shows a localised group of 5 PCTs all with prevalence of 
greater than 5 in 10,000 births. It is probable that the larger cluster will be more easily 
detected, however the north east could also be identified as a secondary cluster hotspot.  
 
Figure 4.4.Prevalence of trisomy 13 according to PCT in England and Wales from 2004 to 2010. 
  
< 1 in 10,000 Births
> 1 in 10,000 Births
> 2 in 10,000 Births
> 3 in 10,000 Births
> 4 in 10,000 Births
> 5 in 10,000 Births
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Section 4.6.2.Trisomy 18 Scan Results 
By Individual Calendar Year 
Table 4.6.1 shows that for trisomy 18 data analysed by individual calendar year there was 
significant evidence of clustering detected by both R and SaTScan. The programs detected 
overlapping clusters in each of the 7 years scanned, and after applying a Bonferroni correction 
for multiple testing the same 5 clusters (2004, 2006, 2008, 2009 and 2010) were judged 
significant by both programs.  
 
Table 4.6.1. Trisomy 18 scan results by calendar year. 
    Centroid Coordinates Circle Radius     
Year 
Cases in 
Cluster Latitude Longitude Vertical Horizontal P Value Scan 
2004  174 51.908 N 0.443 W 111 70 0.001 R 
  186 51.908 N 0.443 W 81.73 81.73 <0.0001 S 
2005 148 50.841 N 0.144 W 99.9 63 0.072 R 
  76 51.509 N 0.477 W 25.86 25.86 0.026 S 
2006 117 51.908 N 0.443 W 66.6 42 0.001 R 
  148 51.908 N 0.443 W 55.27 55.27 <0.0001 S 
2007 194 51.574 N 0.071 E 99.9 63 0.018 R 
  148 51.879 N 0.544 E 70.19 70.19 0.023 S 
2008 235 51.391 N 0.302 W 77.7 49 0.001 R 
  245 51.391 N 0.302 W 72.73 72.73 <0.0001 S 
2009 176 51.206 N 0.797 W 88.8 56 0.001 R 
  170 51.206 N 0.797 W 62.99 62.99 <0.0001 S 
2010 113 51.460 N 0.239 W 22.2 14 0.001 R 
  77 51.351 N 0.165 W 17.87 17.87 <0.0001 S 
 
Indicates overlapping clusters detected in R and SaTScan.  
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SaTScan Radius Limit Comparison 
Table 4.6.2 shows that imposing a 90km limit on the maximum cluster size detected by 
SaTScan had no major effect on the reported clusters. There were small changes in cluster 
centroids for 6 out of 7 years, however the identified clusters showed significant overlap and 
would have included many of the same PCTs. While it would be expected that clusters with 
fewer cases were detected using the 90km limit, results in 2004 show that the most significant 
clusters with and without the 90km radius limit included the same number of cases. This is due 
to a change in the cluster centroid location which meant that the cluster detected using the 
90km limit was in a more densely populated region and therefore included more cases relative 
to the cluster radius. 
 
Table 4.6.2.Trisomy 18 comparison of SaTScan results using a 90km radius limit or no 
geographical limit. 
    Coordinates         
Year 
Cases In 
Cluster Latitude Longitude Radius P-Value Limit Overlap? 
2004 186 50.749 N 1.880 W 155.1 <0.0001 None Yes 
  186 51.908 N 0.443 W 81.73 <0.0001 90km   
2005 197 50.701 N 1.306 W 134.54 0.017 None Yes 
  76 51.509 N 0.477 W 25.86 0.026 90km   
2006 248 52.022 N 0.791 W 92.81 <0.0001 None Yes 
  148 51.908 N 0.443 W 55.27 <0.0001 90km   
2007 263 51.404 N 0.774 W 112.03 0.017 None Yes 
  148 51.879 N 0.544 E 70.19 0.023 90km   
2008 327 51.908 N 0.443 W 125.68 <0.0001 None Yes 
  245 51.391 N 0.302 W 72.73 <0.0001 90km   
2009 307 50.704 N 1.306 W 170.66 <0.0001 None Yes 
  170 51.206 N 0.797 W 62.99 <0.0001 90km   
2010 77 51.351 N 0.165 W 17.87 <0.0001 None Yes 
  77 51.351 N 0.165 W 17.87 <0.0001 90km   
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All Data from 2004 - 2010 
R 
Cases Centroid Coordinates Radius (km)   
Total In Cluster Latitude Longitude Vertical Horizontal P Value 
3321 1068 51.509 N 0.477 W 55.5 35 0.001 
 
 
Figure 4.5. Map of trisomy 18 cluster by PCT using all data from 2004-2010 in R. 
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SaTScan 
Cases Centroid Coordinates     
Total In Cluster Latitude Longitude Radius (km) P Value 
3321 1109 51.404 N 0.774 W 60.21 1E-17 
 
 
Figure 4.6. Map of trisomy 18 cluster by PCT using all data from 2004-2010 in SaTScan. 
 
Figures 4.5 and 4.6 show that when analysing all trisomy 18 data together, R and SaTScan both 
detect very strong clusters in London which are almost identical in size and location. 
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Section 4.6.3 Trisomy 13 Scan Results 
By Individual Calendar Year 
Table 4.6.3 shows that for trisomy 13 data analysed by individual calendar year there was 
significant evidence of clustering detected by both R and SaTScan. After applying the 
Bonferroni correction, significant clusters were detected by both programs in 2006, 2009 and 
2010. Clusters in 2006 and 2010 were located in London while the centroid of the 2009 cluster 
was situated in Bristol.  
 
Table 4.6.3. Trisomy 13 scan results by calendar year. 
    Centroid Coordinates Circle Radius     
Year 
Cases in 
Cluster Latitude Longitude Vertical Horizontal P Value Scan 
2004 18 50.806 N 1.062 W 55.5 35 0.23 R 
  27 50.820 N 0.424 W 63.96 63.96 0.059 S 
2005 4 55.161 N 1.691 W 11.1 7 0.69 R 
  14 51.009 N 3.115 W 62.89 62.89 0.58 S 
2006 27 51.391 N 0.302 W 33.3 21 0.001 R 
  50 51.509 N 0.477 W 25.86 25.86 0.0002 S 
2007 42 51.904 N 2.097 W 77.7 49 0.25 R 
  24 51.904 N 2.097 W 59.82 59.82 0.096 S 
2008 76 51.206 N 0.797 W 88.8 56 0.011 R 
  72 51.206 N 0.797 W 62.99 62.99 0.039 S 
2009 14 51.461 N 2.592 W 33.3 21 0.001 R 
  16 51.461 N 2.592 W 39.15 39.15 0.0062 S 
2010 90 51.492 N 0.137 W 11.1 7 0.005 R 
  27 51.492 N 0.137 W 7.83 7.83 0.006 S 
 
Indicates overlapping clusters detected in R and SaTScan.  
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SaTScan Radius Limit Comparison 
Table 4.6.4 shows that when imposing a 90km limit on the maximum cluster size detected by 
SaTScan, the geographical location of the primary cluster either remained the same or had a 
very strong overlap with the previously identified cluster when there was evidence of 
clustering present in the data. Limiting the size of the cluster did affect the p value on 2 
occasions (2007 and 2008), changing the result for that year from apparent clustering to no 
apparent clustering. In 2009 the introduction of the 90km limit did not change the cluster 
location or size, but did marginally change the p value.  
 
Table 4.6.4.Trisomy 13 comparison of SaTScan results using a 90km radius limit or no 
geographical limit. 
    Centroid Coordinates         
Year 
Cases In 
Cluster Latitude Longitude Radius P-Value Limit Overlap? 
2004 27 50.820 N 0.424 W 64.0 0.061 None Yes 
  27 50.820 N 0.424 W 64.0 0.059 90km   
2005 76 50.749 N 1.880 W 153.3 0.397 None No 
  14 51.009 N 3.115 W 62.9 0.58 90km   
2006 50 51.509 N 0.477 W 25.9 <0.0001 None Yes 
  50 51.509 N 0.477 W 25.9 <0.0001 90km   
2007 119 51.549 N 1.731 W 113.7 0.0021 None Yes 
  24 51.904 N 2.097 W 59.8 0.096 90km   
2008 94 50.704 N 1.306 W 129.2 0.007 None Yes 
  72 51.206 N 0.797 W 63.0 0.039 90km   
2009 16 51.461 N 2.592 W 39.2 0.0084 None Yes 
  16 51.461 N 2.592 W 39.2 0.0062 90km   
2010 132 51.908 N 0.443 W 114.2 0.0033 None Yes 
  27 51.492 N 0.137 W 7.8 0.006 90km   
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All Data from 2004 - 2010 
R 
Cases Centroid Coordinates Radius (km)   
Total In Cluster Latitude Longitude Vertical Horizontal P Value 
1382 219 51.587 N 0.270 W 22.2 14 0.001 
 
 
 
Figure 4.7. Map of trisomy 13 cluster by PCT using all data from 2004-2010 in R. 
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SaTScan 
Cases Centroid Coordinates     
Total In Cluster Latitude Longitude Radius (km) P Value 
1382 334 51.408 N 0.843 W 52.87 5.5E-11 
 
 
 
Figure 4.8. Map of trisomy 13 cluster by PCT using all data from 2004-2010 in SaTScan. 
 
Figures 4.7 and 4.8 show that R and SaTScan both detect very strong evidence of clustering in 
London when analysing trisomy 13 data from 2004 to 2010. The cluster reported by R is 
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smaller than that of SaTScan and the centroid is at a different, although close, PCT site. The 
SaTScan cluster includes the entire R cluster and some additional PCTs to the west of London.  
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Section 4.7.Summary 
R and SaTScan detect the same clusters when significant clusters are present. This was 
assessed using synthetic data, which showed that both methods could detect the same 
clusters and returned comparable p values in a simple scenario with one cluster present in a 
study region of otherwise uniform prevalence. There were small differences in p-values 
between the programs, which are most likely caused by differences in circle size and shape 
having a small effect during Monte Carlo simulation.  
Use of synthetic data demonstrated that both methods can detect clusters with a relative risk 
of between 1.8 and 3 compared to the remainder of the study region. The required relative 
risk changes depending on the prevalence of the condition; as the disease prevalence 
increases, the required relative risk decreases. Given the observed prevalence of trisomies 18 
and 13, a relative risk of between 2 and 3 would be required for a cluster to be deemed 
significant. Required relative risk may also depend on the number and size of PCTs within the 
cluster. Larger clusters will be easier to detect and will require a smaller relative risk to be 
significant, while large PCTs (i.e. PCTs with a large number of births compared to other PCTs) 
are also likely to be easier for the methods to detect.  
An isolated cluster was chosen for the synthetic data testing in order to make comparisons 
between results simpler. If a cluster had been chosen in a more densely populated region then 
the strongest cluster detected by each method may include other PCTs. The different shapes 
(cluster or ellipse) may favour one method over the other, depending on the position of other 
PCTs. Using an isolated cluster favours neither shape. However the results are likely to be 
generalizable to a cluster in another area. 
The primary purpose of chapter 4 was to establish whether there were spatial clusters of 
trisomies 18 and 13 in England and Wales from 2004 to 2010. Significant evidence of clustering 
was detected for both trisomies using both R and SaTScan, the majority of which was in 
London. 
In this chapter, the method detailed by Kulldorff and Nagarwalla was written into a custom 
program in R and compared with SaTScan, a widely used free piece of software for the 
detection of spatial clusters. The main weakness of both of these programs is that each is 
optimised to search for clusters of a predetermined shape. SaTScan is best suited to detecting 
circular clusters, while R is best suited to detecting elliptical clusters. Both programs lose 
power when searching for clusters which are not of their optimal shape (Duczmal & Assuncao, 
2004). It is possible that clusters of alternate shape (such as long, thin clusters), or clusters of 
irregular shape, could be present but cannot be detected using either program.  
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To conclude, it appears likely that the observed clusters in London were caused by advanced 
mean maternal age in London compared to other parts of England and Wales.  
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Chapter 5: Adjusted Spatial Cluster Detection 
 
Section 5.1.Introduction 
In chapter 4, evidence for clustering in both trisomies 18 and 13 was presented. The majority 
of clusters were located in London. Table 5.1 shows that in 2008, the highest proportion of 
births at the high risk maternal age groups (35-39 and 40-44) was observed in London 
compared to other government office regions in England and Wales (Office for National 
Statistics Birth Statistics 2008 Report). The next highest figure for both age groups was 
observed in the South East region. It would therefore be expected that if any age related 
clusters were present in the data, they would be in London.  
 
Table 5.1.Proportion of births by government office region and maternal age group in 2008. 
 
Government Office Region 15-19 20-24 25-29 30-34 35-39 40-44 
North East 9.1 20.8 29.2 26.9 11.9 2.2 
North West  7.4 20.2 29.4 27.5 12.9 2.5 
Yorkshire and the Humber 8.0 20.2 28.4 28.3 12.6 2.4 
East Midlands  6.9 19.5 29.8 28.3 12.8 2.7 
West Midlands  7.3 21.2 29.0 27.2 12.6 2.6 
East of England 5.2 18.3 29.1 29.8 14.7 2.9 
London  5.9 17.5 22.8 28.2 20.0 5.5 
South East 5.1 16.6 27.0 31.3 16.4 3.5 
South West 5.7 17.2 28.9 30.1 15.0 3.1 
Wales  8.0 20.5 29.3 27.2 12.7 2.4 
 
 
It is also possible that the appearance of clusters could be caused by regional differences in 
gestational age at diagnosis. Fetal loss rates are very high in trisomy 18 and trisomy 13 
pregnancies, and areas which routinely screen from 10 weeks gestation will diagnose more 
cases than those which screen later. The observed trisomy prevalence will therefore be higher 
in areas which screen early compared to those which screen late. This difference may be 
sufficient to produce (or at least contribute to) clusters. Prenatal screening from 10 weeks 
gestation is currently offered in all areas of England and Wales, but at the time of data 
collection many areas did not routinely screen at such early gestations,  
In order to detect age-independent clusters, a novel method was  developed to weight cases 
individually based on their maternal age and gestational age at diagnosis. Each case was 
assigned a weight which was then applied to the total number of cases in each PCT; so if a PCT 
contained one case with weight 0.5 and one case with weight 1, there would be a total of 1.5 
cases in that PCT. Weights were retained for each case in Monte Carlo simulation.  
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Methods to account for maternal age and gestational age at diagnosis were required as both 
could be expected to lead to the formation of clusters. One significant advantage of weighting 
cases individually is that for each case, more than 1 weight can be applied at once by assigning 
and multiplying weights, to give an overall weight for each case. This theoretically allows a 
direct case weighting approach to account for as many factors as required.   
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Section 5.2.Methods 
Section 5.2.1.Adjusting in R 
Gestational Age 
All terminations under 20 weeks of gestation at diagnosis were weighted based on their 
likelihood of surviving to 20 weeks based on gestational age-specific fetal loss rates for 
trisomies 18 and 13 in England and Wales (Savva and Morris, 2008) (See table 5.2.1).  
 
Table 5.2.1.Gestational age-specific weights. 
 
  Weight 
Gestational Age at Diagnosis (Weeks) Trisomy 18 Trisomy 13 
< 14 0.754 0.844 
14 0.792 0.869 
15 0.831 0.894 
16 0.864 0.922 
17 0.921 0.941 
18 0.941 0.962 
19 0.971 0.983 
> 19 1 1 
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Maternal Age 
Maternal age weights were calculated using previously published maternal age-specific 
trisomy 18 and 13 prevalence figures (Savvaet al, 2010). The median population maternal age 
of England and Wales is 29.5, and cases born to women aged 29 were assigned a weight of 1. 
All other maternal ages were weighted according to the formula below. 
 
For maternal age x:  Weight = 𝑃𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑎𝑡 𝑎𝑔𝑒 29
𝑃𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑎𝑡 𝑎𝑔𝑒 𝑥  
 
Table 5.2.2.Maternal age-specific weights. 
 
Maternal Age T13 Prevalence T13 Weight T18 Prevalence T18 Weight 
< 24 0.7 1.2857 1.1 1.1818 
24 0.8 1.1250 1.1 1.1818 
25 0.8 1.1250 1.2 1.0833 
26 0.8 1.1250 1.2 1.0833 
27 0.8 1.1250 1.2 1.0833 
28 0.8 1.1250 1.2 1.0833 
29 0.9 1.0000 1.3 1.0000 
30 0.9 1.0000 1.4 0.9286 
31 1.0 0.9000 1.5 0.8667 
32 1.1 0.8182 1.7 0.7647 
33 1.3 0.6923 1.9 0.6842 
34 1.6 0.5625 2.3 0.5652 
35 1.9 0.4737 2.8 0.4643 
36 2.5 0.3600 3.7 0.3514 
37 3.2 0.2813 4.9 0.2653 
38 4.2 0.2143 6.0 0.2167 
39 5.5 0.1636 9.7 0.1340 
40 7.0 0.1286 13.6 0.0956 
41 8.6 0.1047 18.8 0.0691 
42 10.3 0.0874 25.1 0.0518 
43 11.9 0.0756 32.2 0.0404 
44 13.4 0.0672 39.6 0.0328 
45 14.6 0.0616 46.8 0.0278 
46 15.6 0.0577 53.3 0.0244 
47 16.4 0.0549 58.9 0.0221 
48 17.0 0.0529 63.5 0.0205 
49 17.4 0.0517 67.2 0.0193 
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Section 5.2.2.Adjusting in SaTScan 
It is not possible to enter non-integer totals of cases in SaTScan, so another method of 
weighting cases had to be used. While it was possible to apply the weights and round the total 
for each PCT to give an integer value, this would not have been very inaccurate due to the 
small case numbers present in many PCTs and likely errors when reassigning cases for Monte 
Carlo simulation.  
There is a method in SaTScan to adjust for known relative risks by using an adjustment file. 
From the SaTScan user guide: 
“Sometimes it is known a priori that a particular location and/or time has a higher or lower risk 
of known magnitude, and we want to detect clusters above and beyond this, or in other 
words, we want to adjust for this known excess/lower risk. One way to do this is to simply 
change the population at risk numbers in the population file. A simpler way is to use the 
adjustments file. In this file, a relative risk is specified for any location and time period 
combination. The expected counts are then multiplied by this relative risk for that location and 
time. For example, if it is known from historical data that a particular location typically have 50 
percent more cases during the summer months June to August, then for each year one would 
specify a relative risk of 1.5 for this location and these months. A summer cluster will then only 
appear in this location if the excess risk is more than 50 percent.” 
Using the mean of the case weights, specific risks can be calculated for each PCT and applied in 
the adjustments file. For example, a PCT has 3 cases, all of which have older mothers and have 
subsequently been assigned low weights. The resulting adjustment in SaTScan should be 
greater than 1 as more cases are expected in that PCT due to high maternal age. The case 
weights are 0.25, 0.5 and 0.75, with a mean case weight of 0.5. In SaTScan the adjustment is 
applied to the expected number of cases rather than the observed number, so the inverse of 
the mean case weight must be taken. In this example the SaTScan adjustment is 2.  
There are three major differences between this weighting method and the direct case 
weighting method used in R which may affect the results. Firstly, the adjustment is being 
applied to the expected number of cases in a PCT rather than the observed number. Secondly, 
weights are static and cannot be reassigned when calculating p-values. All cases are reassigned 
without weighting, but a PCT will have the same relative risk for the initial scan and then for 
each iteration of the Monte Carlo simulation. Finally, any PCT which has no cases present in 
the scan cannot be adjusted and must instead be assigned a default risk of 1. This is not a 
problem when scanning all cases from 2004-2010 as there are very few PCTs with no cases, but 
for single year scans there are a high proportion of PCTs with no cases in the scan. For 
example, in 2004 there were 91 PCTs (over 50%) without any trisomy 13 cases. This means that 
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when calculating p-values, some weighted PCTs may be assigned no cases and therefore the 
weighting for that PCT will be lost. Applying case weights directly always retains full weighting 
information in Monte Carlo simulation. 
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Section 5.3.Test Data 
Section 5.3.1. Accounting for Simulated Clusters in Synthetic Data 
Methods 
In chapter 4, it was demonstrated that R and SaTScan obtained similar results when calculating 
cluster significance by using an idealised test data set with uniform disease prevalence apart 
from a cluster of 12 PCTs in the North East.  
A similar method can be used to test whether the programs return expected results when 
accounting for a previously detected cluster. Starting with a highly significant cluster, cases 
within the cluster were weighted down gradually until the total number of weighted cases in 
each PCT within the cluster was equal to the total number of cases in all other PCTs. For 
example, starting with 1 case per PCT outside the cluster and 4 cases per PCT within the 
cluster, cases within the cluster were weighted to give a total of 3 cases per PCT, followed by 2 
cases per PCT and finally 1 case per PCT. In SaTScan the corresponding adjustment was 
calculated and applied. As the number of cases per PCT outside the cluster increased, so did 
the number inside the cluster. When there were 2 cases per PCT outside the cluster, the initial 
number within the cluster was set as 5. Similarly, when there were 4 and 6 cases per PCT 
outside the cluster the initial number of cases within was 8 and 11 respectively. These 
numbers were chosen to ensure that the unadjusted scan always returned a very strong 
cluster in order to assess the effect of applying the weights. 
 
Results 
Tables 5.3.1 to 5.3.4 show that R and SaTScan both successfully account for a single test 
cluster. Differences between p-values are mostly small although can exceed an order of 
magnitude, for example the relative risk of 2 in table 5.3.1. However, these differences can be 
attributed to the weights being applied in different ways and differences in Monte Carlo 
simulation which were discussed in chapter 4, which can have a large effect in conditions of 
low prevalence such as in the aforementioned tests. For comparison, the tests in table 5.3.4 
produce much closer p-values when the prevalence is increased to 6 cases per PCT outside the 
cluster. 
 
 
 
 
 
 130 
 
Table 5.3.1. Case adjustment from 4 to 1 cases per PCT within test cluster 
SaTScan Analysis R Analysis 
Adjustment P Value P Value Weighted Cases 
1.00 6.60E-10 0.001 4 
1.33 0.000004 0.001 3 
2.00 0.026 0.304 2 
4.00 1.000 1.000 1 
 
 
Table 5.3.2. Case adjustment from 5 to 2 cases per PCT within test cluster 
SaTScan Analysis R Analysis 
Adjustment P Value P Value Weighted Cases 
1.00 0.000088 0.001 5 
1.25 0.00078 0.006 4 
1.67 0.800 0.942 3 
2.50 1 1 2 
 
 
Table 5.3.3. Case adjustment from 8 to 4 cases per PCT within test cluster 
SaTScan Analysis R Analysis 
Adjustment P Value P Value Weighted Cases 
1 0.0000054 0.001 8 
1.14 0.00083 0.001 7 
1.33 0.115 0.214 6 
1.6 1 1 5 
2 1 1 4 
 
 
Table 5.3.4. Case adjustment from 11 to 6 cases per PCT within test cluster 
SaTScan Analysis R Analysis 
Adjustment P Value P Value Weighted Cases 
1.00 0.0000014 0.001 11 
1.10 0.0061 0.001 10 
1.22 0.011 0.030 9 
1.38 0.640 0.726 8 
1.57 1.000 1.000 7 
1.83 1.000 1.000 6 
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Section 5.3.2.Adjustment using Randomly Allocated Weights 
Methods 
While there were only small differences between p-values when accounting for a single 
cluster, it is possible that the different ways in which weights are applied could create 
differences between the results in R and SaTScan. In order to investigate whether both 
methods give expected results, a set of data was generated which contained a randomly 
allocated set of weights. As all weights were random, no clusters would be expected in this 
data. 
Weights were allocated to PCTs at random in a uniform population of 4 cases and 4,000 births 
per PCT. For the purpose of this test, all cases in a given PCT were assigned the same weight. 
Weights were calculated using a random number generator in R between 1 and a set 
maximum value of 10, 20 or 40, to give a minimum case weight of 0.1, 0.05 or 0.025 
respectively. These figures were selected in order to determine how well each program could 
handle more extreme weighting methods, such as that used to account for maternal age. In 
order to reduce the risk of obtaining anomalous results, 5 sets of random weights were 
calculated for each weighting range.  
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Results 
Tables 5.3.5 and 5.3.6 show the results obtained in R and SaTScan when weights between 0.1 
and 1 were applied to PCTs at random. Table 5.4.1 shows that in R, no clusters were detected 
and for all tests the most likely cluster had a p-value of over 0.5. Table 5.4.2 shows that in 
SaTScan, much stronger clusters were detected with 4 of the 5 p-values falling below 0.1. 
Three p-values fell below 0.05 and would be considered significant at the 5% level. This shows 
a clear difference between R and SaTScan, and given that the randomly assigned weights 
would not be expected to lead to clustering, implies that the weighting method in SaTScan is 
not working as intended. 
 
Table 5.3.5. R, Relative Risk Range 1-10 
 
Cases Centroid Radius (km)   
Total In Cluster Latitude Longitude Horizontal Vertical P Value 
380.4 47.6 51.574 N 0.071 E 14 22.2 > 0.5 
410.0 42.8 51.681 N 0.614 W 28 44.4 > 0.5 
388.0 11.6 52.521 N 2.012 W 7 11.1 > 0.5 
371.2 40.8 50.820 N 0.424 W 49 77.7 > 0.5 
353.2 16.8 51.700 N 4.121 W 42 66.6 > 0.5 
 
Table 5.3.6.SaTScan, Relative Risk Range 1-10 
 
Cases Centroid Radius (km)   
Total In Cluster Latitude Longitude Horizontal Vertical P Value 
696 12 53.544 N 2.128 W 12.37 12.37 0.021 
696 8 52.265 N 0.870 W 27.51 27.51 0.083 
696 16 53.158 N 1.605 W 30.93 30.93 0.032 
696 24 52.580 N 0.249 W 62.55 62.55 0.037 
696 20 51.700 N 4.121 W 48.51 48.51 0.266 
 
Tables 5.3.7 and 5.3.8 show the results obtained in R and SaTScan when weights between 0.05 
and 1 were applied to PCTs at random. No clusters were detected in R, while SaTScan detected 
significant clusters (p < 0.05) in 4 of the 5 tests. In 2 of these tests, the p-value was below 
0.001.  
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Table 5.3.7. R, Relative Risk Range 1-20 
 
Cases Centroid Radius (km)   
Total In Cluster Latitude Longitude Horizontal Vertical P Value 
370.6 76.8 52.265 N 0.870 W 70 111.0 > 0.5 
368.6 26.6 53.424 N 1.351 W 35 55.5 > 0.5 
354.4 16.2 51.587 N 0.270 W 7 11.1 > 0.5 
389.4 14.6 51.348 N 1.400 E 63 99.9 > 0.5 
345.6 30.6 54.983 N 1.552 W 42 66.6 > 0.5 
 
Table 5.3.8.SaTScan, Relative Risk Range 1-20 
 
Cases Centroid Radius (km)   
Total In Cluster Latitude Longitude Horizontal Vertical P Value 
696 8 51.196 N 0.278 E 22.01 22.01 0.016 
696 4 53.578 N 2.389 W 0 0 0.151 
696 8 53.601 N 3.034 W 18.11 18.11 0.00089 
696 12 51.681 N 0.614 W 22.73 22.73 0.0051 
696 12 51.495 N 3.228 W 20.18 20.18 0.00028 
 
Tables 5.3.9 and 5.3.10 show the results obtained in R and SaTScan when weights between 
0.025 and 1 were applied to PCTs at random. Again, no clusters were detected in R while 
SaTScan detected significant clusters (p < 0.05) in all 5 tests. In 4 of these tests, the p-value was 
less than or equal to 0.001.  
 
Table 5.3.9. R, Relative Risk Range 1-40 
 
Cases Centroid Radius (km)   
Total In Cluster Latitude Longitude Horizontal Vertical P Value 
361.6 20.5 53.255 N 3.437 W 35 55.5 > 0.5 
362.5 36.0 53.556 N 0.484 W 63 99.9 > 0.5 
365.2 11.1 52.056 N 2.709 W 35 55.5 > 0.5 
355.9 28.1 54.919 N 1.447 W 28 44.4 > 0.5 
358.1 20.3 53.781 N 1.589 W 21 33.3 > 0.5 
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Table 5.3.10.SaTScan, Relative Risk Range 1-40 
 
Cases Centroid Radius (km)   
Total In Cluster Latitude Longitude Horizontal Vertical P Value 
696 8 52.485 N 1.884 W 3.02 3.02 0.00011 
696 12 53.754 N 0.435 W 22.27 22.27 0.0014 
696 8 53.514 N 1.115 W 16.88 16.88 0.0009 
696 8 51.584 N 2.974 W 13.64 13.64 0.001 
696 20 53.701 N 1.777 W 26.76 26.76 0.000032 
 
Tables 5.3.6, 5.3.8 and 5.3.10 all show that SaTScan detects significant clusters in a scenario in 
whichthere would not be expected to be any clusters present. More significant clusters are 
detected as the weights become more extreme. When weights between 0.1 and 1 were 
applied the mean and median p-values were 0.088 and 0.037 respectively. These figures 
compare to a mean of 0.035 and median of 0.0051 when weights between 0.05 and 1 were 
applied, and a mean and median of 0.0007 and 0.0009 when using weights between 0.025 and 
1.  
 
Assuming that there genuinely would not be expected to be clusters present in randomly 
generated data of this type, there are 2 possible explanations for these results. Either the 
weights do not work in SaTScan, or this application of the weighting does not.The results 
shown in section 5.3.1 indicate that this is an effective weighting method in a highly simplified 
scenario. However it is likely that complications could arise when scanning more complex 
data,such as that generated in this simulation. 
Discrepancies in the results generated in R and SaTScan were greatest when the weighting 
structure being simulated was the most extreme. When simulating a more mild weighting 
method (relative risks between 1 and 10), the difference in p values between R and SaTScan 
was smaller than when the weighting method generated relative risks between 1 and 40. The 
most apparent explanation of these results is that weighting in SaTScan is unreliable when 
using an extreme weighting method. Were this the case, it would create a problem when 
applying the maternal age weighting in SaTScan for both trisomy 18 (relative weight range 1 – 
61.2) and trisomy 13 (relative weight range 1 – 24.9). 
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Section 5.3.3.Adjustment using Different Case Distributions 
Methods 
One advantage of direct case weighting in R compared to PCT adjustment in SaTScan is that R 
takes into account the exact case weights during Monte Carlo simulation.  
Weights remain static at each PCT in SaTScan while in R weighted cases are randomly 
reassigned during each iteration of the Monte Carlo simulation. This means that in SaTScan 
only the mean weight per PCT is used, whereas in R the weighting structure could also affect 
results even if the mean weight per PCT does not change.  
When weights are used, those cases with the largest weights contribute the most to potential 
clusters. So, for example, a case with weight 2 is equal to 2 cases with weight 1. The more 
extreme the weighting method, the greater the difference becomes between the greatest and 
least weighted cases, and the most highly weighted cases have an even greater contribution to 
clusters. It may be that having very highly weighted cases in the data increases the chance of 
observing clusters after data has been reassigned during Monte Carlo simulation, as having 
only small number of highly weighted cases in a region could be sufficient to create a cluster. 
This effect would only be visible in R. 
A synthetic set of data was generated to test this effect. For the sake of convenience, this data 
had a uniform prevalence of 4 cases and 4,000 births per PCT, with the exception of one 
cluster (the standard test cluster region consisting of 12 PCTs) in which there were 8 cases and 
4,000 births. In the test cluster, each PCT was assigned a mean weight of 0.25 to represent the 
region being populated by older mothers. The remaining PCTs were assigned a mean weight of 
0.625 to represent these regions being of average maternal age. However, one region of 51 
PCTs in and around West London (region chosen for convenience) was simulated to be 
populated by younger mothers, and all PCTs within this region were assigned a weight of 1. 
The expectation in this simulation is that the 12 PCTs with 8 cases per PCT would appear as a 
cluster in the absence of weighting, however once the weights were applied this cluster would 
be accounted for. Meanwhile the region of younger mothers, despite having average disease 
prevalence, would appear as a cluster due to the relatively high weight assigned to PCTs within 
this region. A cluster of this type can be termed an emerging cluster. This scenario could 
potentially appear in the NDSCR data, but has been  simplified for the purpose of this 
simulation.  
 
In R, a series of tests were performed by changing the case structure in each region using 2 
different case weights in each region, so for example in PCT x, rather than weighting all cases 
1, half would be weighted 1.5 and the other half 0.5. This would have no effect on the mean 
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weight so the SaTScan p-value would remain the same, but in R this change could lead to a 
change in the calculated p-value. This is another simplification of an event which will appear in 
the NDSCR data, as PCTs with multiple cases are likely to contain multiple weights. 
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Results 
Table 5.3.11 shows that changing the case weights in R could change the p-value by up to 
approximately 3 orders of magnitude compared to SaTScan. However, the weights have to 
changed dramatically in all 3 regions to observe such a change. Tests 2, 3 and 4 all simulated 
having a half and half mixture of younger and older women in region 1. 
 
Table 5.3.11. R vs SaTScan, Cluster Emerging as the Result of Weighting 
 
 
Weighting Structure P Value 
Test Region 1 Region 2 Region 3 R SaTScan 
1 1 0.625 0.25 0.001 0.000022 
2 1.5, 0.5 1, 0.25 0.25 0.001 0.000022 
3 1.75, 0.25 1, 0.25 0.25 0.001 0.000022 
4 1.98, 0.02 0.625 0.25 0.001 0.000022 
5 1.98, 0.02 1.23, 0.02 0.48, 0.02 0.017 0.000022 
 
 
Results in table 5.3.11 show that it is possible to obtain a p-value in R which is around 3 orders 
of magnitude higher than that in SaTScan, but this requires that a very extreme weighting 
method is used. In test 5, half of cases in each were assigned very low weights which the 
remaining half were assigned a much higher weight which varied depending on which region 
the PCT was in. The weighting ratio for each region in test 5 was 99:1 in region 1, 123:2 in 
region 2 and 24:1 in region 3.  
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Section 5.3.4.Summary of Test Data Results 
 
Previously in section 5.3, 3 tests were performed using synthetic data. Firstly in section 5.3.1, a 
single cluster was successfully accounted for in R and SaTScan by assigning low weights to each 
case / PCT within the cluster. In section 5.3.2, weights were applied at random to assess the 
effect of using weighting scales of varying severity. Finally in section 5.3.3, the effect of using 
different weights in R was tested by altering the weights within each PCT while keeping the 
mean weight in each PCT the same. 
Results varied between R and SaTScan to varying degrees in all of these tests. When 
accounting for a single cluster, small differences were observed which can be attributed to the 
different ways in which weights are applied in R and SaTScan. However, in the other 2 tests 
there were greater differences between the methods. In the random weights tests, significant 
clusters were observed in SaTScan while the p value in R never dropped below 0.5. Clusters in 
SaTScan became more significant as the weights used became more severe. In the third test, 
changing the weighting structure in R did have an effect on the resulting p value, but only 
when very extreme changes had been made. When smaller changes were made, no difference 
was observed. 
Having observed some significant differences between R and SaTScan in these simple tests, it 
seems likely that when scanning NDSCR data similar differences may be present. As the NDSCR 
data is much more complex, with the potential for a different trisomy prevalence in each PCT 
and tens of possible weights for each trisomy, it is also possible that these differences may be 
much greater when scanning NDSCR data. 
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Section 5.4. Analysis 
Section 5.4.1. Cases excluded from the analysis 
Calculating weights for cases requires additional information compared to unadjusted scans. In 
this chapter maternal age and gestational age at diagnosis are being accounted for individually 
and simultaneously. To allow unbiased comparison between results and to compare the effect 
of the weighting methods, cases which were missing either maternal age or gestational age at 
diagnosis were excluded from all weighted scans. The full data cleaning process was detailed in 
chapter 2.  
Table 5.3.1 shows the number and percentage of cases which were excluded from the 
weighted spatial scans due to missing information. 5.3% of trisomy 18 cases and 6.2% of 
trisomy 13 cases were missing PCT and could not be included in all spatial scans, including the 
unadjusted scans detailed in chapter 4. 2.6% of trisomy 18 cases and 4.1% of trisomy 13 cases 
were excluded from weighted scans due to missing maternal age, in addition to 3.0% of 
trisomy 18 cases and 4.5% of trisomy 13 cases which were excluded due to missing gestational 
age. In total, 10.9% of trisomy 18 cases and 14.8% of trisomy 13 cases were excluded from 
weighted scans due to missing information, compared to 5.3% and 6.2% for trisomies 18 and 
13 respectively from the unadjusted scans.  
A further 13.9% of trisomy 18 cases and 14.5% of trisomy 13 cases were excluded as they were 
classed as fetal losses under 20 weeks of age at diagnosis. The intention of weighting for 
gestational age is to eliminate the effect of regional differences in prenatal screening methods 
which may create or contribute to clusters. It is assumed that all cases in England and Wales 
which survive to 20 weeks are detected and diagnosed, as any fetal losses from this age 
onwards are rare and would be genetically karyotyped. Fetal losses under the age of 20 weeks 
may be detected in some regions but not others. For the purpose of this weighting method, all 
fetal losses under 20 weeks had to be excluded.  
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Table 5.4.1. Cases Excluded from Weighted Spatial Scans 
 
  Trisomy 18 Trisomy 13 
  Number % Number % 
Total Cases 3507 100 1473 100 
Excluded - No PCT 186 5.3 91 6.2 
Excluded - No Maternal Age 91 2.6 61 4.1 
Excluded - No Gestational Age 105 3.0 67 4.5 
Excluded - Fetal Loss Under 20 Wks 488 13.9 213 14.5 
Total Cases Excluded 870 24.8 432 29.3 
Total Cases Remaining 2637 75.2 1041 70.7 
 
 
In total, 24.8% of trisomy 18 cases and 29.3% of trisomy 13 cases were excluded from all 
weighted scans. These are very high percentages of cases which cannot be included, and 
demonstrate what could be considered to be a major weakness of utilising weighting methods 
in cluster scanning. In the unadjusted scans, a total of 94.7% and 93.8% of cases of trisomies 
18 and 13 could be included. When using both weighting methods, only 75.2% and 70.7% can 
be included respectively.    
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Section 5.4.2. Distribution of Weights 
In chapter 4.6.1, the distribution of cases for trisomies 18 and 13 was displayed on PCT maps 
of England and Wales. It was thought that groups of high prevalence PCTs could indicate the 
location of potential clusters, and for both trisomies it was apparent that the prevalence in 
London was greater than elsewhere in England and Wales. The same analysis can be used to 
attempt to visualise whether there are regions of particularly high or low case weights. 
The distribution of weights was mapped for each trisomy by calculating the mean maternal 
age, gestational age and both weights combined in each PCT. It would be expected that 
maternal age weights would be low in London as that is where maternal age is highest. 
Gestational age weights may also be low in London if gestational age contributed to the 
clusters reported in chapter 4. The combined weight should reflect the maternal age weight 
distribution as maternal age weight is the stronger of the two weights. 
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Maternal Age 
Figure 5.1 shows the trisomy 18 maternal age distribution. The figure shows a cluster of PCTs 
in London with low mean weight, which may be sufficient to account for the very strong 
clusters reported in chapter 4. There are no other regions in England and Wales with such a 
uniformly low weight. 
 
Figure 5.1. Trisomy 18 Mean Maternal Age Weight by PCT. 
 
Figure 5.2 shows the trisomy 13 maternal age distribution. This figure shows that many PCTs in 
London have been assigned low mean weights, however PCTs are not all heavily weighted 
down as they were for trisomy 18. In London there are several coloured PCTs which have a 
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Mean Weight = 1.0 or Above
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mean weight of above 0.75. This may be sufficient to account for the clusters reported in 
chapter 4 as trisomy 13 clusters were not as strong as those of trisomy 18.  
 
Figure 5.2. Trisomy 13 Mean Maternal Age Weight by PCT. 
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Gestational Age 
Figure 5.3 shows the trisomy 18 gestational age distribution. The map appears to show that 
PCTs in London are mostly weighted down compared to the rest of England and Wales. London 
is the only large group of low-weighted PCTs. Although the gestational age weights are mild 
compared to those for maternal age, this may still account for some of the clustering observed 
in chapter 4.  
 
Figure 5.3. Trisomy 18 Mean Gestational Age Weight by PCT. 
 
Figure 5.4 shows the trisomy 13 gestational age distribution. The majority of PCTs in England 
and Wales have been assigned weights between 0.9 and 1. There is not much of a pattern to 
the gestational age weights, although there is a higher concentration of PCTs with mean 
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weight below 0.9 in London than anywhere else in England and Wales. This may be sufficient 
to account for a small part of the clusters reported in chapter 4, however the gestational age 
weights for trisomy 13 are mild and unlikely to have a large effect on the results.  
 
Figure 5.4. Trisomy 13 Mean Gestational Age Weight by PCT. 
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Both Weights Combined 
Figure 5.5 shows the trisomy 18 combined weight distribution. When both weights are 
combined there is clearly a low weighted region in London compared to the rest of England 
and Wales. The weighting effect is stronger combined than for each weighted variable 
combined, and is therefore more likely to be sufficient to account for clusters reported in 
chapter 4. There are no other regions which show such consistently low weights, although 
many PCTs outside London were still heavily weighted down. 
 
Figure 5.5. Trisomy 18 Combined Weight by PCT 
 
 
Figure 5.6 shows the trisomy 13 combined weight distribution. There is a higher concentration 
of low-weighted PCTs in London than anywhere else in England and Wales, however this is less 
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apparent than it is for trisomy 18. Weights may still be sufficient to account for clusters as 
trisomy 13 clusters were weaker than those for trisomy 18, and therefore less adjustment is 
required to account for those clusters.  
 
Figure 5.6. Trisomy 13 Combined Weight by PCT 
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Section 5.4.3. Scan Results 
Trisomy 18 
Table 5.4.2shows that without weights applied, both R and SaTScan identify 4 clusters, 
although the programs are not entirely consistent. Both methods return significant trisomy 18 
clusters in 2004, 2008 and 2010, however R also shows a significant cluster in 2007 while 
SaTScan shows a cluster in 2006. Without weighting applied there were 5 significant clusters 
identified by each program with p = 0.001 in R and p < 0.0001 in SaTScan. Therefore, excluding 
cases which were ineligible for the weighted scans has had a considerable effect on the results.  
 
Table 5.4.2.Unweighted Trisomy 18 Scan Results 
 
  Cases Centroid  Radius (km)     
Year Total In Cluster Latitude Longitude Vertical Horizontal P Value Scan 
2004 290 146 51.908 N 0.443 W 111 70 0.001 R 
 290 146 51.908 N 0.443 W 81.73 81.73 < 0.0001 S 
2005 357 37 51.497 N 0.107 W 11.1 7 0.101 R 
 357 59 51.486 N 0.169 W 14 14 0.103 S 
2006 362 110 52.035 N 0.484 W 77.7 49 0.01 R 
 362 115 51.908 N 0.443 W 55.27 55.27 0.0023 S 
2007 406 187 51.624 N 0.054 W 99.9 63 0.007 R 
 406 123 51.879 N 0.544 E 70.19 70.19 0.036 S 
2008 410 214 51.646 N 0.202 W 111 70 0.001 R 
 410 193 51.391 N 0.302 W 72.73 72.73 < 0.0001 S 
2009 410 135 51.206 N 0.797 W 88.8 56 0.017 R 
 410 132 51.206 N 0.797 W 62.99 62.99 0.01 S 
2010 402 154 51.408 N 0.843 W 88.8 56 0.001 R 
  402 61 51.351 N 0.165 W 17.87 17.87 < 0.0001 S 
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Tables 5.4.3shows that there is a very large difference between results generated in R and 
SaTScan. Weights in R appear to have worked as expected, and accounted for all previously 
observed clustering. In SaTScan, highly significant clusters have been identified in every year. 6 
out of 7 of these clusters include PCTs in West London, a region which was shown in chapter 
5.3.b to be weighted down on average.   
 
Table 5.4.3. Trisomy 18 Scan Results, Cases Weighted for Maternal Age 
 
  Cases Centroid  Radius (km)     
Year Total In Cluster Latitude Longitude Vertical Horizontal P Value Scan 
2004 117.1 56.9 51.908 N 0.443 W 70 111 0.052 R 
 290 79 51.509 N 0.477 W 28.82 28.82 < 0.0001 S 
2005 152.8 9.5 51.433 N 2.844 W 21 33.3 0.012 R 
 357 63 51.549 N 1.731 W 86.83 86.83 0.0007 S 
2006 151.6 4.6 51.009 N 3.115 W 7 11.1 0.655 R 
 362 32 51.549 N 1.731 W 61.22 61.22 < 0.0001 S 
2007 169.8 10.9 52.475 N 1.940 W 7 11.1 0.853 R 
 406 103 53.181 N 2.445 W 88.63 88.63 < 0.0001 S 
2008 166.2 45 52.022 N 0.791 W 56 88.8 0.053 R 
 410 140 52.022 N 0.791 W 74.49 74.49 < 0.0001 S 
2009 187.3 4.9 51.555 N 0.700 E 7 11.1 0.313 R 
 410 94 51.404 N 0.774 W 47.58 47.58 < 0.0001 S 
2010 163.1 6.7 50.340 N 4.799 W 49 77.7 0.397 R 
  402 116 51.206 N 0.797 W 59.38 59.38 < 0.0001 S 
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Table 5.4.4 shows that the gestational age weighting method has been effective in both R and 
SaTScan, and has reduced the significance of all results in both programs. The reduction is 
small as the weighting method is mild, but the 2007 cluster in R has been accounted for and is 
no longer significant. All other clusters identified in tables 5.3.9 and 5.3.10 are still present 
although not as strongly. 
 
Table 5.4.4. Trisomy 18 Scan Results, Cases Weighted for Gestational Age 
 
  Cases Centroid  Radius (km)     
Year Total In Cluster Latitude Longitude Vertical Horizontal P Value Scan 
2004 250.8 122.7 51.908 N 0.443 W 70 111 0.001 R 
 290 146 51.908 N 0.443 W 81.73 81.73 0.0003 S 
2005 312.2 31.5 51.497 N 0.107 W 7 11.1 0.196 R 
 357 37 51.527 N 0.104 W 6.98 6.98 0.234 S 
2006 313.5 93.7 52.033 N 0.484 W 49 77.7 0.018 R 
 362 115 51.908 N 0.443 W 55.27 55.27 0.0044 S 
2007 351.3 160 51.624 N 0.054 W 63 99.9 0.075 R 
 406 123 51.879 N 0.544 E 70.19 70.19 0.105 S 
2008 353 180.5 51.646 N 0.202 W 70 111 0.001 R 
 410 193 51.391 N 0.302 W 72.73 72.73 < 0.0001 S 
2009 350.9 112.8 51.206 N 0.797 W 56 88.8 0.153 R 
 410 132 51.206 N 0.797 W 62.99 62.99 0.030 S 
2010 341.1 72.4 51.467 N 0.370 W 21 33.3 0.001 R 
  402 61 51.351 N 0.165 W 17.87 17.87 < 0.0001 S 
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Table 5.4.5shows that when trisomy 18 cases were weighted for both maternal age and 
gestational age at diagnosis, all clusters are accounted for in R whereas strong clusters were 
detected in every year in SaTScan. 4 of these clusters are situated in and around London, an 
area which would be expected to be accounted for by the maternal and gestational age 
weighting.  
 
Table 5.4.5. Trisomy 18 Scan Results, Both Weights Combined 
 
 
 
Tables 5.4.3 and 5.4.5 show that weighting cases for maternal age and for maternal; and 
gestational ages combined on the basis of risk has been successful in trisomy 18 cluster scans 
in R, but not in SaTScan. Adjusting for gestational age alone has been successful using both 
programs. Results indicate that adjusting for maternal age has a much larger effect on results 
than adjusting for gestational age as the weights are much more extreme.  
 
  
  Cases Centroid  Radius (km)     
Year Total In Cluster Latitude Longitude Vertical Horizontal P Value Scan 
2004 103.8 48.3 51.908 N 0.443 W 70 111 0.314 R 
 290 148 51.908 N 0.443 W 88.65 88.65 < 0.0001 S 
2005 138.1 9.3 51.433 N 2.845 W 21 33.3 0.008 R 
 357 12 51.433 N 2.845 W 19.05 19.05 < 0.0001 S 
2006 134.5 4.3 51.009 N 3.115 W 7 11.1 0.598 R 
 362 32 51.549 N 1.731 W 61.22 61.22 < 0.0001 S 
2007 150.5 9.9 52.475 N 1.940 W 7 11.1 0.852 R 
 406 50 53.544 N 2.128 W 50.18 50.18 < 0.0001 S 
2008 146.2 39.7 52.022 N 0.791 W 56 88.8 0.065 R 
 410 195 52.022 N 0.791 W 87.37 87.37 < 0.0001 S 
2009 163.8 3.8 51.555 N 0.700 W 7 11.1 0.670 R 
 410 28 51.348 N 1.400 E 82.76 82.76 0.0004 S 
2010 140.6 6.1 50.340 N 4.799 W 49 77.7 0.330 R 
  402 173 52.022 N 0.791 W 84.4 84.4 < 0.0001 S 
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Trisomy 13 
Table 5.4.6shows scan results without any weighting applied. In chapter 5.3.a, the number of 
cases lost in weighted scans due to missing information was found to be very high with 24.8% 
of total trisomy 18 cases and 29.3% of trisomy 13 cases having to be excluded. It is possible 
that excluding these cases could affect the findings which were reported in chapter 4. 
After applying the Bonferroni correction there is no evidence of clustering in R and 1 significant 
cluster in SaTScan, observed in London in 2006. The equivalent scan results before cases were 
excluded were presented in chapter 4 and featured 3 significant clusters in both R and 
SaTScan.  
 
Table 5.4.6. Unweighted Trisomy 13 Scan Results 
 
  Cases Centroid  Radius (km)     
Year Total In Cluster Latitude Longitude Vertical Horizontal P Value Scan 
2004 128 17 50.806 N 1.062 W 55.5 35 0.057 R 
 128 25 50.820 N 0.424 W 63.96 63.96 0.017 S 
2005 130 3 55.161 N 1.691 W 11.1 7 0.900 R 
 130 14 52.079 N 0.436 E 54.12 54.12 0.910 S 
2006 162 43 51.391 N 0.302 W 33.3 21 0.010 R 
 162 33 51.571 N 0.336 W 16.76 16.76 0.0023 S 
2007 177 9 51.461 N 2.592 W 22.2 14 0.100 R 
 177 20 51.904 N 2.097 W 59.82 59.82 0.143 S 
2008 156 67 50.820 N 0.424 W 99.9 63 0.010 R 
 156 49 50.820 N 0.424 W 78.36 78.36 0.058 S 
2009 134 9 51.433 N 2.845 W 33.3 21 0.044 R 
 134 20 51.393 N 0.105 W 12.24 12.24 0.028 S 
2010 154 55 52.265 N 0.870 W 111 70 0.010 R 
  154 21 51.206 N 0.797 W 40.12 40.12 0.054 S 
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Table 5.4.7 shows that after weighting for maternal age only, p-values in R are much higher 
and those in SaTScan are much lower than when scans were performed without weighting. 
Similarly to the results presented in chapter 5.2.c, this is likely due to the inability of SaTScan 
to accurately scan when an extreme weighting method has been applied. In SaTScan a total of 
4 significant clusters were detected, all of which included the area of West London which was 
identified in chapter 4 to be the primary location for maternal age related clusters. In chapter 
5.3.b it was demonstrated that using the proposed maternal age weighting method, cases in 
this area would on average be weighted down compared to other regions of England and 
Wales.  
 
Table 5.4.7. Trisomy 13 Scan Results, Cases Weighted for Maternal Age 
 
  Cases Centroid  Radius (km)     
Year Total In Cluster Latitude Longitude Vertical Horizontal P Value Scan 
2004 67.1 4.4 54.562 N 1.304 W 7 11.1 0.018 R 
 128 5 54.562 N 1.304 W 5.09 5.09 0.0077 S 
2005 71.9 3.3 54.071 N 2.855 W 7 11.1 0.565 R 
 130 9 52.606 N 1.548 E 89.67 89.67 0.06 S 
2006 93.1 19.8 51.587 N 0.270 W 14 22.2 0.203 R 
 162 31 51.587 N 0.270 W 15.03 15.03 < 0.0001 S 
2007 102.6 25.9 51.549 N 1.731 W 70 111 0.943 R 
 177 35 51.549 N 1.731 W 83.31 83.31 0.0029 S 
2008 90.3 6.0 51.426 N 0.339 W 7 11.1 0.812 R 
 156 28 50.806 N 1.062 W 83.86 83.86 0.033 S 
2009 74.1 5.5 51.433 N 2.845 W 42 66.6 0.186 R 
 134 50 51.562 N 0.135 W 57.78 57.78 < 0.0001 S 
2010 94.2 34.7 52.265 N 0.870 W 70 111 0.043 R 
  154 35 51.408 N 0.843 W 49.76 49.76 0.007 S 
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Table 5.4.8shows that the gestational age weighting has had a small effect on p values in both 
R and SaTScan. In both programs, p values are mostly higher than those calculated without 
weighting applied, although this has had very little effect on cluster significance. The 2006 
cluster is SaTScan is still identified as the only significant cluster in either program, although 
the same cluster is identified in R and is only marginally non-significant after applying the 
Bonferroni correction.  
 
Table 5.4.8. Trisomy 13 Scan Results, Cases Weighted for Gestational Age 
 
  Cases Centroid  Radius (km)     
Year Total In Cluster Latitude Longitude Vertical Horizontal P Value Scan 
2004 117.7 15.4 50.806 N 1.062 W 35 55.5 0.174 R 
 128 25 50.820 N 0.424 W 63.96 63.96 0.021 S 
2005 120.8 3 55.161 N 1.691 W 7 11.1 0.957 R 
 130 14 52.079 N 0.436 E 54.12 54.12 0.940 S 
2006 151.2 39.9 51.391 N 0.302 W 21 33.3 0.008 R 
 162 33 51.571 N 0.336 W 16.76 16.76 0.003 S 
2007 161.9 28.7 51.904 N 2.097 W 49 77.7 0.205 R 
 177 20 51.904 N 2.097 W 59.82 59.82 0.111 S 
2008 143.8 52.1 51.206 N 0.797 W 56 88.8 0.232 R 
 156 49 50.820 N 0.424 W 78.36 78.36 0.084 S 
2009 123.3 8.3 51.433 N 2.845 W 21 33.3 0.098 R 
 134 20 51.393 N 0.105 W 12.24 12.24 0.084 S 
2010 140.2 50.3 52.265 N 0.870 W 70 111  0.014 R 
  154 21 51.206 N 0.797 W 40.12 40.12 0.116 S 
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Tables 5.4.9shows that when both weights are combined there are no clusters present in R and 
4 in SaTScan.  
 
Table 5.4.9. Trisomy 13 Scan Results, Both Weights Combined 
 
  Cases Centroid  Radius (km)     
Year Total In Cluster Latitude Longitude Vertical Horizontal P Value Scan 
2004 62.9 4.2 54.562 N 1.304 W 11.1 7 0.024 R 
 128 5 54.561 N 1.304 W 5.09 5.09 0.0082 S 
2005 67.9 3.3 54.071 N 2.855 W 11.1 7 0.524 R 
 130 9 52.606 N 1.548 E 89.67 89.67 0.037 S 
2006 88.1 18.5 51.587 N 0.270 W 22.2 14 0.32 R 
 162 31 51.587 N 0.270 W 15.03 15.03 < 0.0001 S 
2007 94.5 23.8 51.549 N 1.731 W 111 70 0.926 R 
 177 35 51.549 N 1.731 W 83.31 83.31 0.002 S 
2008 84.3 5.6 51.426 N 0.339 W 11.1 7 0.824 R 
 156 28 50.806 N 1.062 W 83.86 83.86 0.045 S 
2009 69.2 6.4 51.009 N 3.115 W 66.6 42 0.238 R 
 134 50 51.562 N 0.135 W 57.78 57.78 < 0.0001 S 
2010 85.8 31.9 52.265 N 0.870 W 111 70 0.056 R 
  154 35 51.408 N 0.843 W 49.76 49.76 0.013 S 
 
 
Tables 5.4.6 to 5.4.9 show similar results for trisomy 13 as were observed for trisomy 18 in 
tables 5.4.2 to 5.4.5. Weighting for gestational age alone was successful in both methods, 
however adjusting for maternal age and both weights combined was successful in R but not 
SaTScan. Again, adjusting for maternal age had a much larger effect on the results. 
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Section 5.5.Summary 
In chapter 5, a novel weighting method was detailed which assigns weights directly to cases 
based on observed and quantifiable risk factors. This was tested in a custom program in R by 
comparing results with those using an alternate weighting method in SaTScan. Weights could 
not be assigned directly to cases in SaTScan, so instead the inverse of the mean case weight for 
each PCT was applied as a PCT adjustment value. 
Synthetic data was used to compare R and SaTScan in 3 simple scenarios. Firstly, a single test 
cluster in a uniform population was accounted for by assigning progressively lower weights to 
cases within the cluster. Both methods successfully accounted for the test cluster. Secondly, 
weights were applied at random to PCTs throughout the study region in order to test how each 
method handled extreme weights in a scenario in which no clusters would be expected. In this 
test, there was no evidence of clustering in R while SaTScan reported significant clusters which 
became more significant as the weights used became more extreme. Finally, a dataset was 
created to simulate how different case weights affected the p-value in R. The mean case 
weight for each PCT remained constant so that SaTScan would always return the same p-value. 
As the weighting method became more extreme, it was possible to obtain a p-value in R which 
was around 3 orders of magnitude greater than that in SaTScan. However, to observe a 
difference of this magnitude weights a very extreme weighting had to be applied which would 
not realistically be used in an actual study. When more moderate weights were applied, there 
was no observed difference between R and SaTScan.  
It is therefore reasonable to assume that direct case weights in R are more accurate than PCT 
adjustments in SaTScan as results were consistent between the two programs except for the 
randomly assigned weights test, where SaTScan detected significant clusters in data which in 
all likelihood contained no clusters. 
Cases of trisomies 18 and 13 were then weighting according to their maternal age and 
gestational age at diagnosis in order to attempt to account for the observed clustering in 
chapter 4. For both trisomies, it was observed that direct case weighting in R had worked as 
expected when weighting for both variables individually and combined. Results in R suggest no 
evidence of clustering beyond maternal age and gestational age at diagnosis. Results in 
SaTScan were not consistent with those in R when extreme weights were used, and showed 
very strong clusters when cases were weighted by maternal age or both weights combined. 
When cases were weighted by gestational age at diagnosis alone, results were consistent with 
R and showed a slight decrease in cluster significance.  
Assuming that results in R are accurate, there is no evidence of trisomy 18 or trisomy 13 
clustering in England and Wales between 2004 and 2010 after adjusting for maternal age and 
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gestational age at diagnosis. Results indicate that the clusters reported in chapter 4 were 
mostly caused by advanced maternal age in London, with gestational age at diagnosis 
contributing a small amount to these clusters. Table 5.1 on page 123 shows that the 
proportion of births in high risk age groups was higher in London than any other region in 
England and Wales.  
 
As part of the NDSCR data processing and quality control, data are matched with the Regional 
Congenital Anomaly Registers to improve data quality. A previous study showed that the 
NDSCR data was over 94% complete (Savva & Morris 2009). Most labs provide data within 6 
months of diagnosis, and regular requests are also sent for additional information on cases 
with incomplete data (NDSCR Annual Report 2010). Any obvious gaps in the data (for example, 
time periods with noticeably few cases reported) are also identified and raised with the 
appropriate lab(s). The analysis for the spatial cluster scans was undertaken in 2012 on cases 
diagnosed between 2004 and 2010, meaning that there was no substantial outstanding data 
for any of the labs, and followup had been undertaken to ensure that the data was as 
complete as possible. While it is reasonable to believe that there may be slight differences in 
reporting to the NDSCR by the individual labs, it is therefore unlikely that there is substantial 
variation in terms of the  proportion of cases reported in each region.  
Differences in ascertainment are also caused by regional differences in prenatal diagnosis 
methods, as regions which use the earliest or most effective screening procedures detect more 
cases than those which do not. This was accounted for both by gestational age weighting and 
excluding foetal losses under 20 weeks (full explanation in chapter 5.1).  
 
Another issue which must be considered is whether multiplying the weights was an 
appropriate way to account for both risk factors simultaneously. It is possible that more 
affluent mothers may choose to wait before starting a family and be older when having 
children. The fact that trisomy risk increases with maternal age is well publicised, and these 
women may have been more active in selecting the earliest screening methods possible, either 
through the NHS or private care. The maternal age weight is applied as trisomy risk is higher in 
older mothers, while the gestational age weight is applied as the risk of fetal loss varies by 
gestational age. It may be that older mothers are more likely to miscarry than younger 
mothers, however this has not been demonstrated in trisomy 18 or 13 pregnancies. There has 
also been no reported evidence that more affluent mothers are less likely to have either a 
miscarriage or an affected pregnancy than less affluent mothers. I therefore believe that 
multiplication of the weights is a valid way to account for both risk factors. 
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Chapter 6: Conclusions 
 
 
In section 1.3.4, the aims of this thesis were stated as: 
 
1. To scan trisomy data in England and Wales from the NDSCR for temporal and spatial 
clusters. 
2. To develop a statistical method capable of accounting for two risk factors 
simultaneously, and to demonstrate the effectiveness of this method using simulated 
data. 
3. To scan the same data for clusters after adjusting for maternal age and gestational age 
at diagnosis using the novel method. 
4. To assess the impact of the findings in the context of both previously undertaken and 
future congenital anomaly research, and NHS policy. 
 
The first three aims on this list have already been completed. A summary and analysis of the 
findings in this thesis is presented in section 6.1. In section 6.2, a more detailed discussion of 
the wider impact of the findings of this thesis is presented. Finally, section 6.3 looks to future 
work which could be carried out building on what has been developed and performed during 
this thesis. 
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Section 6.1. Summary and Analysis of Findings 
 
Temporal Cluster Detection 
Analysis of cases from the NDSCR found no evidence of temporal clustering for either trisomy 
in England and Wales between 2004 and 2010, using the Nagarwalla temporal cluster scanning 
method published in 1996. Maternal age at conception would not be expected to produce 
distinct, visible temporal clusters, however as prenatal diagnosis techniques improve and 
mean maternal age continues to rise, both of these factors may contribute to a long term 
increase of observed prevalence of both trisomy 18 and trisomy 13.   
The only published evidence of temporal trisomy clustering remains that linking Down 
syndrome risk to ionising radiation exposure caused by the Chernobyl disaster, in which a 
strong, quick burst of radiation was detected in multiple European countries. While extreme 
events may have the potential to increase trisomy risk sufficiently to produce clusters, in the 
absence of such events it may be that no individual factor is strong enough to produce clusters 
which can be detected using this method.  
The Nagarwalla temporal cluster scanning method has been proven to be effective both in the 
original publication and numerous studies since then. The method is quick to run, can easily be 
adapted to the needs of the investigator and requires only the bare minimum of information 
meaning that very few cases are excluded from analysis on the basis of missing data. Also of 
note is the ability to search for clusters of any size in a single scan without having to adjust for 
multiple testing. 
Data was scanned for clusters by individual government office region to give the analysis some 
resolution in space and to allow comparison of regional results. Analysing data in this way is 
advantageous as it allows regions to be scanned as soon as complete data is available, but it is 
possible that clusters occurring on the border or 2 or more regions could be missed. In the 
event of significant or nearly significant results being obtained in 2 or more connecting regions, 
it would be possible to combine these regions and perform another scan which would be able 
to detect clusters occurring at the boundary. This analysis was not performed in this thesis due 
to the lack of evidence of temporal clusters for either trisomy in any region.  
Separate scans were performed using cases arranged by date of sample, and by estimated 
date of conception. Date of sample scans are useful in biosurveillance where cases are 
routinely scanned for clusters, but their relevance is limited in trisomy scanning as the genetic 
errors occur at the time of conception. Samples can be taken from a range of gestational ages 
from approximately 10 to 40 weeks, so a cluster of cases by date of sample does not 
necessarily mean that a genuine cluster has occurred. Running scans by date of conception is 
necessary to search for trisomy clusters, however there are 2 main disadvantages to such an 
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approach. Date of conception is estimated by subtracting gestational age at sample from the 
sample date, or gestational age at outcome from the outcome date. In both cases, gestational 
age is only recorded in completed weeks so the estimated conception date is only accurate to 
the week. Also, estimating date of conception requires more information than scanning by 
date of sample so fewer cases can be included in the scan. 2.2% of trisomy 18 cases and 2.8% 
of trisomy 13 cases were excluded from the scans by sample date due to missing information, 
compared to 8.2% of trisomy 18 cases and 10.5% of trisomy 13 cases when using estimated 
date of conception. A sensitivity analysis was performed by imputing date of conception using 
less accurate assumptions and imputing gestational age at sample as the mean gestational age 
for the sample tissue taken, which resulted in excluding only 1.6% of trisomy 18 and 2.0% of 
trisomy 13 cases. Including these cases in the analysis did not have any effect on the results 
and no significant clusters were detected. Weighted temporal scans were not performed in 
this thesis due to the expectation that the factors being adjusted for would not result in 
temporal clusters, and to focus on the weighted spatial analyses in which regional variation in 
maternal age and gestational age at diagnosis could be masking other possible clusters. 
However, such scans could be performed in future analyses. 
  
Unadjusted Spatial Cluster Detection 
Strong evidence of spatial clustering in London was observed for both trisomies when cases 
were unadjusted. When analysing data by individual calendar year, 5 trisomy 18 and 3 trisomy 
13 clusters were identified. Very strong clusters were observed for both trisomies when all 
years were analysed together.  The high maternal age in this region compared to the 
remainder of England and Wales was very likely to be the primary cause of all observed 
clusters for both trisomies, and it was also possible that regional differences in prenatal 
screening methods contributed to the clustering effect.  
Results in R were compared to those using the freely available program SaTScan, which is a 
commonly used tool for temporal, spatial and space-time cluster scanning. Both programs 
used the same statistical methodology but differed slightly in the way circles were generated 
at each PCT site. These differences were responsible for small differences in p-values, but 
overall the same findings were obtained using both programs.  
Given that maternal age has a very strong influence over trisomy risk, it is surprising that 
clusters were not observed in London in every scan when data was analysed by calendar year. 
Of the 8 clusters (5 for trisomy 18 and 3 for trisomy 13), 7 were in London with one small 
cluster in Bristol (trisomy 13 in 2009). Therefore, what could be considered as the expected 
result was only observed in half of the scans. It is worth noting that all 5 trisomy 18 clusters 
had p-values of 0.001 in R and below 0.0001 in SaTScan. In the remaining 2 years, 1 cluster was 
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observed with p < 0.05 in R and both years had clusters with p < 0.05 in SaTScan, however 
these results were non-significant after applying a Bonferroni correction for multiple testing. 
Evidence of trisomy 13 clustering was not as strong, with only 2 clusters discovered in London. 
However, this may be due to trisomy 13 being less prevalent than trisomy 18.  There was an 
additional year in which both methods identified a cluster with p < 0.05 which was not 
significant after applying a Bonferroni correction.  
The power of both of these methods was evaluated using a set of synthetic data. A set of 12 
PCTs was selected as an artificial cluster site in the North East of England which could be 
uniquely identified using both programs. It was found in both programs that as the prevalence 
outside the cluster increased, the excess risk required for the cluster to be judged to be 
significant decreased. This is important as trisomies 18 and 13 are rare conditions, and 
therefore any potential clustering effect would have to be strong in order to be detected. 
Trisomy 18 is more common than trisomy 13, which may explain the relative strength of the 
observed trisomy 18 clusters compared to those of trisomy 13.  
Cases were analysed by maternal PCT, which was the smallest available population unit for 
which population birth data was available. During the study period there were 174 PCTs in 
England and Wales, and on average in an individual calendar year there would be expected to 
be between 2 and 3 cases of trisomy 18 and between 1 and 2 cases of trisomy 13. As such, 
PCTs are an acceptable population unit for this analysis as there are not so many cases per PCT 
that smaller population blocks would be obviously more accurate, and there are not commonly 
too many PCTs with 0 cases present. There were a number of years in which around half of all 
PCTs had 0 trisomy 13 cases, however zero count PCTs do not adversely affect the statistical 
method. It is therefore unlikely that use of smaller population blocks would have been more 
accurate, or that the results would have been different using smaller population units. This 
could again suggest that the scarcity of trisomy 13 cases compared to trisomy 18 explains why 
trisomy 18 clusters were more prevalent and stronger than those of trisomy 13. 
 
Adjusted Spatial Cluster Detection 
A novel method was proposed to account for risk factors in spatial cluster analyses. By 
weighting each case directly, the program is able to effectively account for previously observed 
clusters on the basis of risk as the case structure is taken into account during Monte Carlo 
simulation to calculate p-values. Cases could be directly weighted in R but not in SaTScan. In 
SaTScan, the inverse of the mean weight for each PCT was calculated and applied as a PCT 
specific adjustment.  
This method was tested thoroughly using synthetic data. A simple dataset was created and 
weights were applied in both programs to adjust for advanced maternal age in a single test 
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cluster. The cluster was successfully accounted for using both methods, and both returned 
similar p-values. Two further scenarios were then created. The first involved weights being 
applied at random throughout the study region. This was not expected to lead to any clusters 
being present, but examined how each method responded to the application of extreme 
weights. In this test, no clusters were present at all in R but in SaTScan significant clusters were 
detected which became more significant as the weights became more extreme. The final test 
using synthetic data tested how the effect of different case weights affected the p-value in R. 
Different case weights were applied to cases in R which did not change the mean weight in 
each PCT, so the weighting (and consequently, p-value) in SaTScan remained the same. By 
increasing the extremity of the weighting method, it was possible to obtain a p-value in R 
which was around 3 orders of magnitude greater than that in SaTScan (0.017 in R compared to 
0.000022 in SaTScan). However, the weighting scale used to obtain this p-value was very 
extreme and ranged from 0.02 to 1.98 (relative scale 1-99).  
These results show that there is a clear difference between R and SaTScan when weights are 
applied. The direct case weights in R appear to offer increased accuracy, reliability and 
flexibility compared to SaTScan. Results in R depend on the exact weights being used rather 
than just the average, and the significant clusters in SaTScan when weights were applied at 
random indicate that SaTScan cannot accurately use extreme weighting methods.  
Maternal age was adjusted for by weighting cases based on maternal age at diagnosis. 
Maternal age weights ranged from 0.019 to 1.182 for trisomy 18 (relative scale 1 – 62), and 
from 0.052 to 1.286 for trisomy 13 (relative scale 1 – 25). Both of these weighting ranges are 
extreme as the largest weight is worth several times that of the smallest. These weighting 
ranges were comparable to those in the randomly assigned weight test using the synthetic 
data set. The weighting range for trisomy 18 was greater than any range tested using synthetic 
data, while the range of trisomy 13 cases fell between the 1 – 20 and 1 – 40 ranges which were 
tested.. No clusters were detected for either trisomy after weights were applied in R, while 
SaTScan detected strong trisomy 18 clusters in every year scanned and significant trisomy 13 
clusters in 4 of 7 years.  
Gestational age was adjusted for by weighting cases based on their likelihood of surviving to 
20 weeks gestation. Gestational age weights ranged from 0.754 – 1 for trisomy 18 and from 
0.844 – 1 for trisomy 13. Compared to the maternal age weights this is a minor adjustment, as 
there is only a small difference between the largest and smallest weight for either trisomy. 
After weights were applied there was a small decrease in significance in all scans for both 
trisomies in both methods.  
A final set of scans were then performed using both weights combined. For each case, weights 
were multiplied to give a combined weight which was applied directly in R and as a PCT 
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adjustment in SaTScan. As the maternal age weight was much more extreme, it would be 
expected that results obtained using both weights combined would be similar to those 
obtained using the maternal age weight alone. No clusters were detected for either trisomy 
after weights were applied in R, while SaTScan detected the same clusters which were found 
after applying the maternal age weight only. 
The scan results using trisomy 18 and trisomy 13 case data provide further evidence that R 
outperforms SaTScan when the weighting method used is extreme. After weighting for 
maternal age, it would be expected that the clusters discovered in chapter 4 would be 
accounted for as they were most likely age-dependant. This result was observed in R, but 
SaTScan appeared to amplify existing clusters rather than account for them. However, both 
methods performed as expected when the relatively minor adjustment for gestational age at 
diagnosis was applied. This suggests that SaTScan is suitable to use when the weights being 
applied are small. 
The novel weighting method offers a number of advantages over methods available in 
SaTScan. Weights are accurate and highly adaptable, and can be calculated based on whatever 
criteria is required by the investigator. It is theoretically possible to account for as many 
different factors as is desired, although there could be adverse effects caused by using too 
many weights simultaneously.  
Calculating case weights requires the availability of precise information regarding every 
weighting variable for every case. In total, 24.8% of trisomy 18 cases and 29.3% of trisomy 13 
cases were excluded from weighted analyses due to either missing information or ineligibility 
(all fetal losses under 20 weeks were excluded). Losing this many cases resulted in a change of 
results even without applying weights. In chapter 4, 7 clusters of trisomy 18 and 3 clusters of 
trisomy 13 were identified using both R and SaTScan. In chapter 5, only 4 trisomy 18 clusters 
were detected with no evidence of trisomy 13 clustering. It may be that the cases excluded 
were those responsible for the clusters reported in chapter 4, but it is more likely that simply 
excluding such a high proportion of cases negatively affected the power of both methods to 
detect genuine clusters. One potential conclusion already outlined in this chapter stated that 
both programs may have struggled to identify trisomy 13 clusters compared to trisomy 18 due 
to lower prevalence. Reducing sample size results in a loss of power, so excluding 20-30% of all 
cases from the analysis would also have a similar effect. Adjusting for maternal age resulted in 
a loss of 2.6% of trisomy 18 cases and 4.1% of trisomy 13 cases, compared to a loss of 16.9% 
and 19% of total cases respectively when adjusting for gestational age. In addition to the 
unadjusted results from chapter 5, it would be worth performing a sensitivity analysis to assess 
the effect of excluding such a high proportion of cases. It may also be worth adjusting for 
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maternal age alone in order to avoid having to exclude so many cases from the weighted 
scans. 
The effect of losing cases is compounded when multiple factors are being accounted for 
simultaneously. Each case in the combined weighted analysis must have complete information 
regarding each weighting variable in order to maintain accuracy. Therefore, as more factors 
are being adjusted for, the more likely it is that each individual case will be excluded due to 
missing information. It is impossible to impose an arbitrary limit on the number of cases which 
can be adjusted for simultaneously, but there will come a point where the benefit of 
adjustment is outweighed by the number of cases being lost. 
However, a large percentage of the cases excluded from the weighted scans in chapter 5 were 
excluded due to being fetal losses under 20 weeks rather than for missing information. In total, 
56% of trisomy 18 cases and 49% of trisomy 13 cases which were excluded were fetal losses 
under 20 weeks, while only 23% of trisomy 18 exclusions and 29% of trisomy 13 exclusions 
were due to missing maternal age or gestational age at diagnosis. It seems that the maximum 
number of factors which can be accounted for simultaneously depends on the proportion of 
cases which will be lost when the weights are calculated. 
Strong clusters were detected in chapter 4 when cases were not adjusted, and adjustment is 
therefore necessary in order to account for known risk factors. However, in chapter 5 there 
were a large number of cases excluded from analysis due to missing gestational age 
information. Adjusting for gestational age had a relatively small effect on the results compared 
to maternal age, and it may be that the benefit of adjusting for gestational age did not merit 
the large number of cases which were lost and subsequent loss of power. The best analysis for 
trisomy clustering may therefore be to adjust for maternal age only.  
These analyses have led to the initial conclusion that in scenarios where there is a significant 
variation in the size of case weights being applied, the novel method in R uniformly 
outperforms SaTScan and is therefore recommended for use. However, when cases are not 
weighted this new method offers no noticeable advantage over SaTScan.  
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Section 6.2. Comparison with Other Studies 
 
In 2008, McNally et al found evidence of clustering of trisomy 21 in the North of England 
between 1985 and 2003 using a nearest neighbour method after accounting for maternal age. 
The authors theorised that an infectious agent may be responsible for this, which is consistent 
with their finding that cases clustered most strongly within densely populated where infection 
can spread more easily. In the same study, the investigators looked for clustering in trisomies 
18 and 13, finding no evidence of clustering for either trisomy.  
In section 1.3.1 of this thesis it was speculated that the lack of evidence for clustering in this 
study may have been due to their low available sample size of trisomies 18 and 13, and that 
the greater sample size available in the NDSCR data may enable the detection of weaker 
clustering effects. There are three main differences between the cluster scans carried out in 
this thesis compared to those in the McNally et al study, which are the cluster detection 
method, the timeframe of data included, and the scale of the area scanned. However, this is 
still the best available study to compare with the work carried out in this thesis as the majority 
of trisomy cluster analyses are performed on cases of the much more common trisomy 21. The 
results reported in this thesis are consistent with those in the McNally et al report, and the 
scans performed were unable to detect any evidence of clustering. 
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Section 6.3. Wider Impact of Findings 
 
Implications for Policy 
The only clusters detected in this thesis were demonstrated to be the result of regional 
variation in maternal age, which is already a known risk factor for trisomic pregnancies and an 
important part of all screening procedures. Owing to the lack of novel findings, there are no 
recommended changes to be made to policy as a result of the findings made in the cluster 
scans performed in this thesis.  
 
Recommendations for Research 
The NDSCR remains a very valuable resource for future trisomy research, in particular being 
able to monitor trisomy prevalence and trends as mean maternal age continues to change and 
more accurate screening methods are developed and adopted. As a result of the lack of 
temporal and spatial clusters detected (after adjustment) of trisomies 18 and 13 detected in 
England and Wales in 2004-2010, I would not recommend that such scans were added to the 
NDSCR routine analysis. However, the findings in this thesis do not mean that there is no 
potential for trisomy clusters to appear in future. The majority of trisomy clusters reported to 
date occurred apparently as a result of the nuclear disaster in Chernobyl, and while it is still 
disputed whether all of these clusters could have been caused by the expected levels of 
radiation dispersed over Europe, there is very strong evidence that exposure to ionising 
radiation and trisomy prevalence are linked. The recent nuclear disaster arising as a result of 
the Japan earthquake in 2011 provides an opportunity to examine this link further, however it 
is possible that low ascertainment of trisomy cases in Japan may hinder this analysis. In 1999, 
Hoshi et al reported a study of trends in Down syndrome prevalence in Japan between 1980 
and 1997, using data obtained from the Japan Association of Obstetricians and Gynecologists 
(JAOG). JOAG operates a hospital based register of congenital anomalies, however this is only 
maintained in selected hospitals in Japan and ascertainment in the Hoshi et al study was 
estimated at 60-70%.  
The study of other diseases could also be improved using this method. For example, 
gastroschisis is a congenital anomaly in which the abdominal contents can protrude through a 
small hole in the anterior abdominal wall, and is more common amongst younger mothers 
(Kirby et al 2013). Multiple studies have indicated that maternal aspirin use during pregnancy 
can increase gastroschisis risk (Werler et al 2002), with one large study by the California Birth 
Defects Monitoring Program (Torfs et al 1996) finding that aspirin could quadruple 
gastroschisis risk. It is possible that, using cluster analysis weighting for maternal age, alternate 
risk factors may be identified.  
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Use of this method is not restricted to the study of congenital anomalies. Age related 
conditions such as Alzheimer’s disease are not well understood and although prevalence 
increases with age, there is a wide range of proposed factors which could increase the risk of 
developing the disease. One particularly strong link is that between Alzheimer’s and exposure 
to aluminium (Crapper et al 1976, Martyn et al 1989). Scanning Alzheimer’s cases for clusters 
weighting for age at diagnosis could help to identify environmental effects which contribute to 
the disease risk. This could also be extended to look for regions with unusually low prevalence, 
which could help to identify factors with a protective effect.  
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Section 6.4: Future Work 
 
The weighting method developed in this thesis can be extended to have a wider range of uses 
in biosurveillance. The method has been demonstrated to be effective in quadrat based spatial 
cluster scanning, and the most apparent extension of the method is to include quadrat based 
temporal and spatio-temporal cluster scanning. Both of these techniques also use the ratio of 
cases inside and outside the quadrat to determine cluster location and significance, so 
implementation would be very similar to that in the spatial scanning method in chapter 5. 
Besides maternal age, risk factors previously theorised as being associated with trisomy 
prevalence (such as ionising radiation and exposure to an infectious agent) have presented as 
space time effects arising from a single time point in a single location. While the temporal and 
spatial scans in this thesis also have some resolution in space and time respectively, dedicated 
spatio-temporal methods would have greater power to detect space-time clusters.  
Another potential extension of the method is to examine temporal trends in addition to 
clusters, which would be able to detect risk factors which do not result in the creation of 
clusters. For example, the changes in maternal age in England and Wales during the time 
period studied in this thesis are not detected through temporal cluster scanning as the result is 
an increase in prevalence of both trisomies rather than the occurrence of clusters. Testing the 
temporal data for trend would reveal this steady increase. Weighting the data by maternal age 
would also enable the detection of alternate risk factors simultaneously causing long term 
increases or decreases in prevalence which are too small to be detected in addition to the very 
strong maternal age effect. For example, when studying trisomy data weighted by maternal 
age the underlying trend may reflect the improvement in prenatal screening over time 
resulting in more cases being detected prior to fetal loss.  
 
It is also important to consider potential extension of this weighting method to distance based 
spatial clustering methods. These methods examine the distribution of cases to test for an 
overall clustering effect, rather than scanning through the study area to find cluster locations. 
In chapter 1, 2 such approaches were considered. The first, detailed by Whittemore et al, was 
a test which measured the distance between each case and its nearest neighbour case and 
compared the findings to an expected distance assuming all cases were independent and there 
was no clustering present. The second was detailed by Cuzick and Edwards, and examined the 
distance between each case and its nearest neighbour control, where controls were randomly 
selected from the population at risk. These methods are completely different to the quadrat 
based methods which the weighting technique was developed for, and it would be more 
difficult to adapt the novel method to such analyses. It would be easier and more effective to 
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stratify cases on the basis of one observed variable and look for clustering within each 
individual stratum. Currently, it is not envisaged that the weighting method can be easily 
adapted for use in distance-based spatial cluster detection methods. 
The weighting method has been demonstrated to be effective when accounting for 2 
clustering factors simultaneously, and is technically capable of accounting for as many factors 
as required by multiplying each weight to give an overall weight for each case. However, 
introducing too many weighting variables could diminish the effect of the weighting method. 
Chapter 5 examined the effect of weighting for maternal age at conception, gestational age at 
diagnosis, and both factors combined. The weighting method was effective in all 3 scenarios. 
These factors were very different in scale, as the maternal age weighting is an extreme weight 
with a factor of around 60 dividing the largest and smallest weights, while the gestational age 
weighting was comparatively mild and only weighted cases between 0.75 and 1. In this sense, 
maternal age can be classified as a major weight and gestational age as a minor weight. It may 
be that attempting to use 2 major weights in the same analysis diminishes the effect of both 
weights as they cancel each other out. Further work is necessary to understand the possible 
outcomes when multiple extreme weighting methods are applied simultaneously. 
There are also applications for this type of weighting outside biosurveillance. For example, 
clusters of road traffic accidents could be searched for by weighting the driver based on age 
and sex, as there is a much higher risk of accidents being caused by young men than by any 
other demographic.  
In conclusion, this thesis has developed a simple method to adjust for risk factors when 
searching for spatial clusters. The method could be adapted for use in searching for temporal, 
spatial or spatio-temporal clusters for other congenital anomalies or other diseases. 
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Appendices 
 
Appendix 1. Data Cleaning Tables 
 
Table 2.9. Number of diagnoses for trisomies 21, 18, and 13 combined from each cytogenetic 
laboratory by Government Office Region. 
 
  Government Office Region 
Lab A B D E F G H J K W 
1 0 1 0 3 7 1 1 1 1286 15 
2 0 0 5 383 1 2 0 0 0 0 
3 0 2 1 0 0 289 1085 9 1 0 
4 1 1068 7 19 9 1 3 0 1 1 
5 776 89 6 1 0 0 0 1 0 0 
6 0 0 0 0 1 11 357 453 1 1 
7 0 1 0 2 1 0 2 654 268 3 
8 1 0 397 163 1 0 1 0 0 0 
9 5 31 986 4 0 0 2 1 1 0 
13 0 0 0 259 5 1 1 0 0 1 
14 0 2 1 0 0 1 501 351 1 0 
15 0 601 0 0 4 1 1 0 0 54 
16 0 2 0 2 3 406 944 10 1 1 
19 0 0 0 0 1 0 48 22 0 0 
22 8 4 2 44 1597 3 1 1 2 20 
23 0 0 0 205 4 20 3 722 117 0 
24 0 0 0 29 0 550 0 1 1 0 
26 0 0 0 1 0 169 1 0 0 0 
27 0 1 0 0 6 1 0 0 3 654 
28 0 1 0 0 0 0 0 0 0 0 
30 2 8 4 16 15 406 1109 571 24 36 
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Table 2.10. Proportion of diagnoses for trisomies 18 and 13 combined from each 
Government Office Region in each Cytogenetic Laboratory. 
 
  Government Office Region 
Lab A B D E F G H J K W 
1 0 0.1 0 0.2 0.5 0.1 0.1 0.1 97.8 1.1 
2 0 0 1.3 98 0.3 0.5 0 0 0 0 
3 0 0.1 0.1 0 0 20.8 78.2 0.6 0.1 0 
4 0.1 96.2 0.6 1.7 0.8 0.1 0.3 0 0.1 0.1 
5 88.9 10.2 0.7 0.1 0 0 0 0.1 0 0 
6 0 0 0 0 0.1 1.3 43.3 55 0.1 0.1 
7 0 0.1 0 0.2 0.1 0 0.2 70.2 28.8 0.3 
8 0.2 0 70.5 29 0.2 0 0.2 0 0 0 
9 0.5 3 95.7 0.4 0 0 0.2 0.1 0.1 0 
13 0 0 0 97 1.9 0.4 0.4 0 0 0.4 
14 0 0.2 0.1 0 0 0.1 58.5 41 0.1 0 
15 0 90.9 0 0 0.6 0.2 0.2 0 0 8.2 
16 0 0.1 0 0.1 0.2 29.7 69 0.7 0.1 0.1 
19 0 0 0 0 1.4 0 67.6 31 0 0 
22 0.5 0.2 0.1 2.6 94.9 0.2 0.1 0.1 0.1 1.2 
23 0 0 0 19.1 0.4 1.9 0.3 67.4 10.9 0 
24 0 0 0 5 0 94.7 0 0.2 0.2 0 
26 0 0 0 0.6 0 98.8 0.6 0 0 0 
27 0 0.2 0 0 0.9 0.2 0 0 0.5 98.3 
28 0 100 0 0 0 0 0 0 0 0 
30 0.1 0.4 0.2 0.7 0.7 18.5 50.6 26.1 1.1 1.6 
 
Highlighted numbers show proportions which were sufficiently high to impute government 
office region from cytogenetic lab. 
 
 
Table 2.11. Trisomy 18 cases assigned to a government office region using cytogenetic lab 
information. 
 
Case Cytogenetic Lab Government Office Region 
31488 Lab 1 K 
31512 Lab 4 B 
36159 Lab 27 W 
39405 Lab 4 B 
40656 Lab 27 W 
41195 Lab 1 K 
49350 Lab 9 C 
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Table 2.12. Trisomy 13 Cases Assigned to a Government Office Region using cytogenetic lab 
information. 
 
Case Cytogenetic Lab Government Office Region 
31586 4 B 
38176 27 W 
42583 15 B 
50645 4 B 
50652 9 D 
 
 
Table 2.13. Gestational ages for all CVS diagnoses between 2004 and 2010. 
 
Week of Gestation % Diagnosed 
< 11 0.48 
11 10.20 
12 42.76 
13 32.80 
14 9.31 
> 14 4.45 
Total 100 
 
 
Table 2.14. Gestational ages for all amniocentesis diagnoses between 2004 and 2010. 
 
Week of Gestation % Diagnosed 
< 15 4.38 
15 13.46 
16 19.27 
17 15.16 
18 8.94 
19 5.21 
20 11.34 
> 20 22.24 
Total 100 
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Table 2.15. Trisomy 18 cases assigned sample dates using the immediately adjacent cases. 
 
 
        Previous Sample Following Sample     
Case Lab ID Lab Sample Year Lab ID Date Lab ID Date Accuracy (days) Sample Date Estimated 
30954 C040222 30 2004 C040084 08/01/2004 C040316 28/01/2004 21 - 
31564 A043835 30 2004 A0403567 29/06/2004 A0403849 13/07/2004 15 - 
33542 C0503530 22 2005 C0502813 07/02/2005 C0503656 16/02/2005 10 11/02/2005 
33546 C0507590 22 2005 C0507156 31/03/2005 C0507840 08/04/2005 9 04/04/2005 
33565 C050002 30 2005 - - C050058 10/01/2005 10 05/01/2005 
34733 C050522 3 2005 C050482 19/09/2005 C050527 19/10/2005 31 - 
34772 F0518810 22 2005 F0518427 08/08/2005 F0519167 15/08/2005 8 11/08/2005 
35445 P051118 30 2005 P051104 29/12/2005 - - 3 30/12/2005 
36116 F006206 9 2006 F005406 22/02/2006 F006506 01/03/2006 8 25/02/2006 
36157 F060093 24 2006 F060068 02/02/2006 F060110 23/02/2006 20 - 
36172 P060021 30 2006 - - P060036 09/01/2006 9 05/01/2006 
37203 P060457 30 2006 P060375 20/04/2006 P060623 06/07/2006 78 - 
37204 P060505 30 2006 P060375 20/04/2006 P060623 06/07/2006 78 - 
37807 T0616334 22 2006 T0612441 14/05/2006 T0620785 14/08/2005 93 - 
37808 T0622299 22 2006 T0620785 14/08/2005 T0622735 06/09/2005 28 - 
38058 F031406 9 2006 F030506 13/12/2006 - - 19 - 
40571 AF071433 4 2007 AF071410 15/10/2007 AF071440 19/10/2007 5 17/10/2007 
46885 09CV0174 23 2009 09CV0172 26/08/2009 09CV0178 03/09/2009 9 30/08/2009 
 
 
 
 
 
 
 
 
 182 
 
Table 2.16. Trisomy 13 cases assigned sample dates using the immediately adjacent cases.  
 
        Previous Sample Following Sample     
Case Lab ID Lab Sample Year Lab ID Date Lab ID Date Accuracy (days) Sample Date Estimate 
30369 T0425969 22 2004 T0419608 21/09/2004 - - 102 - 
34294 P050470 30 2005 P050403 19/05/2005 P050482 10/06/2005 23 - 
34825 C050566 3 2005 C050565 08/11/2005 C050597 28/11/2005 21 - 
34827 AF051490 4 2005 AF051489 30/09/2005 AF051565 17/10/2005 18 - 
34845 T0525427 22 2005 T0525340 28/10/2005 T0526668 14/11/2005 18 - 
34858 A0503797 30 2005 A0503591 04/08/2005 A0503814 23/08/2005 20 - 
35482 A0505159 30 2005 A0505010 18/11/2005 A0505203 05/12/2005 19 - 
36221 P060015 30 2006 - - P060036 09/01/2006 9 05/01/2006 
37254 C060959 30 2006 C060931 13/04/2006 C061000 21/04/2006 9 17/04/2006 
38188 P060702 30 2006 P060623 06/07/2006 P060728 03/08/2006 29 - 
38192 P061057 30 2006 P061055 15/11/2006 P061059 16/11/2006 2 15/11/2006 
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Appendix 2. R Code for Temporal Scanning Program 
 
begTime<- Sys.time() 
 
data=read.csv("T18K.csv", header = TRUE, sep = ",", quote="\"", dec=".", fill=TRUE) 
 
sample = sum(data[,2]) 
 
days=2557 # 7 years from Jan 01 2004 to Dec 31 2010, including 2 leap years. 
sdays=nrow(data) 
min=2 # Sets the minimum cluster size. 
div=5 # Sets the maximum cluster size as a division of the total number of cases. 
 
N=sample 
remain=0 
counter=1 
 
case<- array(0, dim=sample) 
cases<- array(0, dim=sample) 
results<- matrix(0, nrow=sample, ncol=3) 
likely<- matrix(0, nrow=10, ncol=5) 
 
dminhold = 0 
 
dmin<- matrix(1, nrow=sample, ncol=2) 
 
for(i in 1:sdays){ 
 
repeat{ 
case[counter]=data[i,1] 
 
data[i,2]=data[i,2]-1 
 
counter=counter+1 
 
if(data[i,2]==0) break 
 
} 
 
} 
 
for(i in 1:sample){ 
 
cases[i]=case[i]/days 
 
} 
 
for(j in 2:sample){ 
 
for(i in 1:sample){ 
 
if(i+j<=(sample+1)) dminhold=(cases[i+j-1]-cases[i]) 
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if(dminhold<dmin[j,1]) dmin[j,2]=i 
 
if(dminhold<dmin[j,1]) dmin[j,1]=dminhold 
 
} 
 
} 
 
for(j in min:(sample/div)){ 
 
results[j,1]=((j/N)^j)*(((N-j)/N)^(N-j))*((1/dmin[j,1])^j)*((1/(1-dmin[j,1]))^(N-j)) 
 
results[j,2]=dmin[j,2] 
 
results[j,3]=j 
 
if(results[j,1]>(5e+100)) results[j,1]=0 
 
if(results[j,1]>likely[10,1]) likely[10,2]=results[j,2] 
 
if(results[j,1]>likely[10,1]) likely[10,3]=results[j,3] 
 
if(results[j,1]>likely[10,1]) likely[10,4]=case[likely[10,2]] 
 
if(results[j,1]>likely[10,1]) likely[10,5]=case[likely[10,2]+likely[10,3]-1] 
 
if(results[j,1]>likely[10,1]) likely[10,1]=results[j,1] 
 
likely<- likely[order(likely[,1]),,drop=FALSE] 
 
likely<- likely[rev(order(likely[,1])),] 
 
} 
 
likely # Returns a table of the 10 strongest clusters. 
 
##### Calculates P-Value using Monte Carlo Simulation 
 
caseno = sample # number of cases. 
repeats = 999 # Number of repeats. 
 
cas<- array(0, dim=caseno) 
result<- matrix(0, nrow=caseno, ncol=3) 
output<- matrix(0, nrow=repeats, ncol=3) 
output2 <- array(0, dim=repeats) 
 
N=caseno 
 
dminvalue=0 
 
set.seed(37587) # Seed values are entered "at random" by the user.  
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for(k in 1:10){ 
 
output[k,1]=likely[k,1] 
 
output[k,2]=k 
 
} 
 
for(k in 11:repeats){ 
 
cas<- array(0, dim=caseno) 
 
for(i in 1:caseno){ 
 
cas[i]=as.integer(runif(1,1,days)) 
 
cas[i]=cas[i]/days 
 
} 
 
cas=cas[order(cas)] 
 
holding=0 
 
dmin<- matrix(1, nrow=caseno, ncol=2) 
 
for(j in 2:caseno){ 
 
for(i in 1:caseno){ 
 
if(i+j<=(caseno+1)) dminhold=(cas[i+j-1]-cas[i]) 
 
if(dminhold<dmin[j,1]) dmin[j,2]=i 
 
if(dminhold<dmin[j,1]) dmin[j,1]=dminhold 
 
} 
 
} 
 
for(j in min:(caseno/div)){ 
 
result[j,1]=((j/N)^j)*(((N-j)/N)^(N-j))*((1/dmin[j,1])^j)*((1/(1-dmin[j,1]))^(N-j)) 
 
result[j,2]=dmin[j,2] 
 
result[j,3]=j 
 
if(result[j,1]>(5e+100)) result[j,1]=0 
 
if(result[j,1]>holding) holding=result[j,1] 
 
} 
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output[k,1]=holding 
 
} 
 
output<- output[order(output[,1]),,drop=FALSE] 
 
for(i in 1:repeats){ 
 
output2[i]=output[i,1] 
output[i,3]=i 
 
} 
 
output[order(output[,2]),,drop=FALSE] 
 
likely 
 
sample 
 
runTime<- Sys.time()-begTime 
 
runtime 
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Appendix 3. R Code for Spatial Scanning Program 
 
Appendix 3.1. Identifying Cluster Locations 
 
begTime<- Sys.time() 
 
data=read.csv("04T13mod.csv", header = TRUE, sep = ",", quote="\"", dec=".", fill=TRUE) 
pcts = nrow(data) 
 
diameter = 10 # Maximum quadrat size of the circle (this value is actually the radius) 
population= sum(data[,4]) # Total population. 
cases= sum(data[,3]) # Number of total population who are also cases. 
noncases=population-cases 
set.seed(1) # Sets seed for the random number generator. 
results<- matrix(0, nrow=(pcts*diameter), ncol=6) 
counter=1 
cluster<- array(0, dim=7) 
holding=-1000000 
pctclust<- array(0 ,dim=50) 
 
likely<- matrix(-1000000, nrow=10, ncol=7) 
 
xhold=0 
yhold=0 
dist=0 
 
casin=0 
nonin=0 
totin=0 
 
outcome=0 
 
lc=log(cases) 
lp=log(population) 
lzero=log(cases)*cases   +   log(population-cases)*(population-cases)   -   
log(population)*population 
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for(g in 1:pcts){ # Scans through different PCT locations. 
 
i=data[g,5] 
j=data[g,6] 
 
for(k in 1:diameter){ # Scans through different diameter sizes for sample circles. 
 
for(l in 1:pcts){ # Uses Pythagoras' theorem to determine how far each individual is from the 
centre of the sample circle. 
 
xhold=data[l,5]-i 
yhold=data[l,6]-j  
dist=yhold^2+xhold^2 
 
if(dist<k^2) totin=totin+data[l,4] # Adds up how many of the population fall within the 
boundaries of the sample circle. 
if(dist<k^2) casin=casin+data[l,3] # Adds up how many cases fall within the boundaries of the 
sample circle. 
 
} 
 
nonin=totin-casin 
 
results[counter,1]=i 
results[counter,2]=j 
results[counter,3]=k 
results[counter,4]=casin 
results[counter,5]=nonin 
 
lcas=log(casin) 
ltot=log(totin) 
 
if(nonin==0) outcome=lzero # Sets the outcome statistic to Lzero if there are no non-cases 
within the sample circle. 
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else if((casin/nonin)<((cases-casin)/(population-totin))) outcome=lzero # Sets the outcome 
statistic to Lzero if the ratio of cases to non-cases is greater outside the sample circle than 
within it. 
 
else outcome= (lcas-ltot)*casin  +  (log(totin-casin) - ltot) * (totin-casin)  +  (log(cases-casin) - 
log(population-totin)) * (cases-casin)  +  (log(population-totin-(cases-casin)) - log (population-
totin)) * (population-totin-(cases-casin))                                      
# Works out Lz for all zones where the case:non-case ratio is higher inside the sample circle 
than it is outside it.         
 
results[counter,6]=outcome 
 
if(outcome>likely[10,6]) likely[10,1]=results[counter,1] 
if(outcome>likely[10,6]) likely[10,2]=results[counter,2] 
if(outcome>likely[10,6]) likely[10,3]=results[counter,3] 
if(outcome>likely[10,6]) likely[10,4]=results[counter,4] 
if(outcome>likely[10,6]) likely[10,5]=results[counter,5] 
if(outcome>likely[10,6]) likely[10,6]=results[counter,6] # If the current outcome statistic is 
greater than the current greatest outcome this saves all information about that cluster to a 
separate array. 
 
likely<- likely[order(likely[,6]),,drop=FALSE] 
 
likely<- likely[rev(order(likely[,6])),] 
 
if(outcome>holding) holding=outcome 
 
counter=counter+1 
 
casin=0 
nonin=0 
totin=0 
outcome=0 # Resets the counting variables. 
 
} 
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} 
 
for(i in 1:10){ 
 
lambda=likely[i,6]-lzero # Works out lambda by dividing the largest value of Lz by Lzero. 
 
likely[i,7]=exp(lambda) 
 
likely[i,1] = (likely[i,1] / 10) + 49 
 
likely[i,2] = (likely[i,2] / 10) - 6 
 
} 
 
likely # Y Coordinate, X Coordinate, Radius, Number of Cases in Circle, Number of Noncases in 
Circle, Log of the Scan Statistic, Scan Statistic 
 
cases 
 
runTime<- Sys.time()-begTime 
 
runtime 
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Appendix 3.2.Calculating P-Values 
 
begTime<- Sys.time() 
 
data=read.csv("testrc3c.csv", header = TRUE, sep = ",", quote="\"", dec=".", fill=TRUE) # Read 
in data file containing cases and population figures aggregated by PCT. 
pcts = nrow(data) 
 
test=1324.97 # Scan Statistic to calculate p-value for. 
 
diameter = 10 # Maximum quadrat size of the circle (this value is actually the radius) 
population= sum(data[,4]) # Total population. 
cases= sum(data[,3]) # Number of total population who are also cases. 
noncases=population-cases 
set.seed(1) # Sets seed for the random number generator. 
 
repeats=999 # Number of repeats to perform. 
monte<- matrix(0, nrow=7, ncol=repeats) 
carlo<- array(0, dim=repeats+1) 
casecheck<- array(0, dim=repeats) 
 
 
for(a in 1:repeats){ 
 
 
pctclust<- array(0 ,dim=50) 
counter=1 
results<- matrix(0, nrow=(pcts*diameter), ncol=6) 
cluster<- array(0, dim=7) 
 
 
datagen<- matrix(0, nrow=pcts, ncol=2) 
 
holding=0 
 
for(h in 1:pcts){ 
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datagen[h,1]=holding+data[h,4] 
 
holding=datagen[h,1] 
 
} 
 
for(h in 1:cases){ 
case<- sample(1:population, 1) 
if(case<=datagen[1,1]) datagen[1,2]=datagen[1,2]+1 
for(i in 2:pcts){ 
if(datagen[i-1,1]<case && case<=datagen[i,1]) datagen[i,2]=datagen[i,2]+1 
} 
} 
for(i in 1:pcts){ 
data[i,3]=datagen[i,2] 
} 
holding=-1000000 
xhold=0 
yhold=0 
dist=0 
casin=0 
nonin=0 
totin=0 
outcome=0 
lc=log(cases) 
lp=log(population) 
lzero=log(cases)*cases   +   log(population-cases)*(population-cases)   -   
log(population)*population 
for(g in 1:pcts){ # Scans through different PCT locations. 
i=data[g,5] 
j=data[g,6] 
 
for(k in 1:diameter){ # Scans through different diameter sizes for sample circles. 
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for(l in 1:pcts){ # Uses Pythagoras' theorem to determine how far each individual is from the 
centre of the sample circle. 
 
xhold=data[l,5]-i 
yhold=data[l,6]-j  
dist=yhold^2+xhold^2 
 
if(dist<k^2) totin=totin+data[l,4] # Adds up how many of the population fall within the 
boundaries of the sample circle. 
if(dist<k^2) casin=casin+data[l,3] # Adds up how many cases fall within the boundaries of the 
sample circle. 
 
} 
 
nonin=totin-casin 
 
results[counter,1]=i 
results[counter,2]=j 
results[counter,3]=k 
results[counter,4]=casin 
results[counter,5]=nonin 
 
lcas=log(casin) 
ltot=log(totin) 
 
if(nonin==0) outcome=lzero # Sets the outcome statistic to Lzero if there are no non-cases 
within the sample circle. 
 
else if((casin/nonin)<((cases-casin)/(population-totin))) outcome=lzero # Sets the outcome 
statistic to Lzero if the ratio of cases to non-cases is greater outside the sample circle than 
within it. 
 
else outcome= (lcas-ltot)*casin  +  (log(totin-casin) - ltot) * (totin-casin)  +  (log(cases-casin) - 
log(population-totin)) * (cases-casin)  +  (log(population-totin-(cases-casin)) - log (population-
totin)) * (population-totin-(cases-casin))                                      
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# Works out Lz for all zones where the case:non-case ratio is higher inside the sample circle 
than it is outside it.         
 
results[counter,6]=outcome 
 
if(outcome>holding) cluster[1]=results[counter,1] 
if(outcome>holding) cluster[2]=results[counter,2] 
if(outcome>holding) cluster[3]=results[counter,3] 
if(outcome>holding) cluster[4]=results[counter,4] 
if(outcome>holding) cluster[5]=results[counter,5] 
if(outcome>holding) cluster[6]=results[counter,6] # If the current outcome statistic is greater 
than the current greatest outcome this saves all information about that cluster to a separate 
array. 
 
if(outcome>holding) holding=outcome 
counter=counter+1 
 
casin=0 
nonin=0 
totin=0 
outcome=0 # Resets the counting variables. 
 
} 
} 
 
lambda=cluster[6]-lzero # Works out lambda by dividing the largest value of Lz by Lzero. 
cluster[7]=exp(lambda) 
for(i in 1:7){ 
monte[i,a] = cluster[i] 
 
} 
 
carlo[a]=cluster[7] 
 
casecheck[a]=cases 
} 
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carlo[repeats+1]=test 
carlo<- carlo[order(carlo),drop=FALSE] 
rank=1 
for(i in 1:(repeats)){ 
if(test>carlo[i]) rank=rank+1 
} 
 
rank 
runTime<- Sys.time()-begTime 
runTime 
